[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 239
1. Bauer S, Maier SK, Neyses L, Maass AH: Optimization of gene transfer into neonatal rat cardiomyocytes and unmasking of cytomegalovirus promoter silencing. DNA Cell Biol; 2005 Jun;24(6):381-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adenoviridae / genetics. Animals. Animals, Newborn. Avian Sarcoma Viruses / genetics. Cells, Cultured. Colforsin / pharmacology. DNA-Binding Proteins / genetics. Gene Expression / drug effects. Luciferases / genetics. Luciferases / metabolism. MEF2 Transcription Factors. Myogenic Regulatory Factors. Plasmids / chemistry. Plasmids / genetics. Plasmids / isolation & purification. Polylysine / chemistry. Rats. Recombinant Fusion Proteins / genetics. Recombinant Fusion Proteins / metabolism. Tetradecanoylphorbol Acetate / pharmacology. Transcription Factors / genetics. beta-Galactosidase / genetics. beta-Galactosidase / metabolism

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. 12-O-TETRADECANOYLPHORBOL-13-ACETATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15941390.001).
  • [ISSN] 1044-5498
  • [Journal-full-title] DNA and cell biology
  • [ISO-abbreviation] DNA Cell Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / MEF2 Transcription Factors; 0 / Myogenic Regulatory Factors; 0 / Recombinant Fusion Proteins; 0 / Transcription Factors; 1F7A44V6OU / Colforsin; 25104-18-1 / Polylysine; EC 1.13.12.- / Luciferases; EC 3.2.1.23 / beta-Galactosidase; NI40JAQ945 / Tetradecanoylphorbol Acetate
  •  go-up   go-down


2. Svoboda J: Foundations in cancer research. The turns of life and science. Adv Cancer Res; 2008;99:1-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It covers the period of the rise of Hasek's immunologic school and application of immunologic tolerance to Rous sarcoma virus (RSV) heterotransmission.
  • Mammalian cells transformed by the reverse transcript of v-src mRNA were characterized, and the resulting provirus was shown to be highly oncogenic for chickens and to carry tumor-specific transplantation antigen.
  • Other areas covering epigenetic reversion of RSV-transformed cells and long-term persistence of chicken leucosis viruses in foreign avian species are discussed.
  • [MeSH-minor] Animals. Cell Transformation, Viral. Czechoslovakia. Genes, src. History, 20th Century. Oncogenic Viruses / physiology. Rous sarcoma virus / physiology. Virus Integration

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18037405.001).
  • [ISSN] 0065-230X
  • [Journal-full-title] Advances in cancer research
  • [ISO-abbreviation] Adv. Cancer Res.
  • [Language] eng
  • [Publication-type] Historical Article; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


3. Park SH, Kim JN, Park TS, Lee SD, Kim TH, Han BK, Han JY: CpG methylation modulates tissue-specific expression of a transgene in chickens. Theriogenology; 2010 Sep 15;74(5):805-16.e1
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The gPGC population was enriched (magnetic-activated cell sorting technique) and then they were transduced with a lentiviral vector expressing enhanced green fluorescent protein (eGFP), under the control of the Rous sarcoma virus (RSV) promoter.
  • In conclusion, the PGC-mediated approach used may be an efficient tool for avian transgenesis, and transgenic chickens could provide a useful model for investigating regulation of gene expression.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20570335.001).
  • [ISSN] 1879-3231
  • [Journal-full-title] Theriogenology
  • [ISO-abbreviation] Theriogenology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 147336-22-9 / Green Fluorescent Proteins
  •  go-up   go-down


Advertisement
4. Bera S, Vora AC, Chiu R, Heyduk T, Grandgenett DP: Synaptic complex formation of two retrovirus DNA attachment sites by integrase: a fluorescence energy transfer study. Biochemistry; 2005 Nov 22;44(46):15106-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Avian Sarcoma Viruses / enzymology. Base Sequence. Fluorescence Resonance Energy Transfer. Molecular Sequence Data. Oligodeoxyribonucleotides / metabolism

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16285714.001).
  • [ISSN] 0006-2960
  • [Journal-full-title] Biochemistry
  • [ISO-abbreviation] Biochemistry
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / AI31334; United States / NCI NIH HHS / CA / CA16312
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / Oligodeoxyribonucleotides; EC 2.7.7.- / Integrases
  •  go-up   go-down


5. Rai T, Caffrey M, Rong L: Identification of two residues within the LDL-A module of Tva that dictate the altered receptor specificity of mutant subgroup A avian sarcoma and leukosis viruses. J Virol; 2005 Dec;79(23):14962-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Identification of two residues within the LDL-A module of Tva that dictate the altered receptor specificity of mutant subgroup A avian sarcoma and leukosis viruses.
  • Avian sarcoma and leukosis virus subgroup A (ASLV-A) entry is mediated by interactions between the viral glycoprotein EnvA and its cognate receptor Tva.

  • SciCrunch. OMIA - Online Mendelian Inheritance in Animals: Data: Gene Expression .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Virology. 2000 Aug 1;273(2):364-73 [10915607.001]
  • [Cites] Biochemistry. 2000 Mar 14;39(10):2564-71 [10704205.001]
  • [Cites] J Virol. 2001 Jan;75(2):726-37 [11134286.001]
  • [Cites] J Virol. 2001 Mar;75(5):2051-8 [11160709.001]
  • [Cites] Biochemistry. 2001 Dec 18;40(50):15127-34 [11735395.001]
  • [Cites] FEBS Lett. 2001 Dec 7;509(2):161-8 [11768384.001]
  • [Cites] J Virol. 2002 Mar;76(6):2848-56 [11861852.001]
  • [Cites] Protein Sci. 2002 Nov;11(11):2596-605 [12381843.001]
  • [Cites] J Virol. 2003 Jun;77(12):6709-19 [12767991.001]
  • [Cites] J Virol. 1999 Dec;73(12):10051-60 [10559319.001]
  • [Cites] J Biol Chem. 2000 Jan 14;275(2):1089-94 [10625650.001]
  • [Cites] J Biol Chem. 2000 Feb 4;275(5):3264-9 [10652313.001]
  • [Cites] J Virol. 2003 Jul;77(13):7517-26 [12805452.001]
  • [Cites] J Virol. 2003 Oct;77(19):10504-14 [12970435.001]
  • [Cites] J Virol. 2004 Jan;78(2):683-91 [14694099.001]
  • [Cites] J Biol Chem. 2004 Apr 16;279(16):16629-37 [14749324.001]
  • [Cites] Science. 1986 Apr 4;232(4746):34-47 [3513311.001]
  • [Cites] J Virol. 1993 Apr;67(4):1811-6 [8383211.001]
  • [Cites] Cell. 1993 Sep 24;74(6):1043-51 [8402880.001]
  • [Cites] J Virol. 1993 Nov;67(11):6889-92 [7692089.001]
  • [Cites] J Virol. 1994 Apr;68(4):2760-4 [8139053.001]
  • [Cites] J Virol. 1995 Jul;69(7):4261-6 [7769686.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6334-8 [7603991.001]
  • [Cites] J Virol. 1995 Aug;69(8):4847-53 [7609052.001]
  • [Cites] J Virol. 1996 Nov;70(11):7510-6 [8892869.001]
  • [Cites] Nature. 1997 Aug 14;388(6643):691-3 [9262405.001]
  • [Cites] J Virol. 1998 Mar;72(3):2505-8 [9499114.001]
  • [Cites] J Virol. 1998 Jun;72(6):4552-9 [9573218.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8467-72 [9671701.001]
  • [Cites] J Virol. 1999 Apr;73(4):3054-61 [10074155.001]
  • [Cites] Biochemistry. 1995 Nov 7;34(44):14474-81 [7578052.001]
  • [Cites] Biochemistry. 2000 Oct 31;39(43):13127-35 [11052664.001]
  • (PMID = 16282495.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA092459; United States / NCI NIH HHS / CA / CA 092459
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Amino Acids; 0 / Avian Proteins; 0 / Receptors, Virus; 0 / Tva receptor
  • [Other-IDs] NLM/ PMC1287562
  •  go-up   go-down


6. Grandgenett DP: Symmetrical recognition of cellular DNA target sequences during retroviral integration. Proc Natl Acad Sci U S A; 2005 Apr 26;102(17):5903-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Animals. DNA / genetics. Genome, Human. Genome, Viral. HIV-1 / genetics. Humans. Leukemia Virus, Murine / genetics. Models, Genetic. Models, Molecular. Nucleic Acid Conformation. Sarcoma, Avian / genetics. Transcription, Genetic

  • COS Scholar Universe. author profiles.
  • HIV InSite. treatment guidelines - Human Herpesvirus-8 .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2003 May 13;100(10):5891-5 [12730380.001]
  • [Cites] Cell. 2002 Aug 23;110(4):521-9 [12202041.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 May 13;100(10):5586-8 [12732725.001]
  • [Cites] Science. 2003 Jun 13;300(5626):1749-51 [12805549.001]
  • [Cites] Science. 2003 Oct 17;302(5644):415-9 [14564000.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11233-8 [15277684.001]
  • [Cites] PLoS Biol. 2004 Aug;2(8):E234 [15314653.001]
  • [Cites] J Virol. 2004 Nov;78(21):11656-63 [15479807.001]
  • [Cites] Cell. 1987 May 8;49(3):347-56 [3032450.001]
  • [Cites] J Virol. 1994 Jul;68(7):4314-21 [8207806.001]
  • [Cites] Virology. 1997 May 12;231(2):210-7 [9168883.001]
  • [Cites] J Virol. 1998 Mar;72(3):1744-53 [9499023.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1436-41 [15659548.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1275-6 [15677323.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6103-7 [15802467.001]
  • [Cites] J Biol Chem. 2001 Dec 7;276(49):45848-55 [11585830.001]
  • [Cites] EMBO J. 2001 Dec 17;20(24):7333-43 [11743009.001]
  • [Cites] Curr Top Microbiol Immunol. 2002;261:165-77 [11892246.001]
  • [CommentOn] Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6103-7 [15802467.001]
  • (PMID = 15840713.001).
  • [ISSN] 0027-8424
  • [Journal-full-title] Proceedings of the National Academy of Sciences of the United States of America
  • [ISO-abbreviation] Proc. Natl. Acad. Sci. U.S.A.
  • [Language] eng
  • [Publication-type] Comment; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 9007-49-2 / DNA
  • [Other-IDs] NLM/ PMC1087955
  •  go-up   go-down


7. Maeda N, Fan H, Yoshikai Y: Oncogenesis by retroviruses: old and new paradigms. Rev Med Virol; 2008 Nov-Dec;18(6):387-405
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Studies of avian Rous sarcoma virus (RSV) led to the discovery of the viral oncogene src, and this was followed by the discovery of other viral oncogenes in retroviruses of mammals including rodents, cats, monkeys and so forth.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18729235.001).
  • [ISSN] 1052-9276
  • [Journal-full-title] Reviews in medical virology
  • [ISO-abbreviation] Rev. Med. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Gene Products, env
  • [Number-of-references] 157
  •  go-up   go-down


8. Vogt PK, Bader AG, Kang S: Phosphoinositide 3-kinase: from viral oncoprotein to drug target. Virology; 2006 Jan 5;344(1):131-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Animals. Avian Sarcoma Viruses / enzymology. Cell Transformation, Neoplastic / metabolism. DNA-Binding Proteins / pharmacology. Humans. Isoenzymes / antagonists & inhibitors. Isoenzymes / genetics. Isoenzymes / physiology. Mutation. Nuclear Proteins. Oncogene Protein v-akt / metabolism. Oncogene Proteins / metabolism. Protein Kinases / metabolism. TOR Serine-Threonine Kinases. Y-Box-Binding Protein 1

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. SIROLIMUS .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16364744.001).
  • [ISSN] 0042-6822
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / Isoenzymes; 0 / Nuclear Proteins; 0 / Oncogene Proteins; 0 / Y-Box-Binding Protein 1; 0 / YBX1 protein, human; EC 2.7.- / Protein Kinases; EC 2.7.1.- / Phosphatidylinositol 3-Kinases; EC 2.7.1.1 / MTOR protein, human; EC 2.7.1.1 / TOR Serine-Threonine Kinases; EC 2.7.11.1 / Oncogene Protein v-akt; W36ZG6FT64 / Sirolimus
  • [Number-of-references] 103
  •  go-up   go-down


9. Scheifele LZ, Kenney SP, Cairns TM, Craven RC, Parent LJ: Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology. J Virol; 2007 Oct;81(19):10718-28
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology.
  • Nucleocytoplasmic shuttling of the Rous sarcoma virus (RSV) Gag polyprotein is an integral step in virus particle assembly.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Jan;74(1):16-23 [10590086.001]
  • [Cites] J Exp Med. 1960 Nov 1;112:945-52 [13693270.001]
  • [Cites] Nature. 1999 Dec 9;402(6762):681-5 [10604476.001]
  • [Cites] EMBO J. 2000 Jan 4;19(1):103-13 [10619849.001]
  • [Cites] J Virol. 2000 Aug;74(16):7250-60 [10906179.001]
  • [Cites] J Virol. 2000 Nov;74(21):10260-8 [11024160.001]
  • [Cites] J Virol. 2001 Jan;75(1):260-8 [11119596.001]
  • [Cites] J Virol. 2001 Jul;75(13):6016-21 [11390603.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] J Virol. 2002 May;76(10):4679-87 [11967285.001]
  • [Cites] J Virol. 2002 Nov;76(22):11177-85 [12388677.001]
  • [Cites] Virology. 2002 Dec 5;304(1):89-96 [12490406.001]
  • [Cites] J Virol. 2003 Feb;77(3):1820-9 [12525616.001]
  • [Cites] J Gen Virol. 2003 Mar;84(Pt 3):517-27 [12604801.001]
  • [Cites] J Virol. 2003 Sep;77(17):9388-98 [12915554.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11678-83 [14504385.001]
  • [Cites] J Mol Biol. 2004 Jan 2;335(1):275-82 [14659756.001]
  • [Cites] J Virol. 2004 Feb;78(3):1411-20 [14722296.001]
  • [Cites] J Gen Virol. 2004 Jul;85(Pt 7):1885-93 [15218173.001]
  • [Cites] J Virol. 1990 Sep;64(9):4169-79 [2166812.001]
  • [Cites] J Virol. 1991 Jan;65(1):272-80 [1845888.001]
  • [Cites] Arch Virol. 1991;118(3-4):279-84 [2069508.001]
  • [Cites] AIDS. 1991 Jun;5(6):639-54 [1883539.001]
  • [Cites] J Virol. 1993 Mar;67(3):1350-6 [8437220.001]
  • [Cites] J Virol. 1993 Jul;67(7):3826-34 [7685400.001]
  • [Cites] J Virol. 1993 Oct;67(10):6246-52 [8396679.001]
  • [Cites] Nature. 1993 Oct 14;365(6447):666-9 [8105392.001]
  • [Cites] J Virol. 1995 Jul;69(7):4213-27 [7769681.001]
  • [Cites] J Virol. 1995 Oct;69(10):6430-8 [7666544.001]
  • [Cites] J Cell Sci. 1995 Sep;108 ( Pt 9):3039-50 [8537443.001]
  • [Cites] J Virol. 1996 Feb;70(2):1016-26 [8551559.001]
  • [Cites] J Exp Med. 1960 Mar 1;111:387-406 [13755924.001]
  • [Cites] J Virol. 2005 Jan;79(2):1262-70 [15613353.001]
  • [Cites] J Virol. 2005 Jul;79(14):8732-41 [15994767.001]
  • [Cites] J Mol Biol. 2006 Jan 6;355(1):157-68 [16289202.001]
  • [Cites] J Virol. 2006 Feb;80(3):1242-9 [16415001.001]
  • [Cites] Nature. 2006 Jan 26;439(7075):490-2 [16437116.001]
  • [Cites] J Virol. 2006 Feb;80(4):1798-806 [16439536.001]
  • [Cites] J Virol. 2006 Jun;80(11):5233-40 [16699003.001]
  • [Cites] J Virol. 2000 Jan;74(1):164-72 [10590103.001]
  • [Cites] Curr Top Microbiol Immunol. 1996;214:65-94 [8791725.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] Curr Biol. 1997 Oct 1;7(10):729-38 [9368755.001]
  • [Cites] J Virol. 1998 Jan;72(1):564-77 [9420260.001]
  • [Cites] Virology. 1998 Jan 5;240(1):127-37 [9448697.001]
  • [Cites] J Virol. 1998 Jun;72(6):4798-810 [9573245.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 May 12;95(10):5746-51 [9576955.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7299-304 [9636143.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Science. 1999 Jan 1;283(5398):80-3 [9872746.001]
  • [Cites] EMBO J. 2007 Apr 18;26(8):2218-26 [17396149.001]
  • (PMID = 17634229.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA076534; United States / NCI NIH HHS / CA / R01 CA100322; United States / NCI NIH HHS / CA / R01 CA76534
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / Nuclear Export Signals; 0 / RNA, Viral; 0 / Recombinant Fusion Proteins; 147336-22-9 / Green Fluorescent Proteins
  • [Other-IDs] NLM/ PMC2045444
  •  go-up   go-down


10. Van Hoeven NS, Miller AD: Use of different but overlapping determinants in a retrovirus receptor accounts for non-reciprocal interference between xenotropic and polytropic murine leukemia viruses. Retrovirology; 2005 Dec 15;2:76
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the case of avian sarcoma and leukosis virus types B, D, and E, the two receptors are distinct protein products of a single gene.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2001 Apr;75(8):3520-6 [11264341.001]
  • [Cites] J Virol. 2001 Jun;75(12):5584-92 [11356966.001]
  • [Cites] J Virol. 1999 Jan;73(1):495-500 [9847355.001]
  • [Cites] J Virol. 1998 Dec;72(12):10242-5 [9811768.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11617-22 [9326659.001]
  • [Cites] J Virol. 1997 Oct;71(10):7619-22 [9311843.001]
  • [Cites] J Virol. 1997 Jun;71(6):4531-5 [9151846.001]
  • [Cites] Cell. 1996 Nov 29;87(5):845-55 [8945512.001]
  • [Cites] J Virol. 1996 Aug;70(8):5564-71 [8764070.001]
  • [Cites] J Virol. 2005 Jan;79(1):87-94 [15596804.001]
  • [Cites] J Virol. 1999 Nov;73(11):9362-8 [10516044.001]
  • [Cites] Mol Membr Biol. 1999 Jan-Mar;16(1):3-9 [10332732.001]
  • [Cites] J Virol. 1999 Apr;73(4):3169-75 [10074169.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1385-90 [9990033.001]
  • [Cites] Nat Genet. 1999 Feb;21(2):216-9 [9988277.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):927-32 [9927670.001]
  • [Cites] J Virol. 2001 Jul;75(13):6007-15 [11390602.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 Apr;4(4):309-19 [12671653.001]
  • [Cites] J Mol Biol. 1967 Jun 14;26(2):365-9 [4291934.001]
  • [Cites] Science. 1970 Oct 16;170(3955):326-7 [4318971.001]
  • [Cites] Science. 1973 Dec 14;182(4117):1151-3 [4356281.001]
  • [Cites] Proc Natl Acad Sci U S A. 1977 Feb;74(2):789-92 [191826.001]
  • [Cites] J Virol. 1980 Jan;33(1):494-506 [6245246.001]
  • [Cites] J Virol. 1982 Jan;41(1):183-91 [6283112.001]
  • [Cites] J Virol. 1983 Oct;48(1):300-3 [6310150.001]
  • [Cites] Virology. 1985 Feb;141(1):119-29 [2983494.001]
  • [Cites] J Virol. 1985 Sep;55(3):690-5 [2991590.001]
  • [Cites] Mol Cell Biol. 1986 Aug;6(8):2895-902 [3785217.001]
  • [Cites] J Virol. 1990 Feb;64(2):757-66 [2153240.001]
  • [Cites] Biotechniques. 1989 Oct;7(9):980-2, 984-6, 989-90 [2631796.001]
  • [Cites] Virology. 1990 May;176(1):58-69 [1691887.001]
  • [Cites] J Virol. 1990 Dec;64(12):6176-83 [1700832.001]
  • [Cites] Cell Growth Differ. 1990 Mar;1(3):119-27 [2078500.001]
  • [Cites] J Virol. 1991 May;65(5):2220-4 [1850008.001]
  • [Cites] J Virol. 1992 Feb;66(2):1219-22 [1309898.001]
  • [Cites] J Virol. 1992 Mar;66(3):1468-75 [1310758.001]
  • [Cites] J Virol. 1993 Sep;67(9):5153-62 [8394443.001]
  • [Cites] J Virol. 1993 Nov;67(11):6733-6 [8411375.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):78-82 [8278411.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1168-72 [8302848.001]
  • [Cites] J Virol. 1994 Dec;68(12):8270-6 [7966619.001]
  • [Cites] J Virol. 1995 Apr;69(4):2401-5 [7884886.001]
  • [Cites] J Biol Chem. 1995 Oct 27;270(43):25435-44 [7592711.001]
  • [Cites] J Virol. 1995 Dec;69(12):7430-6 [7494248.001]
  • (PMID = 16354307.001).
  • [ISSN] 1742-4690
  • [Journal-full-title] Retrovirology
  • [ISO-abbreviation] Retrovirology
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / P30 DK047754; United States / NHLBI NIH HHS / HL / HL36444; United States / NHLBI NIH HHS / HL / P01 HL036444; United States / NHLBI NIH HHS / HL / HL54881; United States / NIDDK NIH HHS / DK / DK47754; United States / NHLBI NIH HHS / HL / P50 HL054881
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Gene Products, env; 0 / Receptors, G-Protein-Coupled; 0 / Receptors, Virus; 0 / Recombinant Fusion Proteins; 0 / xenotropic and polytropic retrovirus receptor
  • [Other-IDs] NLM/ PMC1325250
  •  go-up   go-down


11. LeBlanc JJ, Uddowla S, Abraham B, Clatterbuck S, Beemon KL: Tap and Dbp5, but not Gag, are involved in DR-mediated nuclear export of unspliced Rous sarcoma virus RNA. Virology; 2007 Jul 5;363(2):376-86
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tap and Dbp5, but not Gag, are involved in DR-mediated nuclear export of unspliced Rous sarcoma virus RNA.
  • While the unspliced RNA export pathways for HIV and Mason-Pfizer monkey virus are well characterized, that of Rous sarcoma virus (RSV) is not.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] RNA. 1999 Dec;5(12):1645-55 [10606274.001]
  • [Cites] J Virol. 1996 Jun;70(6):3834-43 [8648719.001]
  • [Cites] J Virol. 2000 Oct;74(20):9507-14 [11000220.001]
  • [Cites] Nature. 2000 Sep 21;407(6802):401-5 [11014198.001]
  • [Cites] Mol Cell. 2001 Apr;7(4):899-905 [11336712.001]
  • [Cites] EMBO J. 2001 Sep 3;20(17):4987-97 [11532962.001]
  • [Cites] Curr Biol. 2001 Oct 30;11(21):1716-21 [11696332.001]
  • [Cites] RNA. 2001 Dec;7(12):1768-80 [11780633.001]
  • [Cites] EMBO J. 2002 Mar 1;21(5):1177-87 [11867546.001]
  • [Cites] Mol Cell Biol. 1997 Jan;17(1):135-44 [8972193.001]
  • [Cites] EMBO J. 1997 Feb 17;16(4):807-16 [9049309.001]
  • [Cites] Cell. 1997 Sep 19;90(6):1051-60 [9323133.001]
  • [Cites] Curr Biol. 1997 Oct 1;7(10):767-75 [9368759.001]
  • [Cites] J Virol. 1997 Dec;71(12):9150-6 [9371572.001]
  • [Cites] EMBO J. 1997 Dec 15;16(24):7500-10 [9405378.001]
  • [Cites] J Virol. 1998 Apr;72(4):3407-11 [9525671.001]
  • [Cites] EMBO J. 1998 May 1;17(9):2663-76 [9564048.001]
  • [Cites] Mol Cell. 1998 Apr;1(5):649-59 [9660949.001]
  • [Cites] Virology. 1998 Jul 20;247(1):86-96 [9683574.001]
  • [Cites] Mol Cell Biol. 1998 Nov;18(11):6826-38 [9774696.001]
  • [Cites] J Biol Chem. 1998 Dec 11;273(50):33414-22 [9837918.001]
  • [Cites] EMBO J. 1999 Apr 1;18(7):1953-65 [10202158.001]
  • [Cites] Genes Dev. 1999 May 1;13(9):1126-39 [10323864.001]
  • [Cites] EMBO J. 1999 Aug 2;18(15):4332-47 [10428971.001]
  • [Cites] J Virol. 1999 Sep;73(9):7421-9 [10438832.001]
  • [Cites] EMBO J. 1999 Oct 15;18(20):5778-88 [10523319.001]
  • [Cites] Mol Cell. 2005 Nov 23;20(4):645-51 [16307927.001]
  • [Cites] J Mol Biol. 2005 Dec 16;354(5):1118-28 [16289115.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] Cell. 2002 Feb 22;108(4):523-31 [11909523.001]
  • [Cites] J Virol. 2002 Dec;76(24):12877-89 [12438613.001]
  • [Cites] Mol Cell. 2003 Mar;11(3):837-43 [12667464.001]
  • [Cites] Genes Dev. 2003 Dec 15;17(24):3075-86 [14701875.001]
  • [Cites] Mol Cell. 2004 Jan 30;13(2):201-12 [14759366.001]
  • [Cites] Exp Cell Res. 2004 May 15;296(1):12-20 [15120988.001]
  • [Cites] Curr Opin Cell Biol. 2004 Jun;16(3):285-92 [15145353.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9666-70 [15210956.001]
  • [Cites] EMBO J. 2004 Jul 7;23(13):2632-40 [15201866.001]
  • [Cites] J Biol Chem. 2004 Jul 23;279(30):31745-9 [15184380.001]
  • [Cites] Cell. 2004 Oct 29;119(3):381-92 [15507209.001]
  • [Cites] Mol Cell Biol. 1982 Sep;2(9):1044-51 [6960240.001]
  • [Cites] J Virol. 1983 Dec;48(3):667-75 [6313966.001]
  • [Cites] Nature. 1989 Mar 16;338(6212):254-7 [2784194.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Oct;87(19):7787-91 [2217212.001]
  • [Cites] Methods Cell Biol. 1991;35:73-99 [1723481.001]
  • [Cites] Mol Cell Biol. 1992 May;12(5):2331-8 [1314954.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1256-60 [8108397.001]
  • [Cites] J Virol. 1994 Dec;68(12):7944-52 [7966585.001]
  • [Cites] RNA. 2000 Apr;6(4):638-50 [10786854.001]
  • (PMID = 17328934.001).
  • [ISSN] 0042-6822
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / T32 GM007231; United States / NCI NIH HHS / CA / R01 CA048746-19; United States / NCI NIH HHS / CA / CA048746-19; United States / NCI NIH HHS / CA / R01 CA048746-18; United States / NCI NIH HHS / CA / CA048746-17; United States / NCI NIH HHS / CA / CA048746-18; United States / NCI NIH HHS / CA / R01 CA048746-17; United States / NIGMS NIH HHS / GM / T32GM07231; United States / NCI NIH HHS / CA / R01 CA048746; United States / NCI NIH HHS / CA / R01 CA48746
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / Nucleocytoplasmic Transport Proteins; 0 / RNA, Viral; 0 / Transcription Factors
  • [Other-IDs] NLM/ NIHMS25189; NLM/ PMC2564995
  •  go-up   go-down


12. Dilley KA, Gregory D, Johnson MC, Vogt VM: An LYPSL late domain in the gag protein contributes to the efficient release and replication of Rous sarcoma virus. J Virol; 2010 Jul;84(13):6276-87
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An LYPSL late domain in the gag protein contributes to the efficient release and replication of Rous sarcoma virus.
  • The major late domain of Rous sarcoma virus (RSV) has been mapped to a PPPY motif in Gag that binds members of the Nedd4 family of ubiquitin ligases.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2009 Jul;83(14):7185-93 [19403673.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10541-6 [18641129.001]
  • [Cites] Virology. 2009 Sep 1;391(2):284-92 [19596386.001]
  • [Cites] J Cell Biol. 2005 Jan 3;168(1):89-101 [15623582.001]
  • [Cites] J Virol. 2005 Mar;79(5):2988-97 [15709019.001]
  • [Cites] Dev Cell. 2005 Jun;8(6):937-47 [15935782.001]
  • [Cites] J Virol. 2005 Jul;79(14):9038-45 [15994797.001]
  • [Cites] Traffic. 2005 Oct;6(10):880-94 [16138902.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15453-8 [16230638.001]
  • [Cites] Virology. 2006 Jan 5;344(1):55-63 [16364736.001]
  • [Cites] Virology. 2006 Mar 30;347(1):226-33 [16406458.001]
  • [Cites] J Virol. 2006 Oct;80(19):9634-40 [16973567.001]
  • [Cites] Retrovirology. 2006;3:77 [17083721.001]
  • [Cites] J Biol Chem. 2007 Feb 9;282(6):3847-55 [17158451.001]
  • [Cites] Nat Struct Mol Biol. 2007 Mar;14(3):194-9 [17277784.001]
  • [Cites] Cell. 2007 Mar 9;128(5):841-52 [17350572.001]
  • [Cites] J Virol. 2008 Oct;82(19):9770-5 [18667521.001]
  • [Cites] Biochem Soc Trans. 2009 Feb;37(Pt 1):181-4 [19143627.001]
  • [Cites] PLoS Pathog. 2009 Mar;5(3):e1000339 [19282983.001]
  • [Cites] J Virol. 2000 Aug;74(16):7250-60 [10906179.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13871-6 [11095724.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7724-9 [11427703.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11199-204 [11562473.001]
  • [Cites] Cell. 2001 Oct 5;107(1):55-65 [11595185.001]
  • [Cites] Nat Med. 2001 Dec;7(12):1313-9 [11726971.001]
  • [Cites] J Virol. 2002 Jan;76(1):105-17 [11739676.001]
  • [Cites] J Virol. 2002 Feb;76(4):1569-77 [11799151.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):955-60 [11805336.001]
  • [Cites] Virology. 2002 Oct 25;302(2):405-12 [12441084.001]
  • [Cites] J Virol. 2003 Feb;77(3):1812-9 [12525615.001]
  • [Cites] J Virol. 2003 Sep;77(17):9474-85 [12915562.001]
  • [Cites] Cell. 2003 Sep 19;114(6):689-99 [14505569.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12414-9 [14519844.001]
  • [Cites] J Virol. 2003 Nov;77(22):11882-95 [14581525.001]
  • [Cites] J Virol. 2003 Nov;77(22):12373-7 [14581576.001]
  • [Cites] J Virol. 2004 Feb;78(3):1503-12 [14722305.001]
  • [Cites] Nat Rev Mol Cell Biol. 2004 Apr;5(4):317-23 [15071556.001]
  • [Cites] J Virol. 2004 Jun;78(11):5554-63 [15140952.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9 [2014240.001]
  • [Cites] Virology. 1991 Nov;185(1):99-108 [1656608.001]
  • [Cites] J Virol. 2007 Jun;81(12):6614-22 [17428861.001]
  • [Cites] Science. 2007 Jun 29;316(5833):1908-12 [17556548.001]
  • [Cites] Nat Rev Microbiol. 2007 Dec;5(12):912-6 [17982468.001]
  • [Cites] Nat Struct Mol Biol. 2008 Jan;15(1):43-9 [18066081.001]
  • [Cites] J Virol. 2008 Feb;82(3):1389-98 [18032513.001]
  • [Cites] J Virol. 1992 Jan;66(1):6-11 [1309264.001]
  • [Cites] J Virol. 1994 Oct;68(10):6605-18 [8083996.001]
  • [Cites] J Virol. 1995 Sep;69(9):5455-60 [7636991.001]
  • [Cites] J Virol. 1996 Aug;70(8):5695-700 [8764091.001]
  • [Cites] J Virol. 1997 Sep;71(9):6541-6 [9261374.001]
  • [Cites] Methods Cell Biol. 1997;52:179-214 [9379950.001]
  • [Cites] J Virol. 2004 Dec;78(24):13943-53 [15564502.001]
  • [Cites] Virus Res. 2004 Dec;106(2):87-102 [15567490.001]
  • [Cites] J Virol. 2008 Feb;82(3):1610-4 [18057258.001]
  • [Cites] Virology. 2008 Jun 5;375(2):637-45 [18355887.001]
  • [Cites] Retrovirology. 2008;5:39 [18477395.001]
  • [Cites] Nature. 2008 Jul 10;454(7201):236-40 [18500329.001]
  • [Cites] PLoS Biol. 2009 Jul;7(7):e1000163 [19636361.001]
  • (PMID = 20392845.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / AI073098; United States / NIAID NIH HHS / AI / R01 AI073098-03; United States / NCI NIH HHS / CA / R01 CA020081; United States / NIAID NIH HHS / AI / R01 AI073098; United States / NCI NIH HHS / CA / CA20081
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Calcium-Binding Proteins; 0 / Cell Cycle Proteins; 0 / Endosomal Sorting Complexes Required for Transport; 0 / Gene Products, gag; 0 / PDCD6IP protein, human
  • [Other-IDs] NLM/ PMC2903267
  •  go-up   go-down


13. Liu Y, Okada T, Nomoto T, Ke X, Kume A, Ozawa K, Xiao S: Promoter effects of adeno-associated viral vector for transgene expression in the cochlea in vivo. Exp Mol Med; 2007 Apr 30;39(2):170-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aims of this study were to evaluate the expression of enhanced green fluorescent protein (EGFP) driven by 6 different promoters, including cytomegalovirus IE enhancer and chicken beta-actin promoter (CAG), cytomegalovirus promoter (CMV), neuron-specific enolase promoter (NSE), myosin 7A promoter (Myo), elongation factor 1alpha promoter (EF-1alpha), and Rous sarcoma virus promoter (RSV), and assess the dose response of CAG promoter to transgene expression in the cochlea.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17464178.001).
  • [ISSN] 1226-3613
  • [Journal-full-title] Experimental & molecular medicine
  • [ISO-abbreviation] Exp. Mol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / enhanced green fluorescent protein; 147336-22-9 / Green Fluorescent Proteins
  •  go-up   go-down


14. Konsavage WM Jr, Sudol M, Lee NE, Katzman M: Retroviral integrases that are improved for processing but impaired for joining. Virus Res; 2007 May;125(2):198-210
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We previously showed that Rous sarcoma virus integrase with a serine-to-aspartate substitution at amino acid 124 was markedly improved for processing but dramatically impaired for joining, making it the first mutant to separate the activities of integrase in this way.
  • [MeSH-major] Integrases / physiology. Rous sarcoma virus / enzymology. Virus Integration

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. MAGNESIUM, ELEMENTAL .
  • Hazardous Substances Data Bank. MANGANESE, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17289204.001).
  • [ISSN] 0168-1702
  • [Journal-full-title] Virus research
  • [ISO-abbreviation] Virus Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / DNA, Viral; 42Z2K6ZL8P / Manganese; EC 2.7.7.- / Integrases; I38ZP9992A / Magnesium
  •  go-up   go-down


15. Bruzzaniti A, Neff L, Sanjay A, Horne WC, De Camilli P, Baron R: Dynamin forms a Src kinase-sensitive complex with Cbl and regulates podosomes and osteoclast activity. Mol Biol Cell; 2005 Jul;16(7):3301-13
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Podosomes are highly dynamic actin-containing adhesion structures found in osteoclasts, macrophages, and Rous sarcoma virus (RSV)-transformed fibroblasts.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arthritis Res. 2002;4 Suppl 3:S227-32 [12110142.001]
  • [Cites] J Biol Chem. 2002 Jul 19;277(29):26642-51 [12011079.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12191-6 [12218189.001]
  • [Cites] FEBS Lett. 2002 Oct 2;529(1):110-5 [12354621.001]
  • [Cites] Curr Opin Cell Biol. 2003 Feb;15(1):31-9 [12517701.001]
  • [Cites] Mol Biol Cell. 2003 Feb;14(2):407-16 [12589043.001]
  • [Cites] Trends Cell Biol. 2003 Jul;13(7):376-85 [12837608.001]
  • [Cites] Dev Biol. 2003 Sep 15;261(2):537-47 [14499658.001]
  • [Cites] Front Biosci. 2004 May 1;9:1944-53 [14977600.001]
  • [Cites] J Biol Chem. 2004 Apr 23;279(17):17660-6 [14739300.001]
  • [Cites] Front Biosci. 1998;3:d757-68 [9682033.001]
  • [Cites] J Bone Miner Res. 1988 Oct;3(5):517-23 [3195364.001]
  • [Cites] Nat Cell Biol. 2000 Jul;2(7):385-91 [10878802.001]
  • [Cites] J Biol Chem. 2000 Jul 21;275(29):21946-52 [10781580.001]
  • [Cites] J Cell Biol. 2000 Jul 24;150(2):377-89 [10908579.001]
  • [Cites] J Cell Biol. 2000 Sep 4;150(5):F111-6 [10974009.001]
  • [Cites] J Cell Biol. 2000 Oct 2;151(1):187-98 [11018064.001]
  • [Cites] Biochem Biophys Res Commun. 2000 Nov 11;278(1):167-74 [11071869.001]
  • [Cites] Exp Cell Res. 2000 Nov 25;261(1):25-36 [11082272.001]
  • [Cites] J Cell Biol. 2001 Jan 8;152(1):181-95 [11149930.001]
  • [Cites] Nat Rev Neurosci. 2000 Dec;1(3):161-72 [11257904.001]
  • [Cites] J Clin Invest. 2001 May;107(9):1137-44 [11342577.001]
  • [Cites] J Biol Chem. 2001 Feb 16;276(7):4957-63 [11067845.001]
  • [Cites] J Biol Chem. 2001 Sep 14;276(37):35185-93 [11448952.001]
  • [Cites] Mol Biol Cell. 2001 Sep;12(9):2578-89 [11553700.001]
  • [Cites] EMBO J. 2001 Oct 15;20(20):5603-14 [11598004.001]
  • [Cites] J Cell Biol. 2001 Oct 15;155(2):193-200 [11604418.001]
  • [Cites] J Cell Sci. 2001 Aug;114(Pt 15):2775-86 [11683411.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):161-6 [11782545.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):167-72 [11782546.001]
  • [Cites] Curr Opin Cell Biol. 2002 Feb;14(1):76-81 [11792548.001]
  • [Cites] Nature. 2002 Mar 14;416(6877):183-7 [11894095.001]
  • [Cites] Nature. 2002 Mar 14;416(6877):187-90 [11894096.001]
  • [Cites] Cell. 2002 Apr 5;109(1):101-12 [11955450.001]
  • [Cites] J Exp Zool. 1989 Aug;251(2):167-85 [2549171.001]
  • [Cites] J Cell Biol. 1989 Oct;109(4 Pt 1):1817-26 [2477382.001]
  • [Cites] Cancer. 1989 Dec 1;64(11):2243-9 [2804914.001]
  • [Cites] Exp Cell Res. 1991 Aug;195(2):368-75 [1712731.001]
  • [Cites] J Cell Biol. 1991 Nov;115(4):1179-86 [1720122.001]
  • [Cites] J Bone Miner Res. 1992 Mar;7(3):345-51 [1585837.001]
  • [Cites] J Cell Biol. 1992 Nov;119(4):1003-13 [1385441.001]
  • [Cites] J Bone Miner Res. 1993 May;8(5):527-33 [8511980.001]
  • [Cites] J Cell Sci. 1993 Mar;104 ( Pt 3):663-70 [7686168.001]
  • [Cites] J Biol Chem. 1993 Aug 5;268(22):16737-45 [8344953.001]
  • [Cites] Cell. 1993 Oct 8;75(1):25-36 [8402898.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11468-72 [7505438.001]
  • [Cites] EMBO J. 1994 Jun 1;13(11):2574-82 [8013457.001]
  • [Cites] J Cell Biol. 1994 Nov;127(4):915-34 [7962076.001]
  • [Cites] Nature. 1995 Mar 9;374(6518):186-90 [7877693.001]
  • [Cites] EMBO J. 1995 Apr 3;14(7):1322-8 [7537212.001]
  • [Cites] J Cell Sci. 1995 Aug;108 ( Pt 8):2729-32 [7593313.001]
  • [Cites] Nature. 1996 Oct 10;383(6600):528-31 [8849724.001]
  • [Cites] J Biol Chem. 1996 Dec 20;271(51):33141-7 [8955163.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8569-74 [9238017.001]
  • [Cites] Genes Dev. 1997 Nov 1;11(21):2835-44 [9353253.001]
  • [Cites] J Biol Chem. 1998 Feb 6;273(6):3791-7 [9452513.001]
  • [Cites] EMBO J. 1998 Aug 3;17(15):4391-403 [9687507.001]
  • [Cites] J Cell Sci. 1998 Sep;111 ( Pt 17):2563-74 [9701555.001]
  • [Cites] Mol Biol Cell. 1998 Sep;9(9):2595-609 [9725914.001]
  • [Cites] J Bone Miner Res. 1998 Nov;13(11):1714-20 [9797480.001]
  • [Cites] J Cell Biol. 1998 Dec 28;143(7):1871-81 [9864361.001]
  • [Cites] J Biol Chem. 1999 Jan 15;274(3):1185-8 [9880482.001]
  • [Cites] Curr Biol. 1999 Mar 11;9(5):261-4 [10074457.001]
  • [Cites] J Bone Miner Metab. 1999;17(1):1-6 [10084394.001]
  • [Cites] J Biol Chem. 1999 Oct 22;274(43):30887-95 [10521482.001]
  • [Cites] J Cell Biol. 1985 Dec;101(6):2210-22 [3905822.001]
  • [Cites] Exp Cell Res. 1987 Mar;169(1):202-14 [3028844.001]
  • [Cites] J Cell Biol. 1987 Jun;104(6):1521-6 [3034916.001]
  • [Cites] Nat Cell Biol. 1999 May;1(1):33-9 [10559861.001]
  • [Cites] Nat Cell Biol. 1999 Aug;1(4):200-6 [10559917.001]
  • [Cites] J Cell Sci. 2000 Feb;113 ( Pt 3):377-81 [10639325.001]
  • [Cites] J Bone Miner Res. 2000 Jan;15(1):41-51 [10646113.001]
  • [Cites] Biochem Biophys Res Commun. 2000 Feb 16;268(2):321-8 [10679202.001]
  • [Cites] J Clin Invest. 2000 Feb;105(4):433-40 [10683372.001]
  • [Cites] J Neurosci. 2000 Jun 1;20(11):4177-88 [10818153.001]
  • [Cites] J Biol Chem. 2002 Jul 12;277(28):24967-75 [11994282.001]
  • (PMID = 15872089.001).
  • [ISSN] 1059-1524
  • [Journal-full-title] Molecular biology of the cell
  • [ISO-abbreviation] Mol. Biol. Cell
  • [Language] ENG
  • [Grant] United States / NIAMS NIH HHS / AR / R01 AR042927; United States / NIAMS NIH HHS / AR / AR42927
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 147336-22-9 / Green Fluorescent Proteins; 86-01-1 / Guanosine Triphosphate; EC 2.5.1.18 / Glutathione Transferase; EC 2.7.10.2 / src-Family Kinases; EC 3.6.5.5 / Dynamins
  • [Other-IDs] NLM/ PMC1165412
  •  go-up   go-down


16. Poleshko A, Palagin I, Zhang R, Boimel P, Castagna C, Adams PD, Skalka AM, Katz RA: Identification of cellular proteins that maintain retroviral epigenetic silencing: evidence for an antiviral response. J Virol; 2008 Mar;82(5):2313-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We previously isolated HeLa cell populations that harbored silent avian sarcoma virus-based green fluorescent protein (GFP) vectors that could be reactivated by treatment with HDAC inhibitors.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Methods. 2006 Sep;3(9):677-81 [16929311.001]
  • [Cites] Genome Biol. 2007;8(11):228 [18036274.001]
  • [Cites] Nat Rev Genet. 2007 Jan;8(1):35-46 [17173056.001]
  • [Cites] Nat Biotechnol. 2007 Jan;25(1):84-90 [17211407.001]
  • [Cites] Mol Cell. 2007 Jan 12;25(1):1-14 [17218267.001]
  • [Cites] Mol Cell. 2007 Jan 12;25(1):15-30 [17218268.001]
  • [Cites] Nat Rev Microbiol. 2007 Feb;5(2):95-106 [17224919.001]
  • [Cites] Mol Cell Biol. 2007 Feb;27(3):949-62 [17101789.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):377-82 [10618426.001]
  • [Cites] J Virol. 2000 Aug;74(15):6790-9 [10888618.001]
  • [Cites] Cytogenet Cell Genet. 2000;90(3-4):279-84 [11124534.001]
  • [Cites] Gene. 2000 Dec 30;261(1):181-8 [11164049.001]
  • [Cites] Nature. 2001 Aug 2;412(6846):561-5 [11484059.001]
  • [Cites] EMBO J. 2002 Mar 1;21(5):1112-20 [11867539.001]
  • [Cites] Curr Biol. 2002 Apr 2;12(7):594-8 [11937030.001]
  • [Cites] Mol Cell Biol. 2002 May;22(9):2965-73 [11940654.001]
  • [Cites] J Virol. 2002 May;76(10):5034-42 [11967319.001]
  • [Cites] J Biol Chem. 2002 May 3;277(18):15859-64 [11850427.001]
  • [Cites] J Virol. 2002 Jun;76(11):5769-83 [11992005.001]
  • [Cites] J Cell Sci. 2002 Aug 15;115(Pt 16):3319-30 [12140263.001]
  • [Cites] J Hematother Stem Cell Res. 2002 Jun;11(3):449-56 [12183830.001]
  • [Cites] Nat Genet. 2003 Mar;33 Suppl:245-54 [12610534.001]
  • [Cites] Biochem J. 2003 Mar 15;370(Pt 3):737-49 [12429021.001]
  • [Cites] Mol Cell. 2003 Dec;12(6):1537-49 [14690606.001]
  • [Cites] AIDS. 2004 May 21;18(8):1101-8 [15166525.001]
  • [Cites] Mol Ther. 2004 Jul;10(1):27-36 [15233939.001]
  • [Cites] Nat Cell Biol. 2004 Aug;6(8):784-91 [15247924.001]
  • [Cites] J Virol. 2004 Nov;78(21):11656-63 [15479807.001]
  • [Cites] J Virol. 1996 Jun;70(6):3922-9 [8648729.001]
  • [Cites] Hum Gene Ther. 2005 Nov;16(11):1241-6 [16259557.001]
  • [Cites] Gene. 2005 Dec 19;363:15-23 [16289629.001]
  • [Cites] EMBO J. 2006 Jan 11;25(1):139-49 [16319923.001]
  • [Cites] Nat Methods. 2006 Mar;3(3):199-204 [16489337.001]
  • [Cites] Trends Microbiol. 2006 Mar;14(3):132-40 [16458005.001]
  • [Cites] J Virol. 2006 Apr;80(8):3863-71 [16571803.001]
  • [Cites] J Gen Virol. 2006 May;87(Pt 5):1113-21 [16603511.001]
  • [Cites] Nat Cell Biol. 2006 Apr;8(4):407-15 [16531993.001]
  • [Cites] J Virol. 2006 Jun;80(12):6188-91 [16731959.001]
  • [Cites] Trends Genet. 1997 Aug;13(8):335-40 [9260521.001]
  • [Cites] Mol Cell. 2004 Nov 19;16(4):549-61 [15546615.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17234-9 [15572445.001]
  • [Cites] Bull Mem Acad R Med Belg. 2004;159(Pt 2):176-89 [15615091.001]
  • [Cites] Genes Dev. 2005 Feb 15;19(4):489-501 [15713842.001]
  • [Cites] Mol Ther. 2005 Apr;11(4):591-9 [15771961.001]
  • [Cites] J Virol. 2005 Apr;79(8):4610-8 [15795247.001]
  • [Cites] J Virol. 2005 Jun;79(11):6610-9 [15890899.001]
  • [Cites] EMBO Rep. 2005 Jun;6(6):520-4 [15940285.001]
  • [Cites] Lancet. 2005 Aug 13-19;366(9485):549-55 [16099290.001]
  • [Cites] Curr Gene Ther. 2005 Aug;5(4):367-73 [16101511.001]
  • [Cites] Development. 2005 Nov;132(21):4645-52 [16224044.001]
  • [Cites] EMBO J. 2007 Jan 24;26(2):412-23 [17245431.001]
  • [Cites] EMBO J. 2007 Jan 24;26(2):424-35 [17245432.001]
  • [Cites] Cell. 2007 Feb 23;128(4):669-81 [17320505.001]
  • [Cites] Cell. 2007 Feb 23;128(4):693-705 [17320507.001]
  • [Cites] J Virol. 2007 Mar;81(6):2592-604 [17202206.001]
  • [Cites] Oncogene. 2007 Feb 26;26(9):1351-6 [17322921.001]
  • [Cites] Subcell Biochem. 2007;41:371-96 [17484137.001]
  • [Cites] Nature. 2007 May 24;447(7143):407-12 [17522673.001]
  • [Cites] Cell. 2007 Oct 5;131(1):46-57 [17923087.001]
  • [Cites] Nat Rev Drug Discov. 2006 Sep;5(9):769-84 [16955068.001]
  • (PMID = 18094192.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA071515; United States / NCI NIH HHS / CA / CA06927; United States / NCI NIH HHS / CA / CA71515; United States / NINDS NIH HHS / NS / NS053666; United States / NINDS NIH HHS / NS / R21 NS053666; United States / NCI NIH HHS / CA / P30 CA006927
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adaptor Proteins, Signal Transducing; 0 / Chromosomal Proteins, Non-Histone; 0 / DAXX protein, human; 0 / DNA Primers; 0 / Histone Deacetylase Inhibitors; 0 / Nuclear Proteins; 0 / Proteins; 0 / RNA, Small Interfering; 107283-02-3 / heterochromatin-specific nonhistone chromosomal protein HP-1; EC 3.5.1.98 / Histone Deacetylases
  • [Other-IDs] NLM/ PMC2258957
  •  go-up   go-down


17. Bagossi P, Sperka T, Fehér A, Kádas J, Zahuczky G, Miklóssy G, Boross P, Tözsér J: Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites. J Virol; 2005 Apr;79(7):4213-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Specificities at this position were compared for HIV-1, HIV-2, equine infectious anemia virus, avian myeloblastosis virus, Mason-Pfizer monkey virus, mouse mammary tumor virus, Moloney murine leukemia virus, human T-cell leukemia virus type 1, bovine leukemia virus, human foamy virus, and walleye dermal sarcoma virus proteases.
  • [MeSH-minor] Amino Acid Sequence. Amino Acid Substitution. Avian Myeloblastosis Virus / enzymology. Binding Sites. Conserved Sequence. Epsilonretrovirus / enzymology. HIV-1 / enzymology. HIV-2 / enzymology. Human T-lymphotropic virus 1 / enzymology. Hydrophobic and Hydrophilic Interactions. Infectious Anemia Virus, Equine / enzymology. Leukemia Virus, Bovine / enzymology. Mammary Tumor Virus, Mouse / enzymology. Mason-Pfizer monkey virus / enzymology. Molecular Sequence Data. Moloney murine leukemia virus / enzymology. Phylogeny. Sequence Alignment. Spumavirus / enzymology. Static Electricity. Substrate Specificity

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] FEBS Lett. 1991 Feb 25;279(2):356-60 [2001747.001]
  • [Cites] J Biol Chem. 1997 Jul 4;272(27):16807-14 [9201986.001]
  • [Cites] FEBS Lett. 1991 Apr 9;281(1-2):77-80 [2015912.001]
  • [Cites] J Biol Chem. 1991 Aug 5;266(22):14539-47 [1860860.001]
  • [Cites] Biochemistry. 1992 May 26;31(20):4793-800 [1591240.001]
  • [Cites] Biochemistry. 1992 Jun 9;31(22):5193-200 [1606143.001]
  • [Cites] FEBS Lett. 1992 Sep 14;309(3):389-93 [1325379.001]
  • [Cites] J Biol Chem. 1992 Nov 25;267(33):24134-9 [1331110.001]
  • [Cites] Biochemistry. 1993 Apr 6;32(13):3347-53 [8384879.001]
  • [Cites] Biochemistry. 1993 Apr 6;32(13):3354-62 [8384880.001]
  • [Cites] J Biol Chem. 1993 Jun 5;268(16):11711-20 [8389361.001]
  • [Cites] FEBS Lett. 1997 Sep 1;414(1):84-8 [9305737.001]
  • [Cites] Biochemistry. 1998 Mar 31;37(13):4518-26 [9521772.001]
  • [Cites] Virology. 1998 Jun 5;245(2):250-6 [9636364.001]
  • [Cites] Protein Sci. 1998 Nov;7(11):2314-23 [9827997.001]
  • [Cites] J Biol Chem. 1999 Mar 5;274(10):6660-6 [10037763.001]
  • [Cites] Eur J Biochem. 1999 Sep;264(3):921-9 [10491141.001]
  • [Cites] FEBS Lett. 1999 Dec 3;462(3):397-401 [10622733.001]
  • [Cites] Biochim Biophys Acta. 2000 Mar 16;1478(1):1-8 [10719169.001]
  • [Cites] Pharmacol Ther. 2000 May;86(2):145-70 [10799712.001]
  • [Cites] Eur J Biochem. 2000 Oct;267(20):6287-95 [11012683.001]
  • [Cites] Adv Pharmacol. 2000;49:111-46 [11013762.001]
  • [Cites] Annu Rev Med. 2002;53:595-614 [11818491.001]
  • [Cites] J Virol. 2002 May;76(9):4341-9 [11932400.001]
  • [Cites] Structure. 2002 Mar;10(3):369-81 [12005435.001]
  • [Cites] Proteins. 2002 Jul 1;48(1):107-16 [12012342.001]
  • [Cites] Eur J Biochem. 2002 Aug;269(16):4114-20 [12180988.001]
  • [Cites] Curr Top Microbiol Immunol. 1990;157:153-85 [2203608.001]
  • [Cites] J Mol Graph. 1990 Mar;8(1):52-6, 29 [2268628.001]
  • [Cites] Curr Pharm Des. 2003;9(22):1803-15 [12871198.001]
  • [Cites] Protein Expr Purif. 2004 May;35(1):62-8 [15039067.001]
  • [Cites] Biochem Biophys Res Commun. 1967 Apr 20;27(2):157-62 [6035483.001]
  • [Cites] Prog Biophys Mol Biol. 1972;24:107-23 [4566650.001]
  • [Cites] J Mol Biol. 1991 Mar 20;218(2):397-412 [2010917.001]
  • [Cites] Virology. 1993 Oct;196(2):557-63 [8372434.001]
  • [Cites] J Mol Biol. 1993 Dec 5;234(3):779-815 [8254673.001]
  • [Cites] J Biol Chem. 1994 Jun 17;269(24):16795-801 [8207003.001]
  • [Cites] Nucleic Acids Res. 1994 Nov 11;22(22):4673-80 [7984417.001]
  • [Cites] Methods Enzymol. 1994;241:254-78 [7854181.001]
  • [Cites] Methods Enzymol. 1994;241:279-301 [7854182.001]
  • [Cites] Structure. 1995 Jan 15;3(1):33-40 [7743130.001]
  • [Cites] J Biol Chem. 1995 Dec 15;270(50):29621-3 [8530341.001]
  • [Cites] Nat Med. 1996 Mar;2(3):274-5 [8612219.001]
  • [Cites] J Virol. 1996 Jun;70(6):3763-9 [8648711.001]
  • [Cites] J Biol Chem. 1996 Mar 22;271(12):6781-8 [8636100.001]
  • [Cites] Protein Sci. 1996 Aug;5(8):1453-65 [8844837.001]
  • [Cites] J Biol Chem. 1997 Jun 20;272(25):15603-6 [9188447.001]
  • [Cites] EMBO J. 1986 Apr;5(4):823-6 [3709526.001]
  • (PMID = 15767422.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Oligopeptides; EC 3.4.- / Peptide Hydrolases
  • [Other-IDs] NLM/ PMC1061542
  •  go-up   go-down


18. Larson DR, Johnson MC, Webb WW, Vogt VM: Visualization of retrovirus budding with correlated light and electron microscopy. Proc Natl Acad Sci U S A; 2005 Oct 25;102(43):15453-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have used correlated scanning EM (SEM) and multiphoton fluorescence microscopy to visualize budding of virus-like particles (VLPs) of Rous sarcoma virus (RSV) and HIV type 1 (HIV-1).

  • COS Scholar Universe. author profiles.
  • Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cell Biol. 2003 Aug 4;162(3):443-55 [12885763.001]
  • [Cites] Trends Cell Biol. 2002 Dec;12(12):569-79 [12495845.001]
  • [Cites] J Cell Biol. 2003 Sep 29;162(7):1233-44 [14517204.001]
  • [Cites] Traffic. 2003 Nov;4(11):785-801 [14617360.001]
  • [Cites] Dev Cell. 2003 Jul;5(1):161-74 [12852860.001]
  • [Cites] J Biol Chem. 2003 Dec 26;278(52):52347-54 [14561735.001]
  • [Cites] J Virol. 2004 Feb;78(3):1552-63 [14722309.001]
  • [Cites] J Virol. 2004 Jul;78(13):7153-64 [15194792.001]
  • [Cites] J Virol. 1994 Oct;68(10):6605-18 [8083996.001]
  • [Cites] Biochemistry. 1997 Jun 3;36(22):6786-91 [9184161.001]
  • [Cites] Nat Biotechnol. 1999 Jul;17(7):691-5 [10404163.001]
  • [Cites] J Virol. 2000 Jul;74(13):5845-55 [10846064.001]
  • [Cites] J Virol. 2000 Sep;74(18):8670-9 [10954568.001]
  • [Cites] J Virol. 2000 Dec;74(23):11222-9 [11070020.001]
  • [Cites] Biophys J. 2002 May;82(5):2775-83 [11964263.001]
  • [Cites] J Virol. 2002 May;76(10):4679-87 [11967285.001]
  • [Cites] J Cell Biol. 2003 Aug 4;162(3):425-34 [12900394.001]
  • (PMID = 16230638.001).
  • [ISSN] 0027-8424
  • [Journal-full-title] Proceedings of the National Academy of Sciences of the United States of America
  • [ISO-abbreviation] Proc. Natl. Acad. Sci. U.S.A.
  • [Language] ENG
  • [Grant] United States / NIBIB NIH HHS / EB / P41 EB001976; United States / NCI NIH HHS / CA / R01 CA020081; United States / NIBIB NIH HHS / EB / 9P41 EB 001976; United States / NCI NIH HHS / CA / CA 20081
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC1266096
  •  go-up   go-down


19. Alter HJ, Stramer SL, Dodd RY: Emerging infectious diseases that threaten the blood supply. Semin Hematol; 2007 Jan;44(1):32-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Many agents have fulfilled the broad definition of emerging blood-transmitted infections, including West Nile virus (WNV), Trypanosoma cruzi, Plasmodium spp., Babesia spp., parvovirus B19, dengue virus, and the prions that cause variant Creutzfeld-Jacob disease (vCJD).
  • Other agents such as human herpes virus-8 (HHV-8-Kaposi's sarcoma virus) and Borellia (Lyme disease) and, perhaps, avian flu virus, are known to have a viremic phase, but have not yet been proved to be transfusion-transmitted.
  • However, to approach near-zero infectious disease risk for emerging and re-emerging pathogens, new strategies such as pathogen inactivation or multi-pathogen microarray technology will need to be developed or refined.

  • MedlinePlus Health Information. consumer health - Blood Transfusion and Donation.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17198845.001).
  • [ISSN] 0037-1963
  • [Journal-full-title] Seminars in hematology
  • [ISO-abbreviation] Semin. Hematol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 33
  •  go-up   go-down


20. Vojtechová M, Turecková J, Kucerová D, Sloncová E, Vachtenheim J, Tuhácková Z: Regulation of mTORC1 signaling by Src kinase activity is Akt1-independent in RSV-transformed cells. Neoplasia; 2008 Feb;10(2):99-107
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the present study, a critical role of the Src activity in the deregulation of mTOR signaling pathway in Rous sarcoma virus (RSV)-transformed hamster fibroblasts, H19 cells, was shown using these cells treated with the Src-specific inhibitor, SU6656, and clones of fibroblasts expressing either the active Src or the dominant-negative Src kinase-dead mutant.
  • [MeSH-minor] Adenoviridae / genetics. Animals. Cell Line. Cell Line, Transformed. Cricetinae. Indoles / pharmacology. Phosphorylation. Protein Kinase Inhibitors / pharmacology. Rous sarcoma virus / genetics. Signal Transduction. Sulfonamides / pharmacology


21. Xia HB, Chen ZY, Chen XG: Overexpression of hepatitis B virus-binding protein, squamous cell carcinoma antigen 1, extends retention of hepatitis B virus in mouse liver. Acta Biochim Biophys Sin (Shanghai); 2006 Jul;38(7):484-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • SCCA1 transgene under the control of Rous sarcoma virus promoter was constructed in a minicircle DNA vector that was delivered to NOD/SCID mouse liver using the hydrodynamic technique.

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • Genetic Alliance. consumer health - Hepatitis.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16820864.001).
  • [ISSN] 1672-9145
  • [Journal-full-title] Acta biochimica et biophysica Sinica
  • [ISO-abbreviation] Acta Biochim. Biophys. Sin. (Shanghai)
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ DQ132809
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Hepatitis B Surface Antigens; 0 / Receptors, Virus; 0 / Serpins; 0 / hepatitis B virus-binding protein, human; 0 / squamous cell carcinoma-related antigen
  •  go-up   go-down


22. Pizzato M, Popova E, Göttlinger HG: Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles. J Virol; 2008 Nov;82(21):10811-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Nef also increased the infectivity of HIV-1 particles pseudotyped with Tva, the receptor for subgroup A Rous sarcoma virus (RSV-A), even though Nef had no effect if the pH-dependent Env protein of RSV-A was used for pseudotyping.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Gen Virol. 1982 Jan;58 Pt 1:47-61 [7142969.001]
  • [Cites] Cell. 1987 Jun 5;49(5):659-68 [3107838.001]
  • [Cites] EMBO J. 1988 Feb;7(2):513-8 [3259178.001]
  • [Cites] J Gen Virol. 1990 Apr;71 ( Pt 4):767-73 [2157795.001]
  • [Cites] Nature. 1991 Apr 11;350(6318):508-11 [2014052.001]
  • [Cites] Cell. 1991 May 17;65(4):651-62 [2032289.001]
  • [Cites] J Virol. 1993 Mar;67(3):1511-6 [8437228.001]
  • [Cites] J Exp Med. 1993 Jun 1;177(6):1561-6 [8098729.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5549-53 [8516299.001]
  • [Cites] Nucleic Acids Res. 1993 Jul 25;21(15):3593-4 [7688457.001]
  • [Cites] Cell. 1993 Sep 24;74(6):1043-51 [8402880.001]
  • [Cites] J Exp Med. 1994 Jan 1;179(1):101-13 [8270859.001]
  • [Cites] J Exp Med. 1994 Jan 1;179(1):115-23 [7903679.001]
  • [Cites] J Biol Chem. 1994 Feb 11;269(6):3917-20 [7905875.001]
  • [Cites] J Virol. 1994 Mar;68(3):1689-96 [8107229.001]
  • [Cites] Cell. 1994 Mar 11;76(5):853-64 [8124721.001]
  • [Cites] J Virol. 1994 Apr;68(4):2760-4 [8139053.001]
  • [Cites] J Virol. 1994 May;68(5):2906-14 [8151761.001]
  • [Cites] J Virol. 1994 Aug;68(8):5156-63 [8035515.001]
  • [Cites] Cell. 1994 Nov 4;79(3):497-506 [7954815.001]
  • [Cites] J Virol. 1995 Jan;69(1):579-84 [7983759.001]
  • [Cites] N Engl J Med. 1995 Jan 26;332(4):228-32 [7808489.001]
  • [Cites] J Virol. 1995 Feb;69(2):1019-24 [7815478.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):349-53 [7831289.001]
  • [Cites] Virology. 1995 Feb 20;207(1):338-41 [7871751.001]
  • [Cites] J Virol. 1995 Jun;69(6):3824-30 [7745730.001]
  • [Cites] J Virol. 1995 Jul;69(7):4053-9 [7539505.001]
  • [Cites] J Virol. 1995 Jul;69(7):4261-6 [7769686.001]
  • [Cites] J Virol. 1995 Aug;69(8):4847-53 [7609052.001]
  • [Cites] J Virol. 1995 Aug;69(8):5048-56 [7541845.001]
  • [Cites] Virology. 1995 Oct 1;212(2):451-7 [7571414.001]
  • [Cites] Science. 1995 Nov 10;270(5238):988-91 [7481804.001]
  • [Cites] Science. 1996 Apr 12;272(5259):263-7 [8602510.001]
  • [Cites] Virology. 1996 May 1;219(1):228-36 [8623533.001]
  • [Cites] J Virol. 1996 Jul;70(7):4283-90 [8676450.001]
  • [Cites] J Virol. 1996 Sep;70(9):6493-6 [8709288.001]
  • [Cites] J Virol. 1996 Nov;70(11):7752-64 [8892896.001]
  • [Cites] J Virol. 1997 Aug;71(8):5871-7 [9223476.001]
  • [Cites] J Virol. 1997 Sep;71(9):6742-8 [9261398.001]
  • [Cites] Science. 1997 Nov 21;278(5342):1462-4 [9367958.001]
  • [Cites] Virology. 1997 Nov 24;238(2):305-15 [9400603.001]
  • [Cites] J Virol. 1998 Jan;72(1):671-6 [9420272.001]
  • [Cites] J Virol. 1998 Mar;72(3):2072-8 [9499062.001]
  • [Cites] Virology. 1998 Feb 15;241(2):224-33 [9499797.001]
  • [Cites] J Virol. 1998 Apr;72(4):3178-84 [9525644.001]
  • [Cites] EMBO J. 1998 May 1;17(9):2699-708 [9564051.001]
  • [Cites] J Biol Chem. 1998 Jun 19;273(25):15773-8 [9624176.001]
  • [Cites] Biotechniques. 1998 Jul;25(1):98-106 [9668983.001]
  • [Cites] J Virol. 1999 Feb;73(2):1350-61 [9882340.001]
  • [Cites] Curr Biol. 1999 Jun 17;9(12):613-21 [10375525.001]
  • [Cites] Curr Biol. 1999 Jun 17;9(12):622-31 [10375528.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9867-72 [10449786.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8728-33 [15937118.001]
  • [Cites] J Virol. 2005 Aug;79(15):10053-8 [16014965.001]
  • [Cites] J Biol Chem. 2006 Jan 6;281(1):528-42 [16195228.001]
  • [Cites] Microbiol Mol Biol Rev. 2006 Jun;70(2):548-63 [16760313.001]
  • [Cites] J Cell Biol. 2006 Oct 23;175(2):201-7 [17043140.001]
  • [Cites] J Virol. 2006 Nov;80(22):11141-52 [16928758.001]
  • [Cites] PLoS Biol. 2006 Oct;4(11):e365 [17076584.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6812-7 [17412836.001]
  • [Cites] Adv Pharmacol. 2007;55:389-409 [17586321.001]
  • [Cites] Retrovirology. 2007;4:70 [17908312.001]
  • [Cites] J Virol. 1997 Feb;71(2):1013-8 [8995620.001]
  • [Cites] J Virol. 2000 Jun;74(12):5395-402 [10823843.001]
  • [Cites] Cell. 2000 Nov 10;103(4):679-89 [11106737.001]
  • [Cites] J Virol. 2001 Mar;75(6):2982-92 [11222723.001]
  • [Cites] J Virol. 2001 Mar;75(6):2993-3000 [11222724.001]
  • [Cites] J Virol. 2001 Apr;75(8):4014-8 [11264394.001]
  • [Cites] J Virol. 2001 Jul;75(13):5851-9 [11390586.001]
  • [Cites] Arch Virol. 2001;146(9):1739-51 [11699959.001]
  • [Cites] Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905 [12019106.001]
  • [Cites] J Virol. 2002 Jul;76(13):6857-62 [12050401.001]
  • [Cites] J Virol. 2003 Apr;77(7):4409-14 [12634398.001]
  • [Cites] J Virol. 2003 Apr;77(8):4685-94 [12663775.001]
  • [Cites] J Virol. 2003 Jun;77(12):6931-45 [12768012.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8460-5 [12824470.001]
  • [Cites] J Virol. 2003 Oct;77(19):10645-50 [12970449.001]
  • [Cites] J Virol. 2004 Jun;78(11):5745-55 [15140972.001]
  • [Cites] J Virol. 2004 Jun;78(12):6287-96 [15163722.001]
  • [Cites] J Virol. 2004 Oct;78(19):10433-41 [15367609.001]
  • [Cites] Virology. 2004 Oct 10;328(1):36-44 [15380356.001]
  • [Cites] J Virol. 2004 Oct;78(20):10920-6 [15452212.001]
  • (PMID = 18715908.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / AI077412; United States / NIAID NIH HHS / AI / R37 AI029873; United States / NIAID NIH HHS / AI / R01 AI077412; United States / NIAID NIH HHS / AI / AI077412-01A1; United States / NIAID NIH HHS / AI / R01 AI077412-01A1; United States / NIAID NIH HHS / AI / AI029873; United States / NIAID NIH HHS / AI / R01 AI029873
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD4; 0 / Avian Proteins; 0 / Receptors, Virus; 0 / Tva receptor; 0 / env Gene Products, Human Immunodeficiency Virus; 0 / nef Gene Products, Human Immunodeficiency Virus; 0 / nef protein, Human immunodeficiency virus 1
  • [Other-IDs] NLM/ PMC2573167
  •  go-up   go-down


23. Lei B, Zhang K, Yue Y, Ghosh A, Duan D: Adeno-associated virus serotype-9 efficiently transduces the retinal outer plexiform layer. Mol Vis; 2009 Jul 17;15:1374-82
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In these vectors, two different promoters (the cytomegalovirus promoter-CMV promoter and the Rous sarcoma virus-RSV promoter) were used to express three different transgenes including the alkaline phosphatase (AP) gene, the enhanced green fluorescent protein (eGFP) gene, and a therapeutic microdystrophin gene (the R4-23/C).

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Invest Ophthalmol Vis Sci. 1992 Mar;33(3):477-83 [1544774.001]
  • [Cites] Hum Gene Ther. 2008 Oct;19(10):979-90 [18774912.001]
  • [Cites] J Clin Invest. 1994 Jun;93(6):2425-30 [8200977.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1995 Feb;36(2):462-6 [7843915.001]
  • [Cites] Histochem Cell Biol. 1997 Sep;108(3):249-55 [9342619.001]
  • [Cites] Prog Retin Eye Res. 1998 Oct;17(4):485-521 [9777648.001]
  • [Cites] Mol Genet Metab. 1999 Feb;66(2):100-10 [10068512.001]
  • [Cites] Mol Ther. 2005 Feb;11(2):245-56 [15668136.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4884-9 [15781871.001]
  • [Cites] Curr Gene Ther. 2005 Jun;5(3):285-97 [15975006.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2006 Jan;47(1):17-24 [16384939.001]
  • [Cites] Mol Ther. 2006 Mar;13(3):565-72 [16223604.001]
  • [Cites] Vis Neurosci. 2006 Jan-Feb;23(1):11-24 [16597347.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2732-8 [16723493.001]
  • [Cites] Mol Ther. 2006 Jul;14(1):45-53 [16713360.001]
  • [Cites] Circ Res. 2006 Aug 18;99(4):e3-9 [16873720.001]
  • [Cites] J Neurosci Res. 2006 Oct;84(5):1139-49 [16881055.001]
  • [Cites] Expert Opin Biol Ther. 2006 Dec;6(12):1279-94 [17223737.001]
  • [Cites] Mol Ther. 2007 Apr;15(4):750-5 [17264855.001]
  • [Cites] Nat Med. 2007 Jun;13(6):685-7 [17515894.001]
  • [Cites] J Virol. 2007 Oct;81(20):11372-80 [17699581.001]
  • [Cites] Gene Ther. 2007 Nov;14(22):1605-9 [17898796.001]
  • [Cites] Curr Eye Res. 2008 Jan;33(1):81-90 [18214745.001]
  • [Cites] J Gene Med. 2008 Apr;10(4):375-82 [18278824.001]
  • [Cites] N Engl J Med. 2008 May 22;358(21):2240-8 [18441370.001]
  • [Cites] N Engl J Med. 2008 May 22;358(21):2231-9 [18441371.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15112-7 [18809924.001]
  • [Cites] J Clin Invest. 2000 Jun;105(11):1573-87 [10841516.001]
  • [Cites] Nat Genet. 2000 Jul;25(3):306-10 [10888879.001]
  • [Cites] Nat Genet. 2001 May;28(1):92-5 [11326284.001]
  • [Cites] Mol Cell Neurosci. 2001 May;17(5):908-20 [11358487.001]
  • [Cites] J Virol. 2002 Jan;76(2):791-801 [11752169.001]
  • [Cites] Nat Med. 2002 Mar;8(3):253-61 [11875496.001]
  • [Cites] J Virol. 2002 Aug;76(15):7651-60 [12097579.001]
  • [Cites] Circulation. 2003 Sep 30;108(13):1626-32 [12952841.001]
  • [Cites] J Virol. 2004 Jun;78(12):6381-8 [15163731.001]
  • [Cites] Arch Ophthalmol. 1986 Jul;104(7):1013-20 [3488053.001]
  • [Cites] Nat Biotechnol. 2009 Jan;27(1):59-65 [19098898.001]
  • [Cites] Nat Genet. 1993 May;4(1):82-6 [8513332.001]
  • (PMID = 19626133.001).
  • [ISSN] 1090-0535
  • [Journal-full-title] Molecular vision
  • [ISO-abbreviation] Mol. Vis.
  • [Language] ENG
  • [Grant] United States / NIAMS NIH HHS / AR / R01 AR049419; United States / NIAMS NIH HHS / AR / AR-49419
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Dystrophin; 0 / enhanced green fluorescent protein; 147336-22-9 / Green Fluorescent Proteins
  • [Other-IDs] NLM/ PMC2713732
  •  go-up   go-down


24. Ott DE, Coren LV, Gagliardi TD, Nagashima K: Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1. J Virol; 2005 Jul;79(14):9038-45
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • One exception was the 11-amino-acid p2b sequence of Rous sarcoma virus (RSV) Gag, which could fully restore HIV-1 budding, while a PPPPY sequence exchange alone did not.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13069-74 [11087861.001]
  • [Cites] J Biochem Biophys Methods. 1984 Dec;10(3-4):203-9 [6530509.001]
  • [Cites] J Virol. 2001 Oct;75(20):9762-70 [11559809.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11199-204 [11562473.001]
  • [Cites] Cell. 2001 Oct 5;107(1):55-65 [11595185.001]
  • [Cites] J Virol. 1987 Jan;61(1):209-13 [3640832.001]
  • [Cites] J Virol. 2000 Aug;74(16):7250-60 [10906179.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13057-62 [11087859.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13063-8 [11087860.001]
  • [Cites] J Virol. 1990 Jul;64(7):3207-11 [2191147.001]
  • [Cites] Biotechniques. 1990 May;8(5):528-35 [2357375.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9 [2014240.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 May 15;88(10):4528-32 [2034693.001]
  • [Cites] AIDS. 1991 Jun;5(6):617-37 [1652977.001]
  • [Cites] J Virol. 1994 Oct;68(10):6605-18 [8083996.001]
  • [Cites] J Virol. 1994 Oct;68(10):6782-6 [8084015.001]
  • [Cites] J Virol. 1995 Sep;69(9):5455-60 [7636991.001]
  • [Cites] J Virol. 1995 Nov;69(11):6810-8 [7474093.001]
  • [Cites] J Virol. 1996 Aug;70(8):5695-700 [8764091.001]
  • [Cites] J Virol. 1997 Sep;71(9):6541-6 [9261374.001]
  • [Cites] J Virol. 1998 May;72(5):4095-103 [9557699.001]
  • [Cites] J Virol. 1998 Dec;72(12):10218-21 [9811764.001]
  • [Cites] J Virol. 2004 Dec;78(24):13943-53 [15564502.001]
  • [Cites] Virus Res. 2004 Dec;106(2):87-102 [15567490.001]
  • [Cites] J Cell Biol. 2005 Jan 3;168(1):89-101 [15623582.001]
  • [Cites] J Virol. 2005 Apr;79(7):4055-65 [15767407.001]
  • [Cites] J Virol. 2001 Nov;75(22):10623-9 [11602704.001]
  • [Cites] Nat Med. 2001 Dec;7(12):1313-9 [11726971.001]
  • [Cites] J Virol. 2002 Jan;76(1):105-17 [11739676.001]
  • [Cites] J Virol. 2002 Feb;76(4):1569-77 [11799151.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):955-60 [11805336.001]
  • [Cites] J Virol. 2002 Mar;76(6):2641-7 [11861830.001]
  • [Cites] J Virol. 2002 Mar;76(6):2789-95 [11861846.001]
  • [Cites] J Virol. 2002 Mar;76(6):3038-44 [11861870.001]
  • [Cites] J Virol. 2002 May;76(10):4679-87 [11967285.001]
  • [Cites] J Virol. 2002 Jun;76(11):5472-9 [11991975.001]
  • [Cites] EMBO Rep. 2002 Jul;3(7):636-40 [12101095.001]
  • [Cites] J Virol. 2002 Oct;76(19):10024-9 [12208980.001]
  • [Cites] Traffic. 2002 Oct;3(10):718-29 [12230470.001]
  • [Cites] Trends Microbiol. 2003 Feb;11(2):56-9 [12598123.001]
  • [Cites] J Virol. 2003 Mar;77(6):3384-93 [12610113.001]
  • [Cites] J Virol. 2003 Apr;77(8):4794-804 [12663786.001]
  • [Cites] J Virol. 2003 Jun;77(11):6507-19 [12743307.001]
  • [Cites] J Virol. 2003 Aug;77(15):8440-7 [12857913.001]
  • [Cites] J Cell Biol. 2003 Aug 4;162(3):443-55 [12885763.001]
  • [Cites] J Cell Biol. 2003 Aug 4;162(3):425-34 [12900394.001]
  • [Cites] J Virol. 2003 Sep;77(17):9173-82 [12915533.001]
  • [Cites] J Virol. 2003 Sep;77(17):9474-85 [12915562.001]
  • [Cites] Cell. 2003 Sep 19;114(6):689-99 [14505569.001]
  • [Cites] Cell. 2003 Sep 19;114(6):701-13 [14505570.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12414-9 [14519844.001]
  • [Cites] J Virol. 2003 Nov;77(22):12373-7 [14581576.001]
  • [Cites] J Virol. 2004 Jan;78(2):724-32 [14694104.001]
  • [Cites] J Virol. 2004 Feb;78(3):1552-63 [14722309.001]
  • [Cites] J Gen Virol. 2004 Apr;85(Pt 4):921-7 [15039534.001]
  • [Cites] J Cell Sci. 2004 May 1;117(Pt 11):2357-67 [15126635.001]
  • [Cites] J Virol. 2004 Jun;78(11):5554-63 [15140952.001]
  • [Cites] J Virol. 2004 Jun;78(12):6636-48 [15163754.001]
  • [Cites] Annu Rev Cell Dev Biol. 2004;20:395-425 [15473846.001]
  • [Cites] Virology. 1973 Apr;52(2):456-67 [4705382.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7724-9 [11427703.001]
  • (PMID = 15994797.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / N01CO12400; United States / NCI NIH HHS / CO / N01-CO-12400
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cysteine Proteinase Inhibitors; 0 / Gene Products, gag; 0 / Proteasome Inhibitors
  • [Other-IDs] NLM/ PMC1168796
  •  go-up   go-down


25. Wesche H, Xiao SH, Young SW: High throughput screening for protein kinase inhibitors. Comb Chem High Throughput Screen; 2005 Mar;8(2):181-95
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Many have sought to develop orally available low molecular weight synthetic kinase modulators (predominantly inhibitors) and thus capitalize on the links between aberrant regulation and disease.
  • [MeSH-minor] Animals. Avian Sarcoma Viruses / metabolism. Binding Sites. Humans. Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology. Lung Neoplasms / pathology. Mass Screening

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Comb Chem High Throughput Screen. 2005 Aug;8(5):455
  • (PMID = 15777182.001).
  • [ISSN] 1386-2073
  • [Journal-full-title] Combinatorial chemistry & high throughput screening
  • [ISO-abbreviation] Comb. Chem. High Throughput Screen.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Peptide Library; 0 / Protein Kinase Inhibitors; EC 2.7.- / Protein Kinases
  • [Number-of-references] 97
  •  go-up   go-down


26. Snásel J, Krejcík Z, Jencová V, Rosenberg I, Ruml T, Alexandratos J, Gustchina A, Pichová I: Integrase of Mason-Pfizer monkey virus. FEBS J; 2005 Jan;272(1):203-16
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The structure-based sequence alignment of M-PMV, HIV-1, SIV, and ASV integrases predicted critical amino acids and motifs of M-PMV integrase for metal binding, interaction with nucleic acids, dimerization, protein structure maintenance and function, as well as for binding of human immunodeficiency virus type 1 and Rous avian sarcoma virus integrase inhibitors 5-CI-TEP, DHPTPB and Y-3.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15634344.001).
  • [ISSN] 1742-464X
  • [Journal-full-title] The FEBS journal
  • [ISO-abbreviation] FEBS J.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] EC 2.7.7.- / Integrases
  •  go-up   go-down


27. Krishnan L, Matreyek KA, Oztop I, Lee K, Tipper CH, Li X, Dar MJ, Kewalramani VN, Engelman A: The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. J Virol; 2010 Jan;84(1):397-406
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we correlate infectivity defects in transportin 3 knockdown cells with in vitro protein binding affinities for an expanded set of retroviruses that include simian immunodeficiency virus (SIV), bovine immunodeficiency virus (BIV), equine infectious anemia virus (EIAV), feline immunodeficiency virus (FIV), and Rous sarcoma virus (RSV) to critically address the role of integrase-transportin 3 interactions in viral infection.

  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gene Ther. 1998 Nov;5(11):1481-7 [9930301.001]
  • [Cites] J Biol Chem. 1993 Jan 15;268(2):1462-9 [8419346.001]
  • [Cites] J Virol. 1999 Apr;73(4):2886-92 [10074136.001]
  • [Cites] J Virol. 1992 Nov;66(11):6361-9 [1404595.001]
  • [Cites] Retrovirology. 2009;6:11 [19193229.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3428-32 [8386373.001]
  • [Cites] EMBO J. 1993 May;12(5):2099-108 [8491198.001]
  • [Cites] J Virol. 1994 Jan;68(1):510-6 [8254763.001]
  • [Cites] J Virol. 1996 Jan;70(1):651-7 [8523588.001]
  • [Cites] Science. 1996 Apr 12;272(5259):263-7 [8602510.001]
  • [Cites] Protein Expr Purif. 1996 Nov;8(3):299-304 [8936591.001]
  • [Cites] Nature. 1997 Feb 13;385(6617):645-9 [9024664.001]
  • [Cites] Virology. 1997 Mar 31;230(1):1-10 [9126257.001]
  • [Cites] J Virol. 1997 Jul;71(7):5382-90 [9188609.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9825-30 [9275210.001]
  • [Cites] Annu Rev Biochem. 1998;67:265-306 [9759490.001]
  • [Cites] J Cell Biol. 1999 Jun 14;145(6):1145-52 [10366588.001]
  • [Cites] J Virol. 2009 Jul;83(13):6522-33 [19369352.001]
  • [Cites] PLoS Pathog. 2007 Oct 26;3(10):1502-10 [17967060.001]
  • [Cites] J Virol. 2001 Apr;75(7):3371-82 [11238863.001]
  • [Cites] J Virol. 2001 Apr;75(8):3626-35 [11264352.001]
  • [Cites] J Virol. 2002 Feb;76(3):1510-5 [11773424.001]
  • [Cites] Methods Mol Biol. 2003;229:251-71 [12824636.001]
  • [Cites] EMBO J. 2003 Jul 15;22(14):3675-85 [12853482.001]
  • [Cites] J Virol. 2004 Jun;78(11):5670-8 [15140964.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11827-32 [15280539.001]
  • [Cites] J Virol. 1982 Apr;42(1):346-51 [6283156.001]
  • [Cites] Genes Dev. 1989 Apr;3(4):469-78 [2721960.001]
  • [Cites] Mol Cell Biol. 1990 Aug;10(8):4239-42 [2370865.001]
  • [Cites] J Exp Med. 1991 Dec 1;174(6):1477-82 [1720811.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6580-4 [1631159.001]
  • [Cites] EMBO J. 1992 Aug;11(8):3053-8 [1322294.001]
  • [Cites] J Virol. 1999 Nov;73(11):8919-25 [10515996.001]
  • [Cites] Dev Biol. 1999 Oct 15;214(2):370-84 [10525341.001]
  • [Cites] J Biol Chem. 2004 Nov 19;279(47):48883-92 [15371438.001]
  • [Cites] J Biol Chem. 2005 May 6;280(18):17841-7 [15749713.001]
  • [Cites] Virology. 2006 Jan 5;344(1):88-93 [16364740.001]
  • [Cites] Virology. 2006 Mar 15;346(2):415-26 [16337983.001]
  • [Cites] PLoS Pathog. 2005 Nov;1(3):e18 [16292356.001]
  • [Cites] Biochem J. 2006 Sep 15;398(3):475-84 [16716146.001]
  • [Cites] Retrovirology. 2006;3:74 [17067381.001]
  • [Cites] J Virol. 2007 Jan;81(1):166-72 [17035312.001]
  • [Cites] Nucleic Acids Res. 2007;35(1):113-24 [17158150.001]
  • [Cites] Bioessays. 2007 May;29(5):441-51 [17450594.001]
  • [Cites] J Biol Chem. 2007 May 4;282(18):13456-67 [17360709.001]
  • [Cites] Virology. 2007 Jul 5;363(2):245-55 [17343889.001]
  • [Cites] Mol Ther. 2008 Jan;16(1):97-106 [17912236.001]
  • [Cites] Science. 2008 Feb 15;319(5865):921-6 [18187620.001]
  • [Cites] PLoS Pathog. 2008 Mar;4(3):e1000046 [18369482.001]
  • [Cites] Cell Mol Life Sci. 2008 May;65(9):1403-24 [18264802.001]
  • [Cites] Curr Biol. 2008 Aug 26;18(16):1192-202 [18722123.001]
  • [Cites] Cell. 2008 Oct 3;135(1):49-60 [18854154.001]
  • [Cites] AIDS Res Hum Retroviruses. 1999 Jan 1;15(1):11-21 [10024048.001]
  • (PMID = 19846519.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / P30 AI060354; United States / NIAID NIH HHS / AI / R01 AI052014; United States / NIAID NIH HHS / AI / AI052014; United States / NIAID NIH HHS / AI / P30AI060354
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Human Immunodeficiency Virus Proteins; 0 / Karyopherins; 0 / TNPO3 protein, human; 0 / beta Karyopherins; EC 2.7.7.- / Integrases
  • [Other-IDs] NLM/ PMC2798409
  •  go-up   go-down


28. Sweny P: Infection and cancer following renal transplantation. Saudi J Kidney Dis Transpl; 2006 Jun;17(2):189-99
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Burkitt's Virus (BKV), West Nile virus and Avian influenza) and will continue to tax the ingenuity of transplant physicians and microbiologists.
  • [MeSH-minor] Antiviral Agents / therapeutic use. BK Virus / pathogenicity. Bacterial Infections / etiology. Cytomegalovirus Infections / etiology. Humans. Lymphoproliferative Disorders / virology. Mycoses / etiology. Neoplasms, Squamous Cell / virology. Sarcoma, Kaposi / etiology. Urinary Tract Infections / etiology

  • Genetic Alliance. consumer health - Kidney cancer.
  • Genetic Alliance. consumer health - Transplantation.
  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Kidney Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16903626.001).
  • [ISSN] 1319-2442
  • [Journal-full-title] Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
  • [ISO-abbreviation] Saudi J Kidney Dis Transpl
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Saudi Arabia
  • [Chemical-registry-number] 0 / Antiviral Agents
  • [Number-of-references] 52
  •  go-up   go-down


29. Natesan S, Kataria JM, Dhama K, Bhardwaj N, Sylvester A: Anti-neoplastic effect of chicken anemia virus VP3 protein (apoptin) in Rous sarcoma virus-induced tumours in chicken. J Gen Virol; 2006 Oct;87(Pt 10):2933-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anti-neoplastic effect of chicken anemia virus VP3 protein (apoptin) in Rous sarcoma virus-induced tumours in chicken.
  • The anti-neoplastic effect of chicken anemia virus VP3 protein (apoptin) was investigated in vitro in Rous sarcoma virus (RSV)-transformed chicken embryo fibroblast (CEF) cells and in RSV-induced tumours of specific-pathogen-free (SPF) chicks in vivo.
  • [MeSH-major] Antineoplastic Agents / metabolism. Avian Sarcoma Viruses / physiology. Capsid Proteins / metabolism. Poultry Diseases / pathology. Poultry Diseases / virology. Sarcoma, Avian / pathology. Sarcoma, Avian / virology
  • [MeSH-minor] Animals. Cell Line, Tumor. Chickens / virology. Gene Expression. Humans. Specific Pathogen-Free Organisms

  • Genetic Alliance. consumer health - Anemia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16963752.001).
  • [ISSN] 0022-1317
  • [Journal-full-title] The Journal of general virology
  • [ISO-abbreviation] J. Gen. Virol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Capsid Proteins; 0 / VP3 protein, Chicken anemia virus
  •  go-up   go-down


30. McNally MM, Wahlin KJ, Canto-Soler MV: Endogenous expression of ASLV viral proteins in specific pathogen free chicken embryos: relevance for the developmental biology research field. BMC Dev Biol; 2010 Oct 18;10:106
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The use of Specific Pathogen Free (SPF) eggs in combination with RCAS retrovirus, a member of the Avian Sarcoma-Leukosis Virus (ASLV) family, is of standard practice to study gene function and development.

  • SciCrunch. The Antibody Registry: Reagent: Antibodies .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Poult Sci. 1991 Mar;70(3):618-23 [1646446.001]
  • [Cites] J Virol. 1988 Jan;62(1):75-83 [2824857.001]
  • [Cites] Poult Sci. 1998 Aug;77(8):1204-12 [9706091.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Virol Methods. 1999 Mar;78(1-2):1-11 [10204692.001]
  • [Cites] Dev Biol. 2006 Jun 1;294(1):119-32 [16564518.001]
  • [Cites] Avian Dis. 2008 Sep;52(3):412-8 [18939628.001]
  • [Cites] Avian Dis. 2008 Sep;52(3):433-40 [18939631.001]
  • [Cites] Dev Dyn. 2009 Apr;238(4):797-811 [19253393.001]
  • [Cites] Poult Sci. 2000 Aug;79(8):1082-93 [10947175.001]
  • [Cites] J Virol. 2001 Apr;75(8):3605-12 [11264350.001]
  • [Cites] DNA Res. 2001 Oct 31;8(5):221-6 [11759842.001]
  • [Cites] J Virol. 2002 Aug;76(15):7518-27 [12097564.001]
  • [Cites] Methods Cell Biol. 2003;71:369-86 [12884700.001]
  • [Cites] Mol Cell Biol. 1982 Jun;2(6):638-52 [14582159.001]
  • [Cites] Avian Pathol. 2004 Apr;33(2):233-43 [15276994.001]
  • [Cites] Acta Biomed. 2004;75 Suppl 1:11-3 [15301282.001]
  • [Cites] Folia Biol (Praha). 2004;50(3-4):107-19 [15373344.001]
  • [Cites] Avian Dis. 1979 Jul-Sep;23(3):698-707 [230808.001]
  • [Cites] Cold Spring Harb Symp Quant Biol. 1980;44 Pt 2,:1105-9 [6253185.001]
  • [Cites] Virus Res. 1998 Mar;54(1):87-98 [9660074.001]
  • (PMID = 20955591.001).
  • [ISSN] 1471-213X
  • [Journal-full-title] BMC developmental biology
  • [ISO-abbreviation] BMC Dev. Biol.
  • [Language] ENG
  • [Grant] United States / NEI NIH HHS / EY / R01 EY004859; United States / NEI NIH HHS / EY / EY1765; United States / PHS HHS / / EYO4859
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Viral Proteins
  • [Other-IDs] NLM/ PMC2973938
  •  go-up   go-down


31. Burnside J, Bernberg E, Anderson A, Lu C, Meyers BC, Green PJ, Jain N, Isaacs G, Morgan RW: Marek's disease virus encodes MicroRNAs that map to meq and the latency-associated transcript. J Virol; 2006 Sep;80(17):8778-86
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Marek's disease virus encodes MicroRNAs that map to meq and the latency-associated transcript.
  • In particular, the oncogenic gammaherpesviruses Kaposi's sarcoma herpesvirus and Epstein-Barr virus encode miRNAs that could potentially regulate either viral or host genes.
  • To determine if Marek's disease virus (MDV), an oncogenic alphaherpesvirus of chickens, encodes miRNAs, we isolated small RNAs from MDV-infected chicken embryo fibroblasts (CEF) and used the 454 Life Sciences sequencing technology to obtain the sequences of 13,679 candidate host and viral small RNAs.
  • [MeSH-minor] Amino Acid Sequence. Animals. Base Sequence. Cell Line, Tumor. Chick Embryo. Fibroblasts / virology. Marek Disease / virology. Molecular Sequence Data. RNA, Viral / genetics. RNA, Viral / metabolism


32. Chang KW, Barsov EV, Ferris AL, Hughes SH: Mutations of a residue within the polyproline-rich region of Env alter the replication rate and level of cytopathic effects in chimeric avian retroviral vectors. J Virol; 2005 Aug;79(16):10258-67
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mutations of a residue within the polyproline-rich region of Env alter the replication rate and level of cytopathic effects in chimeric avian retroviral vectors.
  • Previous attempts to extend the host range of the avian sarcoma/leukosis virus (ASLV)-based RCASBP vectors produced two viral vectors, RCASBP M2C (4070A) and RCASBP M2C (797-8), which replicate using the amphotropic murine leukemia virus 4070A Env protein (2).
  • Both viruses were adapted to replicate efficiently in the avian cell line DF-1, but RCASBP M2C (4070A) caused extensive cytopathic effects (CPE) in DF-1 cells whereas RCASBP M2C (797-8) induced low levels of CPE.
  • [MeSH-major] Cytopathogenic Effect, Viral. Gene Products, env / chemistry. Orthoreovirus, Avian / physiology. Virus Replication

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DANTROLENE .
  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurochem. 2000 Jul;75(1):81-90 [10854250.001]
  • [Cites] J Virol. 1998 Dec;72(12):9955-65 [9811733.001]
  • [Cites] J Virol. 2001 Jun;75(11):4973-83 [11333876.001]
  • [Cites] J Virol. 2001 Jul;75(13):6007-15 [11390602.001]
  • [Cites] EMBO J. 2001 Jun 15;20(12):3272-81 [11406603.001]
  • [Cites] J Virol. 2002 Oct;76(19):9673-85 [12208946.001]
  • [Cites] Mamm Genome. 2002 Oct;13(10):543-7 [12420130.001]
  • [Cites] Biochem Biophys Res Commun. 2003 May 9;304(3):445-54 [12729578.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 Jul;4(7):552-65 [12838338.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8764-9 [12857957.001]
  • [Cites] Nat Rev Neurosci. 2003 Aug;4(8):672-84 [12894242.001]
  • [Cites] J Virol. 2003 Oct;77(20):10841-9 [14512534.001]
  • [Cites] J Virol. 2003 Dec;77(23):12552-61 [14610178.001]
  • [Cites] J Mol Biol. 1967 Jun 14;26(2):365-9 [4291934.001]
  • [Cites] Virology. 1973 Apr;52(2):456-67 [4705382.001]
  • [Cites] J Virol. 1979 Aug;31(2):376-88 [225560.001]
  • [Cites] J Virol. 1980 Jan;33(1):494-506 [6245246.001]
  • [Cites] J Virol. 1981 Sep;39(3):713-21 [6270346.001]
  • [Cites] Virology. 1982 Jan 30;116(2):499-516 [6175079.001]
  • [Cites] Nature. 1986 Jan 23-29;319(6051):333-6 [3001539.001]
  • [Cites] J Virol. 1990 Oct;64(10):4836-41 [2398529.001]
  • [Cites] J Exp Med. 1990 Oct 1;172(4):1035-42 [2212939.001]
  • [Cites] J Virol. 1990 Dec;64(12):6176-83 [1700832.001]
  • [Cites] J Virol. 1992 Mar;66(3):1468-75 [1310758.001]
  • [Cites] J Virol. 1993 Jun;67(6):3489-96 [7684467.001]
  • [Cites] Cell. 1993 Sep 24;74(6):1043-51 [8402880.001]
  • [Cites] J Virol. 1996 Jun;70(6):3922-9 [8648729.001]
  • [Cites] Cell. 1996 Nov 29;87(5):845-55 [8945512.001]
  • [Cites] J Virol. 1997 Nov;71(11):8103-8 [9343159.001]
  • [Cites] Methods Cell Biol. 1997;52:179-214 [9379950.001]
  • [Cites] J Virol. 1998 Jul;72(7):5383-91 [9620992.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Virol. 2001 May;75(9):4357-66 [11287584.001]
  • (PMID = 16051819.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / Gene Products, env; 0 / Peptides; 25191-13-3 / polyproline; F64QU97QCR / Dantrolene; SY7Q814VUP / Calcium
  • [Other-IDs] NLM/ PMC1182669
  •  go-up   go-down


33. Stewart-Maynard KM, Cruceanu M, Wang F, Vo MN, Gorelick RJ, Williams MC, Rouzina I, Musier-Forsyth K: Retroviral nucleocapsid proteins display nonequivalent levels of nucleic acid chaperone activity. J Virol; 2008 Oct;82(20):10129-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this work, complementary experimental approaches were used to characterize and compare the chaperone activities of NC proteins from four different retroviruses: HIV-1, Moloney murine leukemia virus (MLV), Rous sarcoma virus (RSV), and human T-cell lymphotropic virus type 1 (HTLV-1).

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Mol Biol. 2003 Feb 21;326(3):691-700 [12581633.001]
  • [Cites] J Mol Biol. 2003 Mar 28;327(3):571-8 [12634053.001]
  • [Cites] J Mol Biol. 2003 Apr 18;328(1):95-108 [12684000.001]
  • [Cites] Nucleic Acids Res. 2003 Jul 1;31(13):3406-15 [12824337.001]
  • [Cites] J Mol Biol. 2004 Mar 19;337(2):427-42 [15003457.001]
  • [Cites] J Mol Biol. 2004 Apr 2;337(4):951-68 [15033363.001]
  • [Cites] J Mol Biol. 2004 Feb 27;336(4):851-70 [15095865.001]
  • [Cites] J Mol Biol. 2004 May 7;338(4):711-23 [15099739.001]
  • [Cites] Annu Rev Biophys Biomol Struct. 2004;33:415-40 [15139820.001]
  • [Cites] J Mol Biol. 2004 Jul 30;341(1):27-36 [15312760.001]
  • [Cites] Q Rev Biophys. 1978 May;11(2):179-246 [353876.001]
  • [Cites] J Biol Chem. 1981 Aug 25;256(16):8400-6 [6267042.001]
  • [Cites] Science. 1986 Apr 25;232(4749):485-7 [2421409.001]
  • [Cites] J Biol Chem. 1987 Apr 15;262(11):4961-7 [2435721.001]
  • [Cites] J Virol. 1987 Oct;61(10):3004-12 [3041020.001]
  • [Cites] EMBO J. 1988 Jun;7(6):1777-83 [2458920.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Aug;87(16):6403-7 [2385599.001]
  • [Cites] J Mol Biol. 1990 Dec 5;216(3):689-99 [2124274.001]
  • [Cites] Nucleic Acids Res. 1991 Jul 11;19(13):3533-41 [1906602.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6472-6 [1631144.001]
  • [Cites] Protein Sci. 1993 Jan;2(1):3-19 [8443588.001]
  • [Cites] Protein Sci. 1993 Feb;2(2):231-43 [8443601.001]
  • [Cites] J Biol Chem. 1993 Aug 5;268(22):16519-27 [8344933.001]
  • [Cites] Annu Rev Biochem. 1993;62:255-87 [7688943.001]
  • [Cites] J Virol. 1994 Aug;68(8):5013-8 [8035501.001]
  • [Cites] J Virol. 1994 Sep;68(9):5863-70 [8057466.001]
  • [Cites] J Biol Chem. 1994 Sep 9;269(36):22538-46 [8077202.001]
  • [Cites] J Virol. 1995 Mar;69(3):1907-12 [7853532.001]
  • [Cites] Biopolymers. 1995 Sep;36(3):345-64 [7669919.001]
  • [Cites] J Biol Chem. 1995 Sep 8;270(36):20871-4 [7545662.001]
  • [Cites] J Mol Biol. 1995 Dec 8;254(4):523-37 [7500330.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7577-81 [8755517.001]
  • [Cites] J Virol. 1996 Aug;70(8):4996-5004 [8764006.001]
  • [Cites] Mol Endocrinol. 1996 Jun;10(6):607-12 [8776720.001]
  • [Cites] Curr Top Microbiol Immunol. 1996;214:177-218 [8791728.001]
  • [Cites] Nucleic Acids Res. 1997 Mar 1;25(5):1042-9 [9023116.001]
  • [Cites] Biopolymers. 1997 Mar;41(3):301-12 [9057495.001]
  • [Cites] J Mol Biol. 1997 May 2;268(2):250-60 [9159468.001]
  • [Cites] J Virol. 1997 Jul;71(7):5178-88 [9188585.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13530-5 [9391060.001]
  • [Cites] Science. 1998 Jan 16;279(5349):384-8 [9430589.001]
  • [Cites] Biopolymers. 1998 Mar;45(3):217-29 [9465785.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):459-64 [9892655.001]
  • [Cites] J Mol Biol. 1999 Mar 19;287(1):59-75 [10074407.001]
  • [Cites] Biochemistry. 1999 Mar 23;38(12):3821-30 [10090772.001]
  • [Cites] J Virol. 1999 May;73(5):4251-6 [10196321.001]
  • [Cites] J Virol. 1999 Aug;73(8):6670-9 [10400764.001]
  • [Cites] Nature. 2004 Sep 30;431(7008):586-90 [15457265.001]
  • [Cites] J Biol Chem. 2004 Oct 15;279(42):44154-65 [15271979.001]
  • [Cites] J Mol Biol. 1968 Feb 14;31(3):349-70 [5637197.001]
  • [Cites] Biopolymers. 1976 Jul;15(7):1345-75 [949539.001]
  • [Cites] J Mol Biol. 1976 Oct 25;107(2):145-58 [1003464.001]
  • [Cites] J Virol. 1998 Mar;72(3):1902-9 [9499042.001]
  • [Cites] J Mol Biol. 1998 Mar 27;277(2):225-35 [9514748.001]
  • [Cites] J Biol Chem. 1998 May 8;273(19):11463-71 [9565558.001]
  • [Cites] Biopolymers. 1997;44(3):269-82 [9591479.001]
  • [Cites] Trends Biochem Sci. 1998 Aug;23(8):297-301 [9757830.001]
  • [Cites] Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W577-81 [15980540.001]
  • [Cites] Nucleic Acids Res. 2005;33(14):4395-403 [16077025.001]
  • [Cites] Biophys J. 2005 Sep;89(3):1941-56 [15994897.001]
  • [Cites] Prog Nucleic Acid Res Mol Biol. 2005;80:217-86 [16164976.001]
  • [Cites] Phys Rev Lett. 2005 Oct 7;95(15):158102 [16241765.001]
  • [Cites] Biophys J. 2005 Nov;89(5):3470-9 [16100256.001]
  • [Cites] Nucleic Acids Res. 2006;34(2):472-84 [16434700.001]
  • [Cites] Nucleic Acids Res. 2006;34(2):593-605 [16449201.001]
  • [Cites] J Mol Biol. 2006 Oct 13;363(1):244-61 [16962137.001]
  • [Cites] Biochemistry. 2006 Oct 17;45(41):12617-28 [17029416.001]
  • [Cites] Anal Biochem. 2006 Nov 15;358(2):159-70 [17034752.001]
  • [Cites] J Mol Biol. 2006 Nov 10;363(5):867-77 [16997322.001]
  • [Cites] J Mol Biol. 2006 Dec 1;364(3):496-511 [17020765.001]
  • [Cites] J Biol Chem. 2006 Dec 15;281(50):38689-96 [17050544.001]
  • [Cites] J Mol Biol. 2007 Jan 12;365(2):453-67 [17070546.001]
  • [Cites] Biopolymers. 2007 Feb 5;85(2):154-68 [17080421.001]
  • [Cites] PLoS One. 2007;2(7):e669 [17712401.001]
  • [Cites] Biochemistry. 2007 Dec 18;46(50):14650-62 [18027912.001]
  • [Cites] J Mol Biol. 2002 May 3;318(3):749-64 [12054820.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Jun 28;294(5):949-55 [12074568.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8614-9 [12084921.001]
  • [Cites] Curr Opin Struct Biol. 2002 Jun;12(3):330-6 [12127451.001]
  • [Cites] Prog Nucleic Acid Res Mol Biol. 2002;72:223-68 [12206453.001]
  • [Cites] J Mol Biol. 2003 Jan 3;325(1):1-10 [12473448.001]
  • [Cites] J Virol. 2003 Jan;77(2):1598-603 [12502875.001]
  • [Cites] Biophys J. 1999 Sep;77(3):1547-55 [10465765.001]
  • [Cites] Biochemistry. 2005 Mar 15;44(10):3735-44 [15751950.001]
  • [Cites] J Mol Biol. 2005 May 6;348(3):549-61 [15826653.001]
  • [Cites] J Mol Biol. 2005 May 20;348(5):1059-77 [15854644.001]
  • [Cites] J Mol Biol. 2005 May 20;348(5):1113-26 [15854648.001]
  • [Cites] J Mol Biol. 2005 Jun 3;349(2):317-30 [15890198.001]
  • [Cites] J Mol Biol. 2005 Jun 24;349(5):976-88 [15907938.001]
  • [Cites] Biochemistry. 1999 Dec 21;38(51):16816-25 [10606514.001]
  • [Cites] Nucleic Acids Res. 2000 Jan 15;28(2):634-40 [10606665.001]
  • [Cites] Biopolymers. 2000 Apr 5;53(4):329-41 [10685053.001]
  • [Cites] J Mol Biol. 2000 May 26;299(1):145-56 [10860728.001]
  • [Cites] J Mol Biol. 2000 Aug 11;301(2):491-511 [10926523.001]
  • [Cites] J Virol. 2000 Oct;74(19):8785-92 [10982320.001]
  • [Cites] J Virol. 2000 Oct;74(19):8980-8 [10982342.001]
  • [Cites] Biochim Biophys Acta. 2000 Sep 29;1481(2):381-94 [11018730.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 May 22;98(11):6121-6 [11344257.001]
  • [Cites] J Mol Biol. 2001 May 25;309(1):57-68 [11491301.001]
  • [Cites] J Mol Biol. 2001 Oct 5;312(5):985-97 [11580244.001]
  • [Cites] Biochemistry. 2001 Nov 13;40(45):13644-51 [11695913.001]
  • [Cites] J Mol Biol. 2001 Nov 23;314(2):217-32 [11718556.001]
  • [Cites] J Mol Biol. 2001 Dec 14;314(5):961-70 [11743714.001]
  • [Cites] Protein Eng. 2001 Dec;14(12):993-1000 [11809930.001]
  • [Cites] Acc Chem Res. 2002 Mar;35(3):159-66 [11900519.001]
  • [Cites] J Mol Biol. 2002 Mar 29;317(3):385-99 [11922672.001]
  • (PMID = 18684831.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / GM072396; United States / NIGMS NIH HHS / GM / F32 GM072396; United States / NIGMS NIH HHS / GM / R01 GM065056; United States / NIGMS NIH HHS / GM / GM073462; United States / NIGMS NIH HHS / GM / GM065056; United States / NCI NIH HHS / CA / N01CO12400; United States / NCI NIH HHS / CO / N01-CO-12400
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / Molecular Chaperones; 0 / Nucleic Acids; 0 / Nucleocapsid Proteins; 0 / RNA, Viral
  • [Other-IDs] NLM/ PMC2566285
  •  go-up   go-down


34. Burgos-Rodríguez AG, Garner M, Ritzman TK, Orcutt CJ: Cutaneous lymphosarcoma in a double yellow-headed Amazon parrot (Amazona ochrocephala oratrix). J Avian Med Surg; 2007 Dec;21(4):283-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Because of the rapid and extensive progression of disease, the owners elected euthanasia.
  • [MeSH-major] Amazona. Bird Diseases / diagnosis. Lymphoma, T-Cell, Cutaneous / veterinary. Sarcoma / veterinary. Skin Neoplasms / veterinary

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18351007.001).
  • [ISSN] 1082-6742
  • [Journal-full-title] Journal of avian medicine and surgery
  • [ISO-abbreviation] J. Avian Med. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


35. Driss V, Legrand F, Loiseau S, Capron M: [Eosinophil: a new effector of innate immunity?]. Med Sci (Paris); 2010 Jun-Jul;26(6-7):621-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] L'éosinophile : nouvel acteur de la réponse immunitaire innée ?
  • [MeSH-minor] Animals. Bacterial Infections / immunology. Birds. Cytoplasmic Granules / immunology. Humans. Parasitic Diseases / immunology. Phylogeny. Receptors, Antigen, T-Cell, gamma-delta / immunology. Rous sarcoma virus / immunology. Sarcoma, Avian / virology. Toll-Like Receptors / immunology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20619165.001).
  • [ISSN] 0767-0974
  • [Journal-full-title] Medecine sciences : M/S
  • [ISO-abbreviation] Med Sci (Paris)
  • [Language] fre
  • [Publication-type] Journal Article; Review
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Receptors, Antigen, T-Cell, gamma-delta; 0 / Toll-Like Receptors
  • [Number-of-references] 33
  •  go-up   go-down


36. Chang KW, Oh J, Alvord WG, Hughes SH: The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase. J Virol; 2008 Sep;82(17):8592-604
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase.
  • We previously reported that a mutant Rous sarcoma virus (RSV) with an alternate polypurine tract (PPT), DuckHepBFlipPPT, had unexpectedly high titers and that the PPT was miscleaved primarily at one position following a GA dinucleotide by the RNase H of reverse transcriptase (RT).

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. GUANINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Nov;74(22):10293-303 [11044073.001]
  • [Cites] J Virol. 2008 Jan;82(1):503-12 [17959663.001]
  • [Cites] J Virol. 2001 Jun;75(11):4973-83 [11333876.001]
  • [Cites] EMBO J. 2001 Jun 15;20(12):3272-81 [11406603.001]
  • [Cites] Biochemistry. 2002 Apr 16;41(15):4856-65 [11939780.001]
  • [Cites] J Biol Chem. 2002 May 10;277(19):16689-96 [11875059.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9515-20 [12093908.001]
  • [Cites] J Virol. 2008 Jan;82(2):719-27 [17989171.001]
  • [Cites] J Virol. 2003 Oct;77(20):11150-7 [14512562.001]
  • [Cites] J Mol Biol. 2003 Dec 5;334(4):653-65 [14636594.001]
  • [Cites] Nucleic Acids Res. 2004;32(4):1539-47 [15004241.001]
  • [Cites] Int J Biochem Cell Biol. 2004 Sep;36(9):1752-66 [15183342.001]
  • [Cites] EMBO J. 1990 Apr;9(4):1171-6 [1691093.001]
  • [Cites] J Acquir Immune Defic Syndr. 1990;3(9):852-8 [2384863.001]
  • [Cites] J Virol. 1990 Oct;64(10):4903-6 [1697909.001]
  • [Cites] Biochemistry. 1990 Nov 6;29(44):10141-7 [1703002.001]
  • [Cites] Biochemistry. 1991 Jul 23;30(29):7041-6 [1713059.001]
  • [Cites] J Virol. 1992 Jan;66(1):367-73 [1370087.001]
  • [Cites] J Biol Chem. 1992 Jul 25;267(21):15071-9 [1378844.001]
  • [Cites] Annu Rev Cell Biol. 1992;8:275-306 [1282352.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6320-4 [7687065.001]
  • [Cites] EMBO J. 1998 Jul 1;17(13):3766-74 [9649446.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Virol. 1999 Feb;73(2):948-57 [9882295.001]
  • [Cites] J Virol. 2004 Dec;78(23):13315-24 [15542682.001]
  • [Cites] J Virol. 2005 Jun;79(11):6859-67 [15890925.001]
  • [Cites] J Biol Chem. 2005 May 20;280(20):20154-62 [15778225.001]
  • [Cites] J Virol. 2005 Nov;79(21):13694-704 [16227289.001]
  • [Cites] J Virol. 2006 Jan;80(1):451-9 [16352569.001]
  • [Cites] J Biol Chem. 2006 Jan 27;281(4):1943-55 [16306040.001]
  • [Cites] Nucleic Acids Res. 2007;35(1):256-68 [17164285.001]
  • [Cites] Virology. 2007 Apr 10;360(2):341-9 [17123564.001]
  • [Cites] EMBO J. 2001 Mar 15;20(6):1449-61 [11250910.001]
  • (PMID = 18562520.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Purines; 5Z93L87A1R / Guanine; EC 2.7.7.49 / RNA-Directed DNA Polymerase; EC 3.1.26.4 / Ribonuclease H; JAC85A2161 / Adenine
  • [Other-IDs] NLM/ PMC2519663
  •  go-up   go-down


37. Côté M, Zheng YM, Liu SL: Receptor binding and low pH coactivate oncogenic retrovirus envelope-mediated fusion. J Virol; 2009 Nov;83(22):11447-55
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Fusion of enveloped viruses with host cells is triggered by either receptor binding or low pH but rarely requires both except for avian sarcoma leukosis virus (ASLV).

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Jul;74(14):6469-75 [10864659.001]
  • [Cites] J Virol. 2008 Sep;82(18):9023-34 [18632865.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4443-8 [11296287.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4449-54 [11296288.001]
  • [Cites] Annu Rev Biochem. 2001;70:777-810 [11395423.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12386-90 [12218182.001]
  • [Cites] J Virol. 2003 Mar;77(5):2850-8 [12584308.001]
  • [Cites] Curr Top Microbiol Immunol. 2003;275:139-77 [12596898.001]
  • [Cites] J Virol. 2003 Apr;77(8):4722-30 [12663779.001]
  • [Cites] J Virol. 2003 Jul;77(14):7924-35 [12829832.001]
  • [Cites] J Virol. 2004 Feb;78(3):1403-10 [14722295.001]
  • [Cites] EMBO J. 2004 Jan 14;23(1):54-65 [14685283.001]
  • [Cites] J Virol. 2004 Aug;78(15):8201-9 [15254191.001]
  • [Cites] Virology. 1986 Dec;155(2):484-97 [3788061.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14306-13 [9405608.001]
  • [Cites] J Virol. 2004 Dec;78(24):13430-9 [15564453.001]
  • [Cites] J Virol. 2005 Jan;79(1):79-86 [15596803.001]
  • [Cites] Nature. 2005 Apr 14;434(7035):904-7 [15829964.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8728-33 [15937118.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11876-81 [16081529.001]
  • [Cites] J Virol. 2005 Oct;79(20):12714-20 [16188974.001]
  • [Cites] J Virol. 2005 Dec;79(23):14482-8 [16282447.001]
  • [Cites] J Virol. 2005 Dec;79(23):14489-97 [16282448.001]
  • [Cites] Nat Rev Microbiol. 2006 Jan;4(1):67-76 [16357862.001]
  • [Cites] Virology. 2006 Jan 5;344(1):38-47 [16364734.001]
  • [Cites] J Biol Chem. 2006 Feb 10;281(6):3198-203 [16339146.001]
  • [Cites] Virology. 2006 Mar 15;346(2):251-7 [16460775.001]
  • [Cites] J Virol. 2006 Apr;80(8):4174-8 [16571833.001]
  • [Cites] Science. 2006 Jul 14;313(5784):187-91 [16840692.001]
  • [Cites] Science. 2006 Jul 14;313(5784):217-20 [16840698.001]
  • [Cites] J Virol. 2006 Aug;80(16):8030-7 [16873259.001]
  • [Cites] Retrovirology. 2006;3:94 [17177996.001]
  • [Cites] J Virol. 2007 Apr;81(7):3124-9 [17229709.001]
  • [Cites] Virus Genes. 2007 Aug;35(1):73-80 [17043760.001]
  • [Cites] J Virol. 2007 Jul;81(14):7702-9 [17475648.001]
  • [Cites] J Virol. 2007 Oct;81(19):10506-14 [17634228.001]
  • [Cites] PLoS Pathog. 2007 Dec 21;3(12):e198 [18260686.001]
  • [Cites] J Virol. 2008 Mar;82(5):2555-9 [18094164.001]
  • [Cites] J Virol. 2008 Mar;82(5):2543-54 [18094165.001]
  • [Cites] J Virol. 2008 Mar;82(5):2358-66 [18094169.001]
  • [Cites] Crit Rev Biochem Mol Biol. 2008 May-Jun;43(3):189-219 [18568847.001]
  • [Cites] Cell. 2000 Nov 10;103(4):679-89 [11106737.001]
  • (PMID = 19726505.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] Canada / Canadian Institutes of Health Research / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptors, Virus; 0 / Viral Fusion Proteins
  • [Other-IDs] NLM/ PMC2772678
  •  go-up   go-down


38. Kanno T, Takahashi T, Tsujisawa T, Ariyoshi W, Nishihara T: Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts. J Cell Biochem; 2007 Aug 1;101(5):1266-77
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Small interfering RNA (siRNA) targeting Rous sarcoma kinase (RAS), an upstream regulator of both ERK1/2 and p38 MAPKs, inhibited stretch-induced ERK1/2 activation, but not mechanically induced p38 MAPK activity.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 Wiley-Liss, Inc.
  • (PMID = 17265428.001).
  • [ISSN] 0730-2312
  • [Journal-full-title] Journal of cellular biochemistry
  • [ISO-abbreviation] J. Cell. Biochem.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Core Binding Factor Alpha 1 Subunit; 0 / Enzyme Inhibitors; 0 / RNA, Messenger; 0 / RNA, Small Interfering; 0 / Runx2 protein, mouse; 0 / Runx2 protein, rat; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 1; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 3; EC 3.1.3.1 / Alkaline Phosphatase; EC 3.6.5.2 / ras Proteins
  •  go-up   go-down


39. Briggs JA, Johnson MC, Simon MN, Fuller SD, Vogt VM: Cryo-electron microscopy reveals conserved and divergent features of gag packing in immature particles of Rous sarcoma virus and human immunodeficiency virus. J Mol Biol; 2006 Jan 6;355(1):157-68
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cryo-electron microscopy reveals conserved and divergent features of gag packing in immature particles of Rous sarcoma virus and human immunodeficiency virus.
  • Here we have used cryo-electron microscopy (cryo-EM) and image processing to determine the lateral and radial arrangement of Gag in in vivo and in vitro assembled Rous sarcoma virus (RSV) particles and to compare these features with those of HIV-1.
  • [MeSH-major] Avian Sarcoma Viruses / chemistry. Gene Products, gag / chemistry. HIV / chemistry. Virion / chemistry

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16289202.001).
  • [ISSN] 0022-2836
  • [Journal-full-title] Journal of molecular biology
  • [ISO-abbreviation] J. Mol. Biol.
  • [Language] eng
  • [Grant] United States / NIBIB NIH HHS / EB / 5-P41-EB2181; United States / NCI NIH HHS / CA / CA20081; United Kingdom / Wellcome Trust / /
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Gene Products, gag
  •  go-up   go-down


40. Oh J, Chang KW, Hughes SH: Integration of rous sarcoma virus DNA: a CA dinucleotide is not required for integration of the U3 end of viral DNA. J Virol; 2008 Nov;82(22):11480-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Integration of rous sarcoma virus DNA: a CA dinucleotide is not required for integration of the U3 end of viral DNA.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2001 Apr;75(8):3556-67 [11264345.001]
  • [Cites] J Virol. 2008 Sep;82(17):8592-604 [18562520.001]
  • [Cites] J Virol. 2003 Oct;77(20):11150-7 [14512562.001]
  • [Cites] Nucleic Acids Res. 2004;32(4):1539-47 [15004241.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 May;86(9):3065-9 [2524066.001]
  • [Cites] Cell. 1989 Jul 14;58(1):47-54 [2546673.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jul;87(13):5119-23 [2164223.001]
  • [Cites] Cell. 1990 Aug 24;62(4):829-37 [2167180.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1339-43 [1847518.001]
  • [Cites] J Virol. 1991 Sep;65(9):4636-44 [1870194.001]
  • [Cites] J Virol. 1991 Oct;65(10):5624-30 [1895409.001]
  • [Cites] J Virol. 1992 Apr;66(4):2359-68 [1548767.001]
  • [Cites] J Virol. 1995 May;69(5):3233-6 [7707558.001]
  • [Cites] J Virol. 1995 Sep;69(9):5904-7 [7637038.001]
  • [Cites] J Virol. 1996 Aug;70(8):5288-96 [8764039.001]
  • [Cites] J Virol. 1996 Dec;70(12):9069-73 [8971046.001]
  • [Cites] J Virol. 1997 Feb;71(2):1025-35 [8995622.001]
  • [Cites] J Virol. 1998 Oct;72(10):8396-402 [9733892.001]
  • [Cites] J Virol. 2004 Dec;78(23):13315-24 [15542682.001]
  • [Cites] J Virol. 2005 Nov;79(21):13694-704 [16227289.001]
  • [Cites] J Virol. 2006 Jan;80(1):451-9 [16352569.001]
  • [Cites] J Virol. 2006 Oct;80(20):10281-4 [17005708.001]
  • [Cites] J Virol. 2008 Jan;82(1):503-12 [17959663.001]
  • [Cites] J Virol. 2003 Jun;77(11):6482-92 [12743305.001]
  • (PMID = 18768972.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; EC 2.7.7.- / Integrases
  • [Other-IDs] NLM/ PMC2573277
  •  go-up   go-down


41. Maeda N, Yoshikai Y: [New molecular mechanisms of virus-mediated carcinogenesis: oncogenic transformation of cells by retroviral structural protein Envelope]. Uirusu; 2007 Dec;57(2):159-70
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RNA tumor viruses as classified in Retroviruses have been isolated and identified to induce tumors in a variety of animals including chickens, mice, and rats, or even in human in the last 100 years, since the first one has been reported in 1908.
  • The RNA tumor viruses have been historically classified into two groups, acute transforming RNA tumor viruses and nonacute RNA tumor viruses.
  • Acute transforming RNA tumor viruses are basically replication-defective and rapidly induce tumors by expressing the viral oncogenes captured from cellular genome in host cells.
  • The first oncogene derived from Rous sarcoma virus was the src non-receptor tyrosine kinase, which has been identified to play the significant roles for signal transduction.
  • On the other hand, nonacute RNA tumor viruses, which consist of only gag, pro, pol, and env regions but do not carry oncogenes, are replication-competent and could activate the cellular proto-oncogenes by inserting the viral long terminal repeat close to the proto-oncogenes to induce tumors with a long incubation period, as is termed a promoter insertion.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18357754.001).
  • [ISSN] 0042-6857
  • [Journal-full-title] Uirusu
  • [ISO-abbreviation] Uirusu
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Viral Envelope Proteins; EC 2.7.10.2 / src-Family Kinases
  • [Number-of-references] 100
  •  go-up   go-down


42. Chen P, Tian J, Kovesdi I, Bruder JT: Promoters influence the kinetics of transgene expression following adenovector gene delivery. J Gene Med; 2008 Feb;10(2):123-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In contrast, transgene expression from the Rous sarcoma virus (RSV) promoter increased over time such that, at 3 weeks, expression was 10-fold higher than that from the CMV promoter-containing vector in all tissues.
  • [MeSH-minor] Animals. Cell Line. Cytomegalovirus / genetics. Female. Humans. Immunity, Cellular. Immunocompetence. Injections, Intravenous. Kinetics. Luciferases / metabolism. Mice. Mice, Inbred BALB C. Mice, Inbred C57BL. Mice, Nude. Muscle, Skeletal / metabolism. Rous sarcoma virus / genetics. Time Factors. Transduction, Genetic

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18064718.001).
  • [ISSN] 1099-498X
  • [Journal-full-title] The journal of gene medicine
  • [ISO-abbreviation] J Gene Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] EC 1.13.12.- / Luciferases
  •  go-up   go-down


43. Klucking S, Collins AS, Young JA: Avian sarcoma and leukosis virus cytopathic effect in the absence of TVB death domain signaling. J Virol; 2005 Jul;79(13):8243-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Avian sarcoma and leukosis virus cytopathic effect in the absence of TVB death domain signaling.
  • The cytopathic effect (CPE) seen with some subgroups of avian sarcoma and leukosis virus (ASLV) is associated with viral Env activation of the death-promoting activity of TVB (a tumor necrosis factor receptor-related receptor that is most closely related to mammalian TNF-related apoptosis-inducing ligand [TRAIL] receptors) and with viral superinfection leading to unintegrated viral DNA (UVD) accumulation, which is presumed to activate a cellular DNA damage response.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 2000 Feb 15;60(4):847-53 [10706092.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9867-72 [10449786.001]
  • [Cites] Adv Exp Med Biol. 2000;465:143-51 [10810622.001]
  • [Cites] Leukemia. 2000 Aug;14(8):1509-13 [10942251.001]
  • [Cites] Blood. 2000 Dec 1;96(12):3900-6 [11090076.001]
  • [Cites] J Virol. 2000 Dec;74(24):11490-4 [11090145.001]
  • [Cites] Cell. 2001 Feb 23;104(4):487-501 [11239407.001]
  • [Cites] Apoptosis. 2001 Feb-Apr;6(1-2):103-16 [11321033.001]
  • [Cites] J Virol. 2001 Jul;75(13):6007-15 [11390602.001]
  • [Cites] EMBO J. 2001 Jun 15;20(12):3272-81 [11406603.001]
  • [Cites] Pathol Oncol Res. 2001;7(2):95-106 [11458271.001]
  • [Cites] Virology. 2002 Jan 5;292(1):150-5 [11878917.001]
  • [Cites] J Virol. 2002 Jun;76(11):5404-10 [11991969.001]
  • [Cites] Apoptosis. 2002 Aug;7(4):313-9 [12101390.001]
  • [Cites] Cancer Biol Ther. 2002 Sep-Oct;1(5):520-7 [12496481.001]
  • [Cites] J Virol. 2003 Feb;77(3):1977-83 [12525631.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4778-83 [12679521.001]
  • [Cites] Cancer Biol Ther. 2003 May-Jun;2(3):283-90 [12878867.001]
  • [Cites] J Virol. 2003 Dec;77(23):12552-61 [14610178.001]
  • [Cites] Virology. 2004 Jan 5;318(1):371-80 [14972562.001]
  • [Cites] J Virol. 1979 Aug;31(2):376-88 [225560.001]
  • [Cites] J Virol. 1980 Jan;33(1):494-506 [6245246.001]
  • [Cites] J Virol. 1981 Sep;39(3):713-21 [6270346.001]
  • [Cites] Cell. 1986 May 9;45(3):365-74 [3009025.001]
  • [Cites] J Exp Med. 1990 Oct 1;172(4):1035-42 [2212939.001]
  • [Cites] J Virol. 1991 Aug;65(8):4461-9 [1649341.001]
  • [Cites] J Virol. 1992 Oct;66(10):5777-87 [1527842.001]
  • [Cites] J Virol. 1993 Apr;67(4):1811-6 [8383211.001]
  • [Cites] Cell. 1993 Sep 24;74(6):1043-51 [8402880.001]
  • [Cites] J Gen Virol. 1993 Dec;74 ( Pt 12):2619-28 [8277267.001]
  • [Cites] Curr Top Microbiol Immunol. 1996;205:159-79 [8575195.001]
  • [Cites] Prog Mol Subcell Biol. 1996;16:13-43 [8822790.001]
  • [Cites] Cell. 1996 Nov 29;87(5):845-55 [8945512.001]
  • [Cites] Science. 1997 Apr 4;276(5309):111-3 [9082980.001]
  • [Cites] J Biol Chem. 1997 Oct 10;272(41):25417-20 [9325248.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11617-22 [9326659.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] Cancer Res. 1999 Feb 1;59(3):734-41 [9973225.001]
  • [Cites] Curr Opin Cell Biol. 1999 Apr;11(2):255-60 [10209153.001]
  • [Cites] Science. 1999 Apr 23;284(5414):644-7 [10213687.001]
  • [Cites] J Virol. 2000 Apr;74(8):3572-78 [10729132.001]
  • (PMID = 15956570.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA062000; United States / NCI NIH HHS / CA / CA62000
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA Primers; 0 / Gene Products, env; 0 / Receptors, Virus
  • [Other-IDs] NLM/ PMC1143719
  •  go-up   go-down


44. Lonquety M, Chomilier J, Papandreou N, Lacroix Z: Prediction of stability upon point mutation in the context of the folding nucleus. OMICS; 2010 Apr;14(2):151-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Avian Sarcoma Viruses / enzymology. Avian Sarcoma Viruses / genetics. Integrases / chemistry. Monte Carlo Method. Protein Folding. Protein Stability

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20337532.001).
  • [ISSN] 1557-8100
  • [Journal-full-title] Omics : a journal of integrative biology
  • [ISO-abbreviation] OMICS
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Proteins; EC 2.7.7.- / Integrases
  •  go-up   go-down


45. Majhen D, Brozovic A, Buger T, Gabrilovac J, Osmak M, Ambriović-Ristov A: Vincristine-resistant human laryngeal carcinoma cells demonstrate increased Rous sarcoma virus promoter activity. Life Sci; 2010 Oct 9;87(15-16):468-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vincristine-resistant human laryngeal carcinoma cells demonstrate increased Rous sarcoma virus promoter activity.
  • [MeSH-major] Adenoviridae / genetics. Gene Expression Regulation, Neoplastic. Gene Transfer Techniques. Laryngeal Neoplasms / therapy. Rous sarcoma virus / genetics
  • [MeSH-minor] Antineoplastic Agents, Phytogenic / pharmacology. Cell Line, Tumor. Coxsackie and Adenovirus Receptor-Like Membrane Protein. Drug Resistance, Neoplasm. Genetic Therapy / methods. Genetic Vectors. Humans. Promoter Regions, Genetic. Receptors, Virus / metabolism. Reverse Transcriptase Polymerase Chain Reaction. Transgenes. Vincristine / pharmacology

  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20837033.001).
  • [ISSN] 1879-0631
  • [Journal-full-title] Life sciences
  • [ISO-abbreviation] Life Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / CLMP protein, human; 0 / Coxsackie and Adenovirus Receptor-Like Membrane Protein; 0 / Receptors, Virus; 5J49Q6B70F / Vincristine
  •  go-up   go-down


46. Minemura M, Shimizu Y, Hirano K, Nakayama Y, Tokimitsu Y, Tajiri K, Yamada K, Xue F, Takahara T, Watanabe A, Sugiyama T: Functional analysis of transactivation by mutants of hepatitis B virus X gene in human hepatocellular carcinoma. Oncol Rep; 2005 Aug;14(2):495-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Functional analysis of the mutants of the X gene was performed on the long terminal repeat of the Rous sarcoma virus in a transient transfection assay.
  • [MeSH-minor] Animals. Avian Sarcoma Viruses / genetics. Base Sequence. Carcinoma, Hepatocellular / genetics. Carcinoma, Hepatocellular / pathology. Cell Line, Tumor. Cell-Free System. Genetic Vectors / genetics. Humans. Molecular Sequence Data. Protein Biosynthesis / genetics. Rabbits. Reticulocytes / metabolism. Sequence Homology, Nucleic Acid. Transcription, Genetic / genetics. Transfection

  • Genetic Alliance. consumer health - Hepatitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16012736.001).
  • [ISSN] 1021-335X
  • [Journal-full-title] Oncology reports
  • [ISO-abbreviation] Oncol. Rep.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Trans-Activators; 0 / hepatitis B virus X protein
  •  go-up   go-down


47. Kang Y, Moressi CJ, Scheetz TE, Xie L, Tran DT, Casavant TL, Ak P, Benham CJ, Davidson BL, McCray PB Jr: Integration site choice of a feline immunodeficiency virus vector. J Virol; 2006 Sep;80(17):8820-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • FIV integration preferences are more similar to those of primate lentiviruses and distinct from those of Moloney murine leukemia virus, avian sarcoma leukosis virus, and foamy virus.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2005 Apr;79(8):5211-4 [15795304.001]
  • [Cites] Science. 2003 Jun 13;300(5626):1749-51 [12805549.001]
  • [Cites] J Biol Chem. 2005 May 6;280(18):17841-7 [15749713.001]
  • [Cites] Gene Ther. 2005 Jul;12(14):1089-98 [16003340.001]
  • [Cites] Blood. 2005 Sep 1;106(5):1552-8 [15886327.001]
  • [Cites] J Virol. 2005 Oct;79(19):12199-204 [16160146.001]
  • [Cites] J Virol. 2004 Sep;78(17):9524-37 [15308744.001]
  • [Cites] PLoS Biol. 2004 Aug;2(8):E234 [15314653.001]
  • [Cites] J Mol Biol. 1992 Jun 5;225(3):835-47 [1602485.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2999-3003 [8385354.001]
  • [Cites] Nat Med. 1998 Mar;4(3):354-7 [9500613.001]
  • [Cites] J Virol. 1999 Jun;73(6):4991-5000 [10233961.001]
  • [Cites] Nat Med. 2005 Dec;11(12):1287-9 [16311605.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1498-503 [16428288.001]
  • [Cites] J Clin Invest. 1999 Dec;104(11):R55-62 [10587528.001]
  • [Cites] Mol Ther. 2001 Jun;3(6):850-6 [11407898.001]
  • [Cites] Hum Gene Ther. 2001 Nov 20;12(17):2109-19 [11747600.001]
  • [Cites] Mol Ther. 2002 Jan;5(1):16-24 [11786041.001]
  • [Cites] Hum Gene Ther. 2002 Apr 10;13(6):689-96 [11936968.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6216-21 [11959904.001]
  • [Cites] J Virol. 2002 Sep;76(18):9378-88 [12186920.001]
  • [Cites] Cell. 2002 Aug 23;110(4):521-9 [12202041.001]
  • [Cites] J Gene Med. 2002 Sep-Oct;4(5):463-9 [12221638.001]
  • [Cites] J Mol Biol. 2002 Oct 25;323(3):441-52 [12381300.001]
  • [Cites] N Engl J Med. 2003 Jan 16;348(3):255-6 [12529469.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6103-7 [15802467.001]
  • (PMID = 16912328.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / R01 HL079023; United States / NHLBI NIH HHS / HL / HL-51670; United States / NHLBI NIH HHS / HL / P01 HL051670; United States / NHLBI NIH HHS / HL / R01 HL075363; United States / NIGMS NIH HHS / GM / R01 GM068903; United States / NHLBI NIH HHS / HL / HL-75363; United States / NHLBI NIH HHS / HL / HL-79023
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Proteins
  • [Other-IDs] NLM/ PMC1563849
  •  go-up   go-down


48. McNally MT: RNA processing control in avian retroviruses. Front Biosci; 2008 May 01;13:3869-83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] RNA processing control in avian retroviruses.
  • Polyadenylation of many retroviral mRNAs is inefficient; in avian retroviruses, approximately 15 percent of viral transcripts extend into and are polyadenylated at downstream host genes, which often has profound biological consequences.
  • Retroviruses have served as important models to study RNA processing and this review summarizes a body of work using avian retroviruses that has led to the discovery of novel RNA splicing and polyadenylation control mechanisms.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Cell Biol. 1990 Feb;10(2):696-704 [2153921.001]
  • [Cites] J Virol. 1990 Sep;64(9):4313-20 [2166819.001]
  • [Cites] Genes Dev. 1990 Sep;4(9):1552-9 [1701407.001]
  • [Cites] RNA. 1999 Dec;5(12):1645-55 [10606274.001]
  • [Cites] Trends Biochem Sci. 2000 Mar;25(3):106-10 [10694877.001]
  • [Cites] J Virol. 2000 Sep;74(18):8513-23 [10954552.001]
  • [Cites] RNA. 2000 Sep;6(9):1197-211 [10999598.001]
  • [Cites] J Virol. 2001 Aug;75(16):7763-8 [11462052.001]
  • [Cites] Nature. 2001 Oct 18;413(6857):701-7 [11607023.001]
  • [Cites] J Biol Chem. 2001 Nov 2;276(44):40464-75 [11526107.001]
  • [Cites] Mol Cell Biol. 2002 Jan;22(1):148-60 [11739730.001]
  • [Cites] Nucleic Acids Res. 2002 Feb 1;30(3):810-7 [11809895.001]
  • [Cites] Nature. 2002 Apr 4;416(6880):499-506 [11932736.001]
  • [Cites] Nucleic Acids Res. 2002 Apr 15;30(8):1842-50 [11937639.001]
  • [Cites] Virology. 2002 Oct 25;302(2):405-12 [12441084.001]
  • [Cites] Nucleic Acids Res. 1998 Dec 1;26(23):5343-50 [9826757.001]
  • [Cites] J Virol. 1999 Mar;73(3):2385-93 [9971822.001]
  • [Cites] J Virol. 1999 Mar;73(3):2394-400 [9971823.001]
  • [Cites] Genes Dev. 1999 Mar 1;13(5):593-606 [10072387.001]
  • [Cites] RNA. 1999 Mar;5(3):333-43 [10094303.001]
  • [Cites] Microbiol Mol Biol Rev. 1999 Jun;63(2):405-45 [10357856.001]
  • [Cites] PLoS Biol. 2005 May;3(5):e158 [15828859.001]
  • [Cites] Mol Cell Biol. 2005 Jun;25(11):4397-405 [15899846.001]
  • [Cites] Genes Dev. 2005 Jun 1;19(11):1315-27 [15937220.001]
  • [Cites] J Biol Chem. 2005 Jun 17;280(24):22641-50 [15837790.001]
  • [Cites] RNA. 2005 Oct;11(10):1485-93 [16131587.001]
  • [Cites] J Biol Chem. 2006 Feb 3;281(5):2478-88 [16308319.001]
  • [Cites] PLoS Biol. 2006 Feb;4(2):e21 [16396608.001]
  • [Cites] Retrovirology. 2006;3:18 [16545126.001]
  • [Cites] Mol Cell. 2006 Jul 21;23(2):195-205 [16857586.001]
  • [Cites] J Virol. 2006 Oct;80(19):9634-40 [16973567.001]
  • [Cites] EMBO J. 2006 Oct 18;25(20):4854-64 [17024186.001]
  • [Cites] J Biol Chem. 2007 May 4;282(18):13617-26 [17337441.001]
  • [Cites] Biol Chem. 2007 Jul;388(7):693-7 [17570821.001]
  • [Cites] J Virol. 2007 Oct;81(20):11208-17 [17670832.001]
  • [Cites] Virology. 1998 Jul 20;247(1):86-96 [9683574.001]
  • [Cites] Mol Cell. 2003 Jul;12(1):5-14 [12887888.001]
  • [Cites] J Virol. 2003 Sep;77(17):9378-87 [12915553.001]
  • [Cites] Annu Rev Biochem. 2003;72:291-336 [12626338.001]
  • [Cites] RNA. 2003 Nov;9(11):1400-9 [14561889.001]
  • [Cites] J Comput Biol. 2004;11(2-3):377-94 [15285897.001]
  • [Cites] Mol Cell. 2004 Aug 13;15(3):477-83 [15304226.001]
  • [Cites] J Biol Chem. 2004 Aug 20;279(34):35788-97 [15169763.001]
  • [Cites] RNA. 2004 Sep;10(9):1388-98 [15317975.001]
  • [Cites] J Biol Chem. 2004 Sep 10;279(37):38201-8 [15252020.001]
  • [Cites] Cell. 1977 Sep;12(1):1-8 [902310.001]
  • [Cites] Proc Natl Acad Sci U S A. 1977 Aug;74(8):3171-5 [269380.001]
  • [Cites] J Virol. 1986 Nov;60(2):497-505 [3021984.001]
  • [Cites] J Virol. 1987 Jan;61(1):177-84 [3023695.001]
  • [Cites] J Virol. 1988 Aug;62(8):2686-95 [2839694.001]
  • [Cites] Genes Dev. 1991 Feb;5(2):211-20 [1847346.001]
  • [Cites] J Virol. 1991 May;65(5):2640-6 [1850037.001]
  • [Cites] Virology. 1991 Nov;185(1):99-108 [1656608.001]
  • [Cites] Genes Dev. 1991 Nov;5(11):2086-95 [1657710.001]
  • [Cites] J Virol. 1992 Jan;66(1):6-11 [1309264.001]
  • [Cites] Genes Dev. 1992 May;6(5):837-47 [1577277.001]
  • [Cites] J Virol. 1992 Jul;66(7):4242-51 [1318403.001]
  • [Cites] Genes Dev. 1993 Oct;7(10):1926-36 [8405999.001]
  • [Cites] Mol Cell Biol. 1994 Nov;14(11):7670-82 [7935481.001]
  • [Cites] Genes Dev. 1994 Jul 15;8(14):1703-12 [7958850.001]
  • [Cites] J Biol Chem. 1995 Feb 10;270(6):2411-4 [7852296.001]
  • [Cites] Virology. 1995 Feb 1;206(2):1099-107 [7856084.001]
  • [Cites] Mol Cell Biol. 1995 May;15(5):2663-71 [7739546.001]
  • [Cites] Nucleic Acids Res. 1995 May 11;23(9):1625-31 [7784220.001]
  • [Cites] J Virol. 1995 Aug;69(8):5068-76 [7609076.001]
  • [Cites] Nucleic Acids Res. 1995 Aug 25;23(16):3260-7 [7667103.001]
  • [Cites] J Virol. 1996 Feb;70(2):1163-72 [8551577.001]
  • [Cites] Genes Dev. 1996 Feb 1;10(3):325-37 [8595883.001]
  • [Cites] Science. 1996 Mar 22;271(5256):1716-8 [8596930.001]
  • [Cites] Cell. 1996 Mar 8;84(5):801-11 [8625417.001]
  • [Cites] J Virol. 1996 Jun;70(6):3636-44 [8648698.001]
  • [Cites] J Virol. 1996 Jun;70(6):3834-43 [8648719.001]
  • [Cites] Nucleic Acids Res. 1996 Dec 15;24(24):4962-8 [9016667.001]
  • [Cites] Trends Biochem Sci. 1997 Apr;22(4):132-7 [9149533.001]
  • [Cites] J Virol. 1997 Sep;71(9):6526-33 [9261372.001]
  • [Cites] J Virol. 1997 Sep;71(9):6534-40 [9261373.001]
  • [Cites] J Virol. 1997 Dec;71(12):9150-6 [9371572.001]
  • [Cites] Virology. 1998 Mar 1;242(1):211-20 [9501036.001]
  • [Cites] Mol Cell Biol. 1998 Jun;18(6):3103-11 [9584151.001]
  • [Cites] J Biol Chem. 1998 Jun 12;273(24):15169-76 [9614130.001]
  • [Cites] Proc Natl Acad Sci U S A. 1988 Dec;85(23):8885-9 [2973606.001]
  • [Cites] Mol Cell Biol. 1988 Nov;8(11):4858-67 [2850470.001]
  • [Cites] J Virol. 1989 Apr;63(4):1669-76 [2538650.001]
  • (PMID = 18508481.001).
  • [ISSN] 1093-9946
  • [Journal-full-title] Frontiers in bioscience : a journal and virtual library
  • [ISO-abbreviation] Front. Biosci.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA078709-10; United States / NCI NIH HHS / CA / R01 CA078709; United States / NCI NIH HHS / CA / R01 CA078709-10; United States / NCI NIH HHS / CA / R01 CA78709
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA Precursors; 0 / RNA, Messenger; 0 / RNA, Viral
  • [Number-of-references] 886
  • [Other-IDs] NLM/ NIHMS74074; NLM/ PMC2575692
  •  go-up   go-down


49. Holman AG, Coffin JM: Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites. Proc Natl Acad Sci U S A; 2005 Apr 26;102(17):6103-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites.
  • To investigate retroviral integration targeting on a nucleotide scale, we examined the base frequencies directly surrounding cloned in vivo HIV-1, murine leukemia virus, and avian sarcoma/leukosis virus integrations.
  • Offset symmetry reflecting the topology of the integration reaction was found for HIV-1 and avian sarcoma/leukosis virus but not murine leukemia virus, suggesting fundamental differences in the way different retroviral integration complexes interact with host-cell DNA.

  • Genetic Alliance. consumer health - HIV.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Science. 2003 Jun 13;300(5626):1749-51 [12805549.001]
  • [Cites] J Virol. 1998 May;72(5):4005-14 [9557688.001]
  • [Cites] Nature. 2001 Feb 15;409(6822):860-921 [11237011.001]
  • [Cites] Genome Res. 2002 Apr;12(4):656-64 [11932250.001]
  • [Cites] Cell. 2002 Aug 23;110(4):521-9 [12202041.001]
  • [Cites] Nucleic Acids Res. 2003 Jan 1;31(1):51-4 [12519945.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1436-41 [15659548.001]
  • [Cites] PLoS Biol. 2004 Aug;2(8):E234 [15314653.001]
  • [Cites] J Virol. 2004 Nov;78(21):11656-63 [15479807.001]
  • [Cites] J Virol. 1995 Oct;69(10):6090-7 [7666512.001]
  • [Cites] J Biol Chem. 1997 Mar 28;272(13):8361-9 [9079660.001]
  • [Cites] Virology. 1997 May 12;231(2):210-7 [9168883.001]
  • [CommentIn] Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):5903-4 [15840713.001]
  • [ErratumIn] Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6238
  • (PMID = 15802467.001).
  • [ISSN] 0027-8424
  • [Journal-full-title] Proceedings of the National Academy of Sciences of the United States of America
  • [ISO-abbreviation] Proc. Natl. Acad. Sci. U.S.A.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA092192; United States / NCI NIH HHS / CA / T32 CA065441; United States / NCI NIH HHS / CA / R01-CA-92192; United States / NCI NIH HHS / CA / T32 CA65441
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC1087937
  •  go-up   go-down


50. Maciolek NL, McNally MT: Characterization of Rous sarcoma virus polyadenylation site use in vitro. Virology; 2008 May 10;374(2):468-76
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characterization of Rous sarcoma virus polyadenylation site use in vitro.
  • Polyadenylation of Rous sarcoma virus (RSV) RNA is inefficient, as approximately 15% of RSV RNAs represent read-through transcripts that use a downstream cellular polyadenylation site (poly(A) site).
  • Read-through transcription has implications for the virus and the host since it is associated with oncogene capture and tumor induction.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Cell Biol. 1989 Oct;9(10):4248-58 [2573828.001]
  • [Cites] RNA. 1997 Dec;3(12):1444-55 [9404895.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1403-7 [1741396.001]
  • [Cites] J Virol. 1992 Jul;66(7):4242-51 [1318403.001]
  • [Cites] RNA. 2000 Feb;6(2):170-7 [10688356.001]
  • [Cites] J Virol. 2001 Dec;75(23):11735-46 [11689654.001]
  • [Cites] Nucleic Acids Res. 2002 Feb 1;30(3):810-7 [11809895.001]
  • [Cites] Nature. 2002 Apr 4;416(6880):499-506 [11932736.001]
  • [Cites] Nucleic Acids Res. 2002 Apr 15;30(8):1842-50 [11937639.001]
  • [Cites] J Biol Chem. 2002 Nov 8;277(45):42733-40 [12200454.001]
  • [Cites] Virology. 2002 Oct 25;302(2):405-12 [12441084.001]
  • [Cites] EMBO J. 2003 Jun 2;22(11):2821-30 [12773396.001]
  • [Cites] EMBO J. 2004 Feb 11;23(3):616-26 [14749727.001]
  • [Cites] J Biol Chem. 2004 Feb 20;279(8):7009-13 [14625303.001]
  • [Cites] Nucleic Acids Res. 1983 Mar 11;11(5):1475-89 [6828386.001]
  • [Cites] Cell. 1983 Mar;32(3):853-69 [6299578.001]
  • [Cites] Cell. 1983 Jun;33(2):357-68 [6305505.001]
  • [Cites] Nucleic Acids Res. 1984 Sep 25;12(18):7035-56 [6091052.001]
  • [Cites] Cell. 1986 Mar 28;44(6):935-40 [2420470.001]
  • [Cites] J Virol. 1986 Nov;60(2):497-505 [3021984.001]
  • [Cites] J Virol. 1988 Apr;62(4):1423-32 [2831403.001]
  • [Cites] J Virol. 1988 Jul;62(7):2437-43 [2897475.001]
  • [Cites] J Virol. 1989 Aug;63(8):3301-6 [2473216.001]
  • [Cites] Mol Cell Biol. 1992 Sep;12(9):3699-705 [1508176.001]
  • [Cites] Mol Cell Biol. 1992 Dec;12(12):5386-93 [1333042.001]
  • [Cites] Cell. 1993 Mar 26;72(6):881-92 [8458082.001]
  • [Cites] Genes Dev. 1993 Apr;7(4):647-59 [8384583.001]
  • [Cites] Cell. 1994 Feb 11;76(3):531-41 [8313473.001]
  • [Cites] Genes Dev. 1994 Mar 1;8(5):576-86 [7926751.001]
  • [Cites] Mol Cell Biol. 1994 Oct;14(10):6647-54 [7935383.001]
  • [Cites] Mol Cell. 1998 Jan;1(2):255-64 [9659922.001]
  • [Cites] RNA. 1998 Dec;4(12):1493-9 [9848648.001]
  • [Cites] J Virol. 1999 Jan;73(1):81-91 [9847310.001]
  • [Cites] J Virol. 1999 Mar;73(3):2385-93 [9971822.001]
  • [Cites] J Virol. 1999 Mar;73(3):2394-400 [9971823.001]
  • [Cites] RNA. 1999 Mar;5(3):333-43 [10094303.001]
  • [Cites] Microbiol Mol Biol Rev. 1999 Jun;63(2):405-45 [10357856.001]
  • [Cites] Nucleic Acids Res. 2005;33(1):201-12 [15647503.001]
  • [Cites] J Virol. 2005 Apr;79(7):4270-88 [15767428.001]
  • [Cites] Mol Cell Biol. 2005 Jun;25(11):4397-405 [15899846.001]
  • [Cites] Genes Dev. 2005 Jun 1;19(11):1315-27 [15937220.001]
  • [Cites] RNA. 2005 Oct;11(10):1485-93 [16131587.001]
  • [Cites] J Biol Chem. 2006 Feb 3;281(5):2478-88 [16308319.001]
  • [Cites] Retrovirology. 2006;3:18 [16545126.001]
  • [Cites] J Virol. 2006 Oct;80(19):9634-40 [16973567.001]
  • [Cites] EMBO J. 2007 Jun 6;26(11):2658-69 [17464285.001]
  • [Cites] J Virol. 2007 Oct;81(20):11208-17 [17670832.001]
  • [Cites] Genes Dev. 1995 Jan 1;9(1):72-83 [7828853.001]
  • [Cites] Nucleic Acids Res. 1995 May 11;23(9):1625-31 [7784220.001]
  • [Cites] Nucleic Acids Res. 1995 Jul 25;23(14):2614-20 [7651822.001]
  • [Cites] Genes Dev. 1995 Nov 1;9(21):2672-83 [7590244.001]
  • [Cites] Genes Dev. 1996 Feb 1;10(3):325-37 [8595883.001]
  • [Cites] J Virol. 1996 Mar;70(3):1612-7 [8627681.001]
  • [Cites] Cell. 1996 Nov 29;87(5):941-52 [8945520.001]
  • [Cites] Genes Dev. 1990 Dec;4(12A):2112-20 [1980119.001]
  • (PMID = 18272196.001).
  • [ISSN] 0042-6822
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA078709-10; United States / NCI NIH HHS / CA / CA078709-08; United States / NCI NIH HHS / CA / R01 CA078709; United States / NCI NIH HHS / CA / R01 CA078709-09; United States / NCI NIH HHS / CA / R01 CA78709; United States / NCI NIH HHS / CA / R01 CA078709-08; United States / NCI NIH HHS / CA / R01 CA078709-10; United States / NCI NIH HHS / CA / CA078709-09
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 3' Untranslated Regions; 0 / Cleavage Stimulation Factor; 0 / RNA, Messenger; 0 / RNA, Viral
  • [Other-IDs] NLM/ NIHMS50251; NLM/ PMC2413101
  •  go-up   go-down


51. Jorgenson RL, Vogt VM, Johnson MC: Foreign glycoproteins can be actively recruited to virus assembly sites during pseudotyping. J Virol; 2009 May;83(9):4060-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, in the presence of budding HIV-1 or Rous sarcoma virus (RSV) particles, some glycoproteins, such as those encoded by murine leukemia virus and vesicular stomatitis virus, were dramatically redistributed to viral budding sites.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 1993 Dec;67(12):7067-76 [7693966.001]
  • [Cites] J Virol. 1992 Jun;66(6):3306-15 [1583717.001]
  • [Cites] J Virol. 1995 Jun;69(6):3824-30 [7745730.001]
  • [Cites] Science. 1996 Apr 12;272(5259):263-7 [8602510.001]
  • [Cites] J Biol Chem. 1999 Jan 22;274(4):2038-44 [9890962.001]
  • [Cites] Gene Ther. 1999 May;6(5):715-28 [10505094.001]
  • [Cites] J Virol. 1999 Nov;73(11):9294-302 [10516038.001]
  • [Cites] Virology. 1965 Jun;26:270-6 [14323995.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15453-8 [16230638.001]
  • [Cites] Nat Methods. 2005 Dec;2(12):905-9 [16299475.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14947-52 [17003132.001]
  • [Cites] Cell Host Microbe. 2008 May 15;3(5):285-92 [18474355.001]
  • [Cites] Virology. 1992 Jul;189(1):167-77 [1604808.001]
  • [Cites] J Virol. 2000 Apr;74(7):3264-72 [10708443.001]
  • [Cites] J Virol. 2000 Apr;74(8):3548-54 [10729129.001]
  • [Cites] Virology. 2000 Jul 20;273(1):16-20 [10891403.001]
  • [Cites] J Virol. 2001 May;75(9):4129-38 [11287562.001]
  • [Cites] J Virol. 2001 Aug;75(15):7175-83 [11435598.001]
  • [Cites] J Virol. 2001 Oct;75(19):9339-44 [11533197.001]
  • [Cites] AIDS Res Hum Retroviruses. 2001 Nov 20;17(17):1615-24 [11779349.001]
  • [Cites] J Virol. 2002 Aug;76(15):7518-27 [12097564.001]
  • [Cites] J Gen Virol. 2003 Apr;84(Pt 4):757-68 [12655075.001]
  • [Cites] Traffic. 2003 Nov;4(11):785-801 [14617360.001]
  • [Cites] J Virol. 2004 Apr;78(7):3429-35 [15016865.001]
  • [Cites] Nat New Biol. 1972 Nov 22;240(99):122-4 [4345003.001]
  • [Cites] J Gen Virol. 1982 Nov;63 (Pt 1):15-24 [6757385.001]
  • [Cites] J Virol. 1987 Oct;61(10):2981-8 [3041017.001]
  • [Cites] Science. 1990 Feb 16;247(4944):848-52 [2305256.001]
  • [Cites] Science. 1990 Dec 7;250(4986):1421-3 [2175047.001]
  • [Cites] J Virol. 1995 Mar;69(3):1984-9 [7853546.001]
  • (PMID = 19224995.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI073098-02; United States / NCI NIH HHS / CA / R01 CA020081; United States / NIAID NIH HHS / AI / AI73098; United States / NIAID NIH HHS / AI / R01 AI073098; United States / NCI NIH HHS / CA / CA20081
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, env; 0 / Glycoproteins
  • [Other-IDs] NLM/ PMC2668502
  •  go-up   go-down


52. Takayama K, Torashima T, Horiuchi H, Hirai H: Purkinje-cell-preferential transduction by lentiviral vectors with the murine stem cell virus promoter. Neurosci Lett; 2008 Sep 26;443(1):7-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, we prepared lentiviral vectors that express GFP under the control of various ubiquitous promoters derived from murine stem cell virus (MSCV), cytomegalovirus (CMV), CMV early enhancer/chicken beta actin (CAG), and Rous sarcoma virus (RSV) and compared their potential to transduce Purkinje cells.

  • MedlinePlus Health Information. consumer health - Stem Cells.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18675313.001).
  • [ISSN] 0304-3940
  • [Journal-full-title] Neuroscience letters
  • [ISO-abbreviation] Neurosci. Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / Viral Proteins; 147336-22-9 / Green Fluorescent Proteins
  •  go-up   go-down


53. Chang KW, Julias JG, Alvord WG, Oh J, Hughes SH: Alternate polypurine tracts (PPTs) affect the rous sarcoma virus RNase H cleavage specificity and reveal a preferential cleavage following a GA dinucleotide sequence at the PPT-U3 junction. J Virol; 2005 Nov;79(21):13694-704
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Alternate polypurine tracts (PPTs) affect the rous sarcoma virus RNase H cleavage specificity and reveal a preferential cleavage following a GA dinucleotide sequence at the PPT-U3 junction.
  • We replaced the endogenous PPT from RSVP(A)Z, a replication-competent shuttle vector based on Rous sarcoma virus (RSV), with alternate retroviral PPTs and the duck hepatitis B virus "PPT."

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. GUANINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Apr;74(7):3245-52 [10708441.001]
  • [Cites] J Virol. 2004 Dec;78(23):13315-24 [15542682.001]
  • [Cites] J Virol. 2000 Nov;74(22):10293-303 [11044073.001]
  • [Cites] EMBO J. 2001 Mar 15;20(6):1449-61 [11250910.001]
  • [Cites] J Virol. 2001 Jun;75(11):4973-83 [11333876.001]
  • [Cites] J Virol. 2002 Feb;76(4):1762-8 [11799171.001]
  • [Cites] J Biol Chem. 2002 May 10;277(19):16689-96 [11875059.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9515-20 [12093908.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10090-5 [12119402.001]
  • [Cites] J Mol Biol. 2003 Mar 14;327(1):19-30 [12614605.001]
  • [Cites] J Virol. 2003 Oct;77(20):11150-7 [14512562.001]
  • [Cites] J Mol Biol. 2003 Dec 5;334(4):653-65 [14636594.001]
  • [Cites] J Virol. 2004 Jun;78(12):6112-21 [15163704.001]
  • [Cites] Int J Biochem Cell Biol. 2004 Sep;36(9):1752-66 [15183342.001]
  • [Cites] J Virol. 1984 Mar;49(3):686-91 [6199510.001]
  • [Cites] J Virol. 1987 Oct;61(10):3004-12 [3041020.001]
  • [Cites] J Virol. 1990 Feb;64(2):592-7 [1688626.001]
  • [Cites] J Virol. 1990 Dec;64(12):6274-7 [2173791.001]
  • [Cites] Annu Rev Cell Biol. 1992;8:275-306 [1282352.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1276-80 [7679498.001]
  • [Cites] J Biol Chem. 1993 Mar 25;268(9):6221-7 [7681062.001]
  • [Cites] J Mol Biol. 1993 Oct 5;233(3):509-23 [8411159.001]
  • [Cites] J Virol. 1996 Aug;70(8):5288-96 [8764039.001]
  • [Cites] J Biol Chem. 1997 Aug 29;272(35):22023-9 [9268341.001]
  • [Cites] J Mol Biol. 1998 Apr 3;277(3):559-72 [9533880.001]
  • [Cites] EMBO J. 1998 Jul 1;17(13):3766-74 [9649446.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Virol. 1999 Feb;73(2):948-57 [9882295.001]
  • [Cites] J Virol. 2000 May;74(10):4755-64 [10775614.001]
  • (PMID = 16227289.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / N01CO12400; United States / NCI NIH HHS / CO / N01-CO-12400; United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Purines; 5Z93L87A1R / Guanine; EC 2.7.7.49 / RNA-Directed DNA Polymerase; EC 3.1.26.4 / Ribonuclease H; JAC85A2161 / Adenine
  • [Other-IDs] NLM/ PMC1262584
  •  go-up   go-down


54. de Marco A, Davey NE, Ulbrich P, Phillips JM, Lux V, Riches JD, Fuzik T, Ruml T, Kräusslich HG, Vogt VM, Briggs JA: Conserved and variable features of Gag structure and arrangement in immature retrovirus particles. J Virol; 2010 Nov;84(22):11729-36
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have used cryo-electron tomography together with subtomogram averaging to describe the three-dimensional structure of in vitro-assembled Gag particles from human immunodeficiency virus, Mason-Pfizer monkey virus, and Rous sarcoma virus.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Struct Biol. 2002 Jul;9(7):537-43 [12032547.001]
  • [Cites] J Virol. 2002 Jun;76(11):5452-62 [11991973.001]
  • [Cites] J Virol. 2002 Nov;76(22):11177-85 [12388677.001]
  • [Cites] J Virol. 2002 Nov;76(22):11729-37 [12388733.001]
  • [Cites] J Virol. 2004 Jan;78(1):52-60 [14671087.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):672-5 [15208690.001]
  • [Cites] J Comput Chem. 2004 Oct;25(13):1605-12 [15264254.001]
  • [Cites] J Virol. 2004 Sep;78(18):9675-88 [15331700.001]
  • [Cites] J Virol. 2004 Nov;78(22):12378-85 [15507624.001]
  • [Cites] J Virol. 1986 Apr;58(1):50-8 [3005658.001]
  • [Cites] Cell. 1989 Oct 6;59(1):103-12 [2676191.001]
  • [Cites] J Virol. 1992 May;66(5):3230-5 [1560545.001]
  • [Cites] J Virol. 1992 Dec;66(12):7005-11 [1433505.001]
  • [Cites] J Virol. 1995 Feb;69(2):1093-8 [7815488.001]
  • [Cites] J Virol. 1995 Oct;69(10):6487-97 [7666550.001]
  • [Cites] J Struct Biol. 1996 Jan-Feb;116(1):71-6 [8742726.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] J Virol. 1997 Sep;71(9):6765-76 [9261401.001]
  • [Cites] Curr Biol. 1997 Oct 1;7(10):729-38 [9368755.001]
  • [Cites] Eur J Biochem. 1997 Oct 15;249(2):592-600 [9370371.001]
  • [Cites] J Virol. 1998 Mar;72(3):2072-8 [9499062.001]
  • [Cites] J Virol. 1998 Jun;72(6):4798-810 [9573245.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7299-304 [9636143.001]
  • [Cites] J Virol. 1998 Nov;72(11):9313-7 [9765481.001]
  • [Cites] J Virol. 1999 Oct;73(10):8073-82 [10482556.001]
  • [Cites] Protein Sci. 2005 Feb;14(2):375-86 [15659370.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4729-34 [15774580.001]
  • [Cites] J Virol. 2005 Nov;79(21):13463-72 [16227267.001]
  • [Cites] J Mol Biol. 2006 Jan 6;355(1):157-68 [16289202.001]
  • [Cites] J Virol. 2006 Jul;80(14):7089-99 [16809314.001]
  • [Cites] Virology. 2007 Apr 10;360(2):434-46 [17123565.001]
  • [Cites] EMBO J. 2007 Apr 18;26(8):2218-26 [17396149.001]
  • [Cites] Adv Pharmacol. 2007;55:347-87 [17586320.001]
  • [Cites] J Virol. 2009 Mar;83(5):2216-25 [19073719.001]
  • [Cites] Cell. 2009 Jun 26;137(7):1282-92 [19523676.001]
  • [Cites] Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11090-5 [19549863.001]
  • [Cites] Cell. 2007 Oct 5;131(1):70-9 [17923088.001]
  • [Cites] EMBO J. 2008 May 7;27(9):1411-20 [18401344.001]
  • [Cites] J Virol. 2008 Jul;82(14):6788-97 [18448521.001]
  • [Cites] J Struct Biol. 2008 Oct;164(1):161-5 [18691905.001]
  • [Cites] Nature. 2009 Feb 5;457(7230):694-8 [19194444.001]
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] J Virol. 2000 Sep;74(18):8452-9 [10954545.001]
  • [Cites] J Virol. 2001 Jan;75(2):759-71 [11134289.001]
  • [Cites] J Virol. 2001 Mar;75(6):2753-64 [11222698.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10875-9 [11526217.001]
  • [Cites] Nucleic Acids Res. 2002 Jul 15;30(14):3059-66 [12136088.001]
  • (PMID = 20810738.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA020081; United States / NCI NIH HHS / CA / CA20081
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag
  • [Other-IDs] NLM/ PMC2977881
  •  go-up   go-down


55. Suerth JD, Maetzig T, Galla M, Baum C, Schambach A: Self-inactivating alpharetroviral vectors with a split-packaging design. J Virol; 2010 Jul;84(13):6626-35
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Comparative analyses of integration sites of different retroviral vectors have elucidated distinct target site preferences, highlighting vectors based on the alpharetrovirus Rous sarcoma virus (RSV) as those with the most neutral integration spectrum.

  • MedlinePlus Health Information. consumer health - Genes and Gene Therapy.
  • SciCrunch. The Antibody Registry: Reagent: Antibodies .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2002 Feb;76(3):1488-95 [11773421.001]
  • [Cites] Gene Ther. 2010 Mar;17(3):400-11 [19847204.001]
  • [Cites] Cell. 2002 Aug 23;110(4):521-9 [12202041.001]
  • [Cites] Nucleic Acids Res. 2001 May 1;29(9):e45 [11328886.001]
  • [Cites] Science. 2003 Jun 13;300(5626):1749-51 [12805549.001]
  • [Cites] Blood. 2003 Dec 1;102(12):3934-7 [12881303.001]
  • [Cites] Genomics. 2004 Jan;83(1):76-84 [14667811.001]
  • [Cites] Gene Ther. 2004 Jun;11(11):879-81 [15057265.001]
  • [Cites] J Virol. 2004 Aug;78(16):8421-36 [15280451.001]
  • [Cites] PLoS Biol. 2004 Aug;2(8):E234 [15314653.001]
  • [Cites] Folia Biol (Praha). 2004;50(3-4):107-19 [15373344.001]
  • [Cites] J Virol. 1982 Nov;44(2):725-30 [6183452.001]
  • [Cites] J Virol. 1983 Dec;48(3):667-75 [6313966.001]
  • [Cites] Virology. 1984 Jul 15;136(1):89-99 [6330999.001]
  • [Cites] EMBO J. 1985 Apr;4(4):949-56 [2990916.001]
  • [Cites] J Virol. 1987 Oct;61(10):3004-12 [3041020.001]
  • [Cites] Cell. 1988 Nov 4;55(3):447-58 [2846182.001]
  • [Cites] J Exp Med. 1992 Oct 1;176(4):1125-35 [1383375.001]
  • [Cites] Methods Cell Biol. 1994;43 Pt A:99-112 [7823872.001]
  • [Cites] Nucleic Acids Res. 1995 Feb 25;23(4):628-33 [7899083.001]
  • [Cites] J Virol. 1995 Dec;69(12):7541-7 [7494260.001]
  • [Cites] J Virol. 1996 Jun;70(6):3834-43 [8648719.001]
  • [Cites] J Virol. 1996 Oct;70(10):6642-52 [8794299.001]
  • [Cites] J Virol. 1998 Nov;72(11):8463-71 [9765382.001]
  • [Cites] J Virol. 1998 Dec;72(12):9873-80 [9811723.001]
  • [Cites] J Mol Biol. 1998 Nov 27;284(2):205-25 [9813113.001]
  • [Cites] Mol Ther. 2006 Feb;13(2):391-400 [16226060.001]
  • [Cites] Gene Ther. 2006 Apr;13(7):641-5 [16355114.001]
  • [Cites] Exp Hematol. 2006 May;34(5):588-92 [16647564.001]
  • [Cites] Blood. 2006 Oct 15;108(8):2545-53 [16825499.001]
  • [Cites] Gene Ther. 2006 Nov;13(21):1524-33 [16763662.001]
  • [Cites] Hum Gene Ther. 2007 Aug;18(8):691-700 [17655493.001]
  • [Cites] Mol Ther. 2008 Mar;16(3):590-8 [18180772.001]
  • [Cites] Mol Ther. 2008 Apr;16(4):718-25 [18334985.001]
  • [Cites] Mol Ther. 2008 Sep;16(9):1617-23 [18578011.001]
  • [Cites] Gene Ther. 2000 Jun;7(12):1063-6 [10871756.001]
  • [Cites] J Virol. 2000 Nov;74(22):10822-6 [11044131.001]
  • [Cites] Gene Ther. 2001 Mar;8(6):477-86 [11313827.001]
  • [Cites] DNA Res. 2001 Oct 31;8(5):221-6 [11759842.001]
  • [Cites] J Clin Invest. 2008 Sep;118(9):3132-42 [18688285.001]
  • [Cites] J Clin Invest. 2008 Sep;118(9):3143-50 [18688286.001]
  • [Cites] J Virol. 2009 Jan;83(1):283-94 [18945765.001]
  • [Cites] J Clin Invest. 2009 Apr;119(4):964-75 [19307726.001]
  • [Cites] Expert Opin Biol Ther. 2009 Nov;9(11):1427-36 [19743892.001]
  • [Cites] Mol Ther. 2009 Nov;17(11):1919-28 [19672245.001]
  • [Cites] Blood. 2002 Aug 1;100(3):823-32 [12130492.001]
  • (PMID = 20410274.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Viral
  • [Other-IDs] NLM/ PMC2903275
  •  go-up   go-down


56. Torne-Celer C, Moreau K, Faure C, Verdier G, Ronfort C: An improved self-deleting retroviral vector derived from avian leukemia and sarcoma virus. Arch Virol; 2008;153(12):2233-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An improved self-deleting retroviral vector derived from avian leukemia and sarcoma virus.
  • We have previously developed a self-deleting avian leukosis and sarcoma virus (ALSV)- based retroviral vector carrying an additional attachment (att) sequence.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19018452.001).
  • [ISSN] 1432-8798
  • [Journal-full-title] Archives of virology
  • [ISO-abbreviation] Arch. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Austria
  •  go-up   go-down


57. Morita T, Mayanagi T, Yoshio T, Sobue K: Changes in the balance between caldesmon regulated by p21-activated kinases and the Arp2/3 complex govern podosome formation. J Biol Chem; 2007 Mar 16;282(11):8454-63
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we studied the regulatory mode of caldesmon in podosome formation in Rous sarcoma virus-transformed fibroblasts.
  • Taken together, we conclude that in Rous sarcoma virus-transformed cells, changes in the balance between PAK1/2-regulated caldesmon and the Arp2/3 complex govern the formation of podosomes.
  • [MeSH-minor] Actins / chemistry. Animals. Fibroblasts / metabolism. Genetic Vectors. Models, Biological. Phosphorylation. Protein Binding. Rats. Rous sarcoma virus / metabolism. Transfection. Tropomyosin / chemistry. Wiskott-Aldrich Syndrome Protein, Neuronal / chemistry. p21-Activated Kinases

  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17224451.001).
  • [ISSN] 0021-9258
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actin-Related Protein 2; 0 / Actin-Related Protein 3; 0 / Actins; 0 / Calmodulin-Binding Proteins; 0 / Tropomyosin; 0 / Wiskott-Aldrich Syndrome Protein, Neuronal; EC 2.7.11.1 / Pak1 protein, rat; EC 2.7.11.1 / Protein-Serine-Threonine Kinases; EC 2.7.11.1 / p21-Activated Kinases
  •  go-up   go-down


58. Mandelin J, Lin EC, Hu DD, Knowles SK, Do KA, Wang X, Sage EH, Smith JW, Arap W, Pasqualini R: Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontin. Cancer; 2009 Apr 15;115(8):1753-64
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, the authors used human melanoma and sarcoma cell lines to evaluate the effects of soluble osteopontin on metastasis.
  • In the intracellular environment, osteopontin initially induced rapid tyrosine 418 (Tyr-418) dephosphorylation of the cellular homolog of the Rous sarcoma virus (c-Src), with decreases in actin stress fibers and increased binding to the vascular endothelium.
  • This heretofore undescribed Tyr dephosphorylation was followed by a tandem c-Src phosphorylation after tumor cell attachment to the metastatic site.
  • CONCLUSIONS: The results of this study revealed a complex molecular interaction as well as a dual role for osteopontin in metastasis that depends on whether tumor cells are in circulation or attached.

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Cancer Res. 1997 Apr;3(4):605-11 [9815727.001]
  • [Cites] J Biol Chem. 2004 Mar 19;279(12):11051-64 [14704150.001]
  • [Cites] Cancer Res. 1999 Jan 1;59(1):219-26 [9892210.001]
  • [Cites] Oncogene. 2005 Jan 13;24(3):489-501 [15516973.001]
  • [Cites] Nat Immunol. 2004 Mar;5(3):272-9 [14758359.001]
  • [Cites] Cell. 2008 Jun 13;133(6):994-1005 [18555776.001]
  • [Cites] Int J Cancer. 1977 Jul 15;20(1):1-5 [903179.001]
  • [Cites] Proc Natl Acad Sci U S A. 1984 Oct;81(19):5985-8 [6237366.001]
  • [Cites] Science. 1986 Jul 25;233(4762):467-70 [3726541.001]
  • [Cites] Proc Natl Acad Sci U S A. 1986 Dec;83(23):8819-23 [3024151.001]
  • [Cites] Nature. 1994 Jan 13;367(6459):193-6 [8114919.001]
  • [Cites] J Cell Biochem. 1994 Feb;54(2):247-55 [8175899.001]
  • [Cites] Cancer Res. 1994 Sep 15;54(18):4993-8 [7520832.001]
  • [Cites] Endocrinology. 1995 Jul;136(7):2984-92 [7540546.001]
  • [Cites] Exp Cell Res. 1995 Aug;219(2):571-8 [7641809.001]
  • [Cites] Nat Immunol. 2000 Jul;1(1):23-9 [10881170.001]
  • [Cites] Biochemistry. 2001 Feb 27;40(8):2373-8 [11327857.001]
  • [Cites] J Clin Invest. 2001 May;107(9):1055-61 [11342566.001]
  • [Cites] J Biol Chem. 2001 Dec 7;276(49):46024-30 [11590166.001]
  • [Cites] Biochim Biophys Acta. 2001 Dec 28;1552(2):61-85 [11825687.001]
  • [Cites] Curr Mol Med. 2001 Nov;1(5):621-32 [11899236.001]
  • [Cites] Cancer. 2002 Aug 1;95(3):506-12 [12209742.001]
  • [Cites] Curr Opin Cell Biol. 2002 Oct;14(5):608-16 [12231357.001]
  • [Cites] Clin Cancer Res. 2003 Jan;9(1):59-67 [12538452.001]
  • [Cites] Nat Med. 2003 Apr;9(4):416-23 [12640447.001]
  • [Cites] Trends Cell Biol. 2003 Jul;13(7):376-85 [12837608.001]
  • [Cites] Cancer Cell. 2003 Jun;3(6):537-49 [12842083.001]
  • [Cites] Science. 1996 Jan 26;271(5248):509-12 [8560266.001]
  • [Cites] Nat Med. 1996 Nov;2(11):1197-203 [8898745.001]
  • [Cites] Annu Rev Cell Dev Biol. 1996;12:697-715 [8970741.001]
  • [Cites] Nat Biotechnol. 1997 Jun;15(6):542-6 [9181576.001]
  • [Cites] Science. 1998 Jan 16;279(5349):377-80 [9430587.001]
  • [Cites] J Biol Chem. 1998 May 8;273(19):11908-16 [9565618.001]
  • [Cites] Biotechnology (N Y). 1995 Mar;13(3):265-70 [9634769.001]
  • [Cites] J Biol Chem. 2005 Jun 24;280(25):23918-25 [15851473.001]
  • [Cites] Clin Cancer Res. 2006 Feb 15;12(4):1308-16 [16489088.001]
  • [Cites] Trends Cell Biol. 2006 Feb;16(2):79-87 [16406521.001]
  • [Cites] Cell. 2006 Apr 21;125(2):385-98 [16630824.001]
  • [Cites] Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3337-43 [16740755.001]
  • [Cites] Am J Pathol. 2006 Jul;169(1):233-46 [16816376.001]
  • [Cites] Clin Exp Metastasis. 2005;22(8):663-73 [16691370.001]
  • [Cites] Clin Exp Metastasis. 2006;23(2):123-33 [16830223.001]
  • [Cites] Prostate. 2007 Feb 15;67(3):330-40 [17192877.001]
  • [Cites] Am J Pathol. 2007 Aug;171(2):682-92 [17620367.001]
  • [Cites] Cancer Res. 1998 Nov 15;58(22):5206-15 [9823334.001]
  • (PMID = 19224553.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA069306; United States / NCI NIH HHS / CA / CA90270; United States / NCI NIH HHS / CA / P50 CA140388; United States / NCI NIH HHS / CA / CA69306; United States / NCI NIH HHS / CA / P50 CA090270; United States / NCI NIH HHS / CA / CA30199; United States / NCI NIH HHS / CA / P30 CA030199; United States / NCI NIH HHS / CA / CA069306-05; United States / NCI NIH HHS / CA / R01 CA069306-05
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Oligopeptides; 0 / Recombinant Proteins; 106441-73-0 / Osteopontin; 99896-85-2 / arginyl-glycyl-aspartic acid
  • [Other-IDs] NLM/ NIHMS89125; NLM/ PMC2743165
  •  go-up   go-down


59. Greger JG, Katz RA, Ishov AM, Maul GG, Skalka AM: The cellular protein daxx interacts with avian sarcoma virus integrase and viral DNA to repress viral transcription. J Virol; 2005 Apr;79(8):4610-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The cellular protein daxx interacts with avian sarcoma virus integrase and viral DNA to repress viral transcription.
  • The cellular protein Daxx was identified as an interactor with avian sarcoma virus (ASV) integrase (IN) in a yeast two-hybrid screen.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] EMBO J. 1999 Nov 1;18(21):6037-49 [10545115.001]
  • [Cites] J Cell Biol. 1999 Oct 18;147(2):221-34 [10525530.001]
  • [Cites] J Virol. 2000 Nov;74(21):9994-10005 [11024128.001]
  • [Cites] J Virol. 2001 Feb;75(4):1909-17 [11160690.001]
  • [Cites] Mol Cell Biol. 2001 Feb;21(4):1164-72 [11158303.001]
  • [Cites] Oncogene. 2001 Jan 4;20(1):1-9 [11244500.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3364-8 [11248084.001]
  • [Cites] J Virol. 2001 Jul;75(13):6204-8 [11390623.001]
  • [Cites] Mol Cell. 2001 Jun;7(6):1245-54 [11430827.001]
  • [Cites] EMBO J. 2001 Jul 2;20(13):3495-505 [11432836.001]
  • [Cites] Nat Med. 2001 Aug;7(8):920-6 [11479624.001]
  • [Cites] J Virol. 2002 Jun;76(11):5422-34 [11991971.001]
  • [Cites] Virology. 2002 Mar 30;295(1):97-107 [12033769.001]
  • [Cites] J Virol. 2002 Aug;76(15):7705-12 [12097584.001]
  • [Cites] J Cell Sci. 2002 Aug 15;115(Pt 16):3319-30 [12140263.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Jul 12;295(2):495-500 [12150977.001]
  • [Cites] Nature. 2002 Aug 8;418(6898):646-50 [12167863.001]
  • [Cites] J Virol. 2002 Oct;76(19):9744-55 [12208953.001]
  • [Cites] Oncogene. 2002 Oct 17;21(47):7241-6 [12370815.001]
  • [Cites] J Virol. 2003 Jan;77(2):1357-67 [12502852.001]
  • [Cites] J Biol Chem. 2003 Jan 3;278(1):372-81 [12407101.001]
  • [Cites] J Virol. 2003 Mar;77(5):3167-80 [12584341.001]
  • [Cites] Biochem J. 2003 Mar 15;370(Pt 3):737-49 [12429021.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4778-83 [12679521.001]
  • [Cites] EMBO J. 2003 Jul 15;22(14):3675-85 [12853482.001]
  • [Cites] Cell. 2003 Aug 8;114(3):281-3 [12914693.001]
  • [Cites] Virology. 2003 Sep 15;314(1):161-7 [14517069.001]
  • [Cites] J Virol. 2003 Nov;77(21):11809-21 [14557665.001]
  • [Cites] J Virol. 2003 Dec;77(23):12671-8 [14610189.001]
  • [Cites] Nature. 2004 Feb 26;427(6977):848-53 [14985764.001]
  • [Cites] J Cell Sci. 2004 Aug 1;117(Pt 17):3807-20 [15252119.001]
  • [Cites] J Biol Chem. 2004 Oct 29;279(44):45810-4 [15308627.001]
  • [Cites] Science. 1994 Dec 23;266(5193):2002-6 [7801128.001]
  • [Cites] J Virol. 1995 Sep;69(9):5631-9 [7637009.001]
  • [Cites] Cell. 1997 Feb 21;88(4):483-92 [9038339.001]
  • [Cites] Methods Mol Biol. 1997;63:197-218 [9113651.001]
  • [Cites] Cell. 1997 Jun 27;89(7):1067-76 [9215629.001]
  • [Cites] J Virol. 1997 Dec;71(12):9375-82 [9371597.001]
  • [Cites] J Virol. 1998 Feb;72(2):1043-51 [9444998.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1528-33 [9465049.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] Annu Rev Biochem. 1998;67:227-64 [9759489.001]
  • [Cites] Mediators Inflamm. 1998;7(5):319-25 [9883966.001]
  • [Cites] Science. 1999 Apr 23;284(5414):644-7 [10213687.001]
  • [Cites] Virology. 1999 Jun 5;258(2):435-40 [10366581.001]
  • [Cites] EMBO J. 1999 Jul 1;18(13):3702-11 [10393185.001]
  • [Cites] Stem Cells. 2000;18(5):352-9 [11007919.001]
  • (PMID = 15795247.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA071515; United States / NCI NIH HHS / CA / CA06927; United States / NCI NIH HHS / CA / CA71515; United States / NIAID NIH HHS / AI / AI40385; United States / NIAID NIH HHS / AI / R01 AI040385; United States / NCI NIH HHS / CA / P30 CA006927
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adaptor Proteins, Signal Transducing; 0 / Carrier Proteins; 0 / DAXX protein, human; 0 / DNA Primers; 0 / DNA, Viral; 0 / Histone Deacetylase Inhibitors; 0 / Intracellular Signaling Peptides and Proteins; 0 / Nuclear Proteins; EC 2.7.7.- / Integrases
  • [Other-IDs] NLM/ PMC1069566
  •  go-up   go-down


60. Shirodkar MV, Sehgal PB: Is the anti-sarcoma and anti-viral cytokine "plasma factor" a novel chicken Y-box protein? Indian J Exp Biol; 2006 Oct;44(10):777-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Is the anti-sarcoma and anti-viral cytokine "plasma factor" a novel chicken Y-box protein?
  • A line of research beginning in the early 1960s with the observation that West Nile virus and, later, several strains of rabies virus could inhibit the development of the Rous sarcoma virus-induced tumor in the wing-web of chicken (a "sarcoma-blockade") eventually culminated in the characterization of a 14-kDa circulating anti-sarcoma and anti-viral activity christened "plasma factor" (PF) which, unlike the interferons, inhibited the replication of diverse RNA-containing viruses, but not of any DNA-containing viruses.
  • [MeSH-major] Avian Proteins / physiology. Cytokines / physiology. DNA-Binding Proteins / physiology. Sarcoma, Avian / physiopathology. Transcription Factors / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17131907.001).
  • [ISSN] 0019-5189
  • [Journal-full-title] Indian journal of experimental biology
  • [ISO-abbreviation] Indian J. Exp. Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] India
  • [Chemical-registry-number] 0 / Avian Proteins; 0 / Cytokines; 0 / DNA-Binding Proteins; 0 / Transcription Factors; 0 / YB-2 protein, Gallus gallus
  • [Number-of-references] 39
  •  go-up   go-down


61. Masker K, Golden A, Gaffney CJ, Mazack V, Schwindinger WF, Zhang W, Wang LH, Carey DJ, Sudol M: Transcriptional profile of Rous Sarcoma Virus transformed chicken embryo fibroblasts reveals new signaling targets of viral-src. Virology; 2007 Jul 20;364(1):10-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transcriptional profile of Rous Sarcoma Virus transformed chicken embryo fibroblasts reveals new signaling targets of viral-src.
  • Transformation of chicken fibroblasts in vitro by Rous Sarcoma Virus represents a model of cancer in which a single oncogene, viral src, uniformly and rapidly transforms primary cells in culture.
  • We experimentally surveyed the transcriptional program affected by Rous Sarcoma Virus (RSV) in primary culture of chicken embryo fibroblasts.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5472-6 [1608957.001]
  • [Cites] Cell Biol Int Rep. 1992 Oct;16(10):1003-14 [1384993.001]
  • [Cites] Nucleic Acids Res. 1992 Dec 11;20(23):6377-83 [1475199.001]
  • [Cites] Oncogene. 1993 Apr;8(4):823-31 [8455940.001]
  • [Cites] Biochem Cell Biol. 1992 Oct-Nov;70(10-11):980-97 [1297357.001]
  • [Cites] Oncogene. 1994 Sep;9(9):2729-32 [7520150.001]
  • [Cites] Biochem Biophys Res Commun. 1995 Jan 26;206(3):916-26 [7832805.001]
  • [Cites] Cancer Res. 2006 Feb 15;66(4):2028-37 [16489002.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):502-8 [16537708.001]
  • [Cites] J Biol Chem. 2006 Apr 7;281(14):9450-9 [16461772.001]
  • [Cites] Cancer Res. 2006 Jun 1;66(11):5686-95 [16740706.001]
  • [Cites] Int J Oncol. 2006 Jul;29(1):25-32 [16773181.001]
  • [Cites] J Biol Chem. 2006 Jul 28;281(30):20891-901 [16728406.001]
  • [Cites] Nat Cell Biol. 2006 Sep;8(9):945-56 [16892055.001]
  • [Cites] J Hepatol. 2006 Nov;45(5):673-80 [16935389.001]
  • [Cites] Expert Opin Ther Targets. 2007 Jan;11(1):91-100 [17150037.001]
  • [Cites] Cardiovasc Res. 2007 Jan 1;73(1):19-25 [17045254.001]
  • [Cites] Oncogene. 2007 Jan 4;26(1):1-10 [16799638.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4053-8 [15007166.001]
  • [Cites] Oncogene. 2004 Jul 8;23(31):5330-9 [15064726.001]
  • [Cites] Nat Med. 2004 Aug;10(8):789-99 [15286780.001]
  • [Cites] Mol Cell Proteomics. 2004 Oct;3(10):960-9 [15238602.001]
  • [Cites] Oncogene. 2004 Oct 18;23(48):7910-7 [15489909.001]
  • [Cites] Proc Natl Acad Sci U S A. 1969 Jun;63(2):318-25 [4308272.001]
  • [Cites] J Exp Med. 1973 Jan 1;137(1):85-111 [4347290.001]
  • [Cites] Cell. 1977 Jul;11(3):513-21 [195741.001]
  • [Cites] Nature. 1977 Sep 22;269(5626):346-8 [198667.001]
  • [Cites] J Biol Chem. 1978 Aug 25;253(16):5869-74 [78927.001]
  • [Cites] Cancer Res. 1980 Jul;40(7):2300-9 [7190062.001]
  • [Cites] J Biol Chem. 1981 Jan 10;256(1):520-5 [6256355.001]
  • [Cites] Proc Natl Acad Sci U S A. 1981 Sep;78(9):5633-7 [6272310.001]
  • [Cites] J Virol. 1984 Mar;49(3):881-91 [6321772.001]
  • [Cites] Cell. 1984 Oct;38(3):757-65 [6091899.001]
  • [Cites] Mol Cell Endocrinol. 1985 May;40(2-3):245-55 [2408939.001]
  • [Cites] Proc Natl Acad Sci U S A. 1987 Apr;84(8):2251-5 [2436227.001]
  • [Cites] Cell. 1987 May 8;49(3):321-8 [3032449.001]
  • [Cites] Proc Natl Acad Sci U S A. 1987 Oct;84(19):6715-9 [2821543.001]
  • [Cites] Annu Rev Cell Biol. 1987;3:31-56 [2446642.001]
  • [Cites] J Virol. 1989 Jul;63(7):2929-35 [2542604.001]
  • [Cites] J Biol Chem. 1990 Jan 25;265(3):1339-44 [2295632.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jan;87(2):558-62 [2105487.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Nov;87(21):8592-6 [1700434.001]
  • [Cites] Oncogene. 1991 Jul;6(7):1259-68 [1861868.001]
  • [Cites] Mol Cell Biol. 1996 Feb;16(2):481-6 [8552074.001]
  • [Cites] Cell Growth Differ. 1997 Jan;8(1):113-9 [8993840.001]
  • [Cites] Oncogene. 1997 Oct 16;15(16):1929-36 [9365239.001]
  • [Cites] Biochim Biophys Acta. 1998 Feb 11;1395(3):288-92 [9512662.001]
  • [Cites] Gastroenterology. 1998 Jun;114(6):1287-95 [9609766.001]
  • [Cites] Oncogene. 2004 Nov 4;23(52):8455-63 [15378015.001]
  • [Cites] Carcinogenesis. 2004 Dec;25(12):2467-72 [15308583.001]
  • [Cites] Exp Cell Res. 2001 May 1;265(2):339-47 [11302700.001]
  • [Cites] Nature. 2001 May 17;411(6835):355-65 [11357143.001]
  • [Cites] Oncogene. 2001 Apr 30;20(19):2365-77 [11402333.001]
  • [Cites] Cell. 2002 Jan 25;108(2):135-44 [11832204.001]
  • [Cites] Biochim Biophys Acta. 2002 Jun 21;1602(2):114-30 [12020799.001]
  • [Cites] Nat Rev Cancer. 2002 Oct;2(10):740-9 [12360277.001]
  • [Cites] Oncogene. 2002 Oct 17;21(47):7256-65 [12370817.001]
  • [Cites] Genome Biol. 2003;4(1):R7 [12540299.001]
  • [Cites] Genome Biol. 2003;4(5):P3 [12734009.001]
  • [Cites] Front Biosci. 2004 Jan 1;9:139-44 [14766353.001]
  • [Cites] Nature. 2004 Dec 9;432(7018):695-716 [15592404.001]
  • [Cites] Nature. 2004 Dec 9;432(7018):761-4 [15592415.001]
  • [Cites] Front Biosci. 2005;10:998-1009 [15769600.001]
  • [Cites] FEBS Lett. 2005 Dec 19;579(30):6705-15 [16313905.001]
  • [Cites] Genome Res. 2005 Dec;15(12):1692-8 [16339367.001]
  • [Cites] Cell Commun Adhes. 2005 Jan-Apr;12(1-2):41-57 [16371345.001]
  • [Cites] Cancer Res. 2006 Feb 1;66(3):1543-52 [16452211.001]
  • [Cites] Mol Cell Biol. 1991 Sep;11(9):4448-54 [1875932.001]
  • [Cites] Cell. 1991 Nov 15;67(4):731-40 [1682056.001]
  • [Cites] Oncogene. 1991 Nov;6(11):2129-35 [1682867.001]
  • [Cites] Mol Cell Biol. 1992 Jan;12(1):10-21 [1309586.001]
  • (PMID = 17448514.001).
  • [ISSN] 0042-6822
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA029339; United States / NCI NIH HHS / CA / CA29339; United States / NIDDK NIH HHS / DK / DK062345-02; United States / NIDDK NIH HHS / DK / P01 DK062345-02; United States / NIDDK NIH HHS / DK / P01 DK062345-03; United States / NIDDK NIH HHS / DK / P01 DK062345; United States / NIDDK NIH HHS / DK / DK062345-03; United States / NIDDK NIH HHS / DK / DK62345
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA Primers; 0 / DNA, Viral
  • [Other-IDs] NLM/ NIHMS25800; NLM/ PMC1974879
  •  go-up   go-down


62. Oh J, Chang KW, Wierzchoslawski R, Alvord WG, Hughes SH: Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate. J Virol; 2008 Jan;82(1):503-12
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate.
  • We made mutations in the 5' end of the U3 sequence of the Rous sarcoma virus (RSV)-derived vector RSVP(A)Z.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2005 Nov;79(21):13694-704 [16227289.001]
  • [Cites] EMBO J. 1998 Oct 1;17(19):5832-43 [9755183.001]
  • [Cites] J Virol. 2006 Oct;80(20):10281-4 [17005708.001]
  • [Cites] J Virol. 2001 Feb;75(3):1359-70 [11152509.001]
  • [Cites] J Virol. 2002 Feb;76(4):1762-8 [11799171.001]
  • [Cites] Proc Natl Acad Sci U S A. 1980 Jul;77(7):3937-41 [6254003.001]
  • [Cites] Cell. 1980 Nov;22(2 Pt 2):379-86 [6256079.001]
  • [Cites] Proc Natl Acad Sci U S A. 1981 Jul;78(7):4299-303 [6270669.001]
  • [Cites] Nature. 1983 Nov 10-16;306(5939):155-60 [6316141.001]
  • [Cites] Cell. 1984 Jul;37(3):1043-52 [6204767.001]
  • [Cites] Proc Natl Acad Sci U S A. 1984 Oct;81(20):6461-5 [6208550.001]
  • [Cites] Cell. 1985 Sep;42(2):573-80 [4028161.001]
  • [Cites] J Virol. 1986 Jan;57(1):37-45 [2416955.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 May;86(9):3065-9 [2524066.001]
  • [Cites] Cell. 1989 Jul 14;58(1):47-54 [2546673.001]
  • [Cites] Cell. 1990 Aug 24;62(4):829-37 [2167180.001]
  • [Cites] J Virol. 1990 Nov;64(11):5475-84 [2170682.001]
  • [Cites] J Virol. 1990 Dec;64(12):5958-65 [2173775.001]
  • [Cites] Mol Cell Biol. 1991 Mar;11(3):1419-30 [1847499.001]
  • [Cites] J Virol. 1991 Sep;65(9):4636-44 [1870194.001]
  • [Cites] J Virol. 1991 Oct;65(10):5624-30 [1895409.001]
  • [Cites] J Virol. 1992 Apr;66(4):2359-68 [1548767.001]
  • [Cites] J Virol. 1992 Dec;66(12):7414-9 [1433523.001]
  • [Cites] J Virol. 1994 Aug;68(8):4768-75 [8035478.001]
  • [Cites] J Virol. 1995 May;69(5):3216-9 [7707554.001]
  • [Cites] J Virol. 1995 Nov;69(11):6687-96 [7474078.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Virol. 1998 Oct;72(10):8396-402 [9733892.001]
  • [Cites] J Virol. 2004 Dec;78(23):13315-24 [15542682.001]
  • [Cites] J Virol. 1999 Nov;73(11):9011-20 [10516007.001]
  • [Cites] J Virol. 2006 Jan;80(1):451-9 [16352569.001]
  • (PMID = 17959663.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / RNA, Viral; EC 2.7.7.- / Integrases
  • [Other-IDs] NLM/ PMC2224354
  •  go-up   go-down


63. Barr SD, Leipzig J, Shinn P, Ecker JR, Bushman FD: Integration targeting by avian sarcoma-leukosis virus and human immunodeficiency virus in the chicken genome. J Virol; 2005 Sep;79(18):12035-44
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Integration targeting by avian sarcoma-leukosis virus and human immunodeficiency virus in the chicken genome.
  • We have analyzed the placement of sites of integration of avian sarcoma-leukosis virus (ASLV) and human immunodeficiency virus (HIV) DNA in the draft chicken genome sequence, with the goals of assessing species-specific effects on integration and allowing comparison to the distribution of chicken endogenous retroviruses (ERVs).
  • In contrast, de novo ASLV integration sites within TUs showed no orientation bias.
  • Comparing the distribution of de novo ASLV integration sites to ERVs indicated that purifying selection against gene disruption, and not initial integration targeting, probably determined the ERV distribution.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4894-9 [15044706.001]
  • [Cites] Mol Biol Evol. 2005 Apr;22(4):814-7 [15659556.001]
  • [Cites] Folia Biol (Praha). 2004;50(3-4):136-41 [15373347.001]
  • [Cites] J Virol. 2004 Nov;78(21):11656-63 [15479807.001]
  • [Cites] Cell. 1977 Aug;11(4):933-40 [560916.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8033-7 [8396259.001]
  • [Cites] Genes Dev. 1999 Oct 15;13(20):2738-49 [10541559.001]
  • [Cites] Curr Opin Genet Dev. 1999 Dec;9(6):657-63 [10607616.001]
  • [Cites] Nat Genet. 2000 Jun;25(2):217-22 [10835641.001]
  • [Cites] J Virol. 2000 Sep;74(18):8382-9 [10954538.001]
  • [Cites] Science. 2001 Feb 16;291(5507):1304-51 [11181995.001]
  • [Cites] Nature. 2001 Feb 15;409(6822):860-921 [11237011.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21 [11309499.001]
  • [Cites] Genome Res. 2002 Apr;12(4):656-64 [11932250.001]
  • [Cites] Cell. 2002 Aug 23;110(4):521-9 [12202041.001]
  • [Cites] Genome Res. 2002 Oct;12(10):1483-95 [12368240.001]
  • [Cites] Nature. 2002 Dec 5;420(6915):520-62 [12466850.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 May 13;100(10):5891-5 [12730380.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 May 13;100(10):5586-8 [12732725.001]
  • [Cites] Science. 2003 Jun 13;300(5626):1749-51 [12805549.001]
  • [Cites] Cell. 2003 Oct 17;115(2):135-8 [14567911.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1668-72 [14757818.001]
  • [Cites] Nature. 2004 Apr 1;428(6982):493-521 [15057822.001]
  • [Cites] Science. 1996 Apr 12;272(5259):263-7 [8602510.001]
  • [Cites] Cell. 1998 Jun 26;93(7):1087-9 [9657139.001]
  • [Cites] Curr Biol. 1999 Aug 26;9(16):861-8 [10469592.001]
  • [Cites] PLoS Biol. 2004 Dec;2(12):e423 [15550989.001]
  • [Cites] Nature. 2004 Dec 9;432(7018):695-716 [15592404.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1436-41 [15659548.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1275-6 [15677323.001]
  • [Cites] PLoS Biol. 2004 Aug;2(8):E234 [15314653.001]
  • (PMID = 16140779.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Databank-accession-numbers] GENBANK/ CZ905239/ CZ905240/ CZ905241/ CZ905242/ CZ905243/ CZ905244/ CZ905245/ CZ905246/ CZ905247/ CZ905248/ CZ905249/ CZ905250/ CZ905251/ CZ905252/ CZ905253/ CZ905254/ CZ905255/ CZ905256/ CZ905257/ CZ905258/ CZ905259/ CZ905260/ CZ905261/ CZ905262/ CZ905263/ CZ905264/ CZ905265/ CZ905266/ CZ905267/ CZ905268/ CZ905269/ CZ905270/ CZ905271/ CZ905272/ CZ905273/ CZ905274/ CZ905275/ CZ905276/ CZ905277/ CZ905278/ CZ905279/ CZ905280/ CZ905281/ CZ905282/ CZ905283/ CZ905284/ CZ905285/ CZ905286/ CZ905287/ CZ905288/ CZ905289/ CZ905290/ CZ905291/ CZ905292/ CZ905293/ CZ905294/ CZ905295/ CZ905296/ CZ905297/ CZ905298/ CZ905299/ CZ905300/ CZ905301/ CZ905302/ CZ905303/ CZ905304/ CZ905305/ CZ905306/ CZ905307/ CZ905308/ CZ905309/ CZ905310/ CZ905311/ CZ905312/ CZ905313/ CZ905314/ CZ905315/ CZ905316/ CZ905317/ CZ905318/ CZ905319/ CZ905320/ CZ905321/ CZ905322/ CZ905323/ CZ905324/ CZ905325/ CZ905326/ CZ905327/ CZ905328/ CZ905329/ CZ905330/ CZ905331/ CZ905332/ CZ905333/ CZ905334/ CZ905335/ CZ905336/ CZ905337/ CZ905338/ CZ905339/ CZ905340/ CZ905341/ CZ905342/ CZ905343/ CZ905344/ CZ905345/ CZ905346/ CZ905347/ CZ905348/ CZ905349/ CZ905350/ CZ905351/ CZ905352/ CZ905353/ CZ905354/ CZ905355/ CZ905356/ CZ905357/ CZ905358/ CZ905359/ CZ905360/ CZ905361/ CZ905362/ CZ905363/ CZ905364/ CZ905365/ CZ905366/ CZ905367/ CZ905368/ CZ905369/ CZ905370/ CZ905371/ CZ905372/ CZ905373/ CZ905374/ CZ905375/ CZ905376/ CZ905377/ CZ905378/ CZ905379/ CZ905380/ CZ905381/ CZ905382/ CZ905383/ CZ905384/ CZ905385/ CZ905386/ CZ905387/ CZ905388/ CZ905389/ CZ905390/ CZ905391/ CZ905392/ CZ905393/ CZ905394/ CZ905395/ CZ905396/ CZ905397/ CZ905398/ CZ905399/ CZ905400/ CZ905401/ CZ905402/ CZ905403/ CZ905404/ CZ905405/ CZ905406/ CZ905407/ CZ905408/ CZ905409/ CZ905410/ CZ905411/ CZ905412/ CZ905413/ CZ905414/ CZ905415/ CZ905416/ CZ905417/ CZ905418/ CZ905419/ CZ905420/ CZ905421/ CZ905422/ CZ905423/ CZ905424/ CZ905425/ CZ905426/ CZ905427/ CZ905428/ CZ905429/ CZ905430/ CZ905431/ CZ905432/ CZ905433/ CZ905434/ CZ905435/ CZ905436/ CZ905437/ CZ905438/ CZ905439/ CZ905440/ CZ905441/ CZ905442/ CZ905443/ CZ905444/ CZ905445/ CZ905446/ CZ905447/ CZ905448/ CZ905449/ CZ905450/ CZ905451/ CZ905452/ CZ905453/ CZ905454/ CZ905455/ CZ905456/ CZ905457/ CZ905458/ CZ905459/ CZ905460/ CZ905461/ CZ905462/ CZ905463/ CZ905464/ CZ905465/ CZ905466/ CZ905467/ CZ905468/ CZ905469/ CZ905470/ CZ905471/ CZ905472/ CZ905473/ CZ905474/ CZ905475/ CZ905476/ CZ905477/ CZ905478/ CZ905479/ CZ905480/ CZ905481/ CZ905482/ CZ905483/ CZ905484/ CZ905485/ CZ905486/ CZ905487/ CZ905488/ CZ905489/ CZ905490/ CZ905491/ CZ905492/ CZ905493/ CZ905494/ CZ905495/ CZ905496/ CZ905497/ CZ905498/ CZ905499/ CZ905500/ CZ905501/ CZ905502/ CZ905503/ CZ905504/ CZ905505/ CZ905506/ CZ905507/ CZ905508/ CZ905509/ CZ905510/ CZ905511/ CZ905512/ CZ905513/ CZ905514/ CZ905515/ CZ905516/ CZ905517/ CZ905518/ CZ905519/ CZ905520/ CZ905521/ CZ905522/ CZ905523/ CZ905524/ CZ905525/ CZ905526/ CZ905527/ CZ905528/ CZ905529/ CZ905530/ CZ905531/ CZ905532/ CZ905533/ CZ905534/ CZ905535/ CZ905536/ CZ905537/ CZ905538/ CZ905539/ CZ905540/ CZ905541/ CZ905542/ CZ905543/ CZ905544/ CZ905545/ CZ905546/ CZ905547/ CZ905548/ CZ905549/ CZ905550/ CZ905551/ CZ905552/ CZ905553/ CZ905554/ CZ905555/ CZ905556/ CZ905557/ CZ905558/ CZ905559/ CZ905560/ CZ905561/ CZ905562/ CZ905563/ CZ905564/ CZ905565/ CZ905566/ CZ905567/ CZ905568/ CZ905569/ CZ905570/ CZ905571/ CZ905572/ CZ905573/ CZ905574/ CZ905575/ CZ905576/ CZ905577/ CZ905578/ CZ905579/ CZ905580/ CZ905581/ CZ905582/ CZ905583/ CZ905584/ CZ905585/ CZ905586/ CZ905587/ CZ905588/ CZ905589/ CZ905590/ CZ905591/ CZ905592/ CZ905593/ CZ905594/ CZ905595/ CZ905596/ CZ905597/ CZ905598/ CZ905599/ CZ905600/ CZ905601/ CZ905602/ CZ905603/ CZ905604/ CZ905605/ CZ905606/ CZ905607/ CZ905608/ CZ905609/ CZ905610/ CZ905611/ CZ905612/ CZ905613/ CZ905614/ CZ905615/ CZ905616/ CZ905617/ CZ905618/ CZ905619/ CZ905620/ CZ905621/ CZ905622/ CZ905623/ CZ905624/ CZ905625/ CZ905626/ CZ905627/ CZ905628/ CZ905629/ CZ905630/ CZ905631/ CZ905632/ CZ905633/ CZ905634/ CZ905635/ CZ905636/ CZ905637/ CZ905638/ CZ905639/ CZ905640/ CZ905641/ CZ905642/ CZ905643/ CZ905644/ CZ905645/ CZ905646/ CZ905647/ CZ905648/ CZ905649/ CZ905650/ CZ905651/ CZ905652/ CZ905653/ CZ905654/ CZ905655/ CZ905656/ CZ905657/ CZ905658/ CZ905659/ CZ905660/ CZ905661/ CZ905662/ CZ905663/ CZ905664/ CZ905665/ CZ905666/ CZ905667/ CZ905668/ CZ905669/ CZ905670/ CZ905671/ CZ905672/ CZ905673/ CZ905674/ CZ905675/ CZ905676/ CZ905677/ CZ905678/ CZ905679/ CZ905680/ CZ905681/ CZ905682/ CZ905683/ CZ905684/ CZ905685/ CZ905686/ CZ905687/ CZ905688/ CZ905689/ CZ905690/ CZ905691/ CZ905692/ CZ905693/ CZ905694/ CZ905695/ CZ905696/ CZ905697/ CZ905698/ CZ905699/ CZ905700/ CZ905701/ CZ905702/ CZ905703/ CZ905704/ CZ905705/ CZ905706/ CZ905707/ CZ905708/ CZ905709/ CZ905710/ CZ905711/ CZ905712/ CZ905713/ CZ905714/ CZ905715/ CZ905716/ CZ905717/ CZ905718/ CZ905719/ CZ905720/ CZ905721/ CZ905722/ CZ905723/ CZ905724/ CZ905725/ CZ905726/ CZ905727/ CZ905728/ CZ905729/ CZ905730/ CZ905731/ CZ905732/ CZ905733/ CZ905734/ CZ905735/ CZ905736/ CZ905737/ CZ905738/ CZ905739/ CZ905740/ CZ905741/ CZ905742/ CZ905743/ CZ905744/ CZ905745/ CZ905746/ CZ905747/ CZ905748/ CZ905749/ CZ905750/ CZ905751/ CZ905752/ CZ905753/ CZ905754/ CZ905755/ CZ905756/ CZ905757/ CZ905758/ CZ905759/ CZ905760/ CZ905761/ CZ905762/ CZ905763/ CZ905764/ CZ905765/ CZ905766/ CZ905767/ CZ905768/ CZ905769/ CZ905770/ CZ905771/ CZ905772/ CZ905773/ CZ905774/ CZ905775/ CZ905776/ CZ905777/ CZ905778/ CZ905779/ CZ905780/ CZ905781/ CZ905782/ CZ905783/ CZ905784/ CZ905785/ CZ905786/ CZ905787/ CZ905788/ CZ905789/ CZ905790/ CZ905791/ CZ905792/ CZ905793/ CZ905794/ CZ905795/ CZ905796/ CZ905797/ CZ905798/ CZ905799/ CZ905800/ CZ905801/ CZ905802/ CZ905803/ CZ905804/ CZ905805/ CZ905806/ CZ905807/ CZ905808/ CZ905809/ CZ905810/ CZ905811/ CZ905812/ CZ905813/ CZ905814/ CZ905815/ CZ905816/ CZ905817/ CZ905818/ CZ905819/ CZ905820/ CZ905821/ CZ905822/ CZ905823/ CZ905824/ CZ905825/ CZ905826/ CZ905827/ CZ905828/ CZ905829/ CZ905830/ CZ905831/ CZ905832/ CZ905833/ CZ905834/ CZ905835/ CZ905836/ CZ905837/ CZ905838/ CZ905839/ CZ905840/ CZ905841/ CZ905842/ CZ905843/ CZ905844/ CZ905845/ CZ905846/ CZ905847/ CZ905848/ CZ905849/ CZ905850/ CZ905851/ CZ905852/ CZ905853/ CZ905854/ CZ905855/ CZ905856/ CZ905857/ CZ905858/ CZ905859/ CZ905860/ CZ905861/ CZ905862/ CZ905863/ CZ905864/ CZ905865/ CZ905866/ CZ905867/ CZ905868/ CZ905869/ CZ905870/ CZ905871/ CZ905872/ CZ905873/ CZ905874/ CZ905875/ CZ905876/ CZ905877/ CZ905878/ CZ905879/ CZ905880/ CZ905881/ CZ905882/ CZ905883/ CZ905884/ CZ905885/ CZ905886/ CZ905887/ CZ905888/ CZ905889/ CZ905890/ CZ905891/ CZ905892/ CZ905893/ CZ905894/ CZ905895/ CZ905896/ CZ905897/ CZ905898/ CZ905899/ CZ905900/ CZ905901/ CZ905902/ CZ905903/ CZ905904/ CZ905905/ CZ905906/ CZ905907/ CZ905908/ CZ905909/ CZ905910/ CZ905911/ CZ905912/ CZ905913/ CZ905914/ CZ905915/ CZ905916/ CZ905917/ CZ905918/ CZ905919/ CZ905920/ CZ905921/ CZ905922/ CZ905923/ CZ905924/ CZ905925/ CZ905926/ CZ905927/ CZ905928/ CZ905929/ CZ905930/ CZ905931/ CZ905932/ CZ905933/ CZ905934/ CZ905935/ CZ905936/ CZ905937/ CZ905938/ CZ905939/ CZ905940/ CZ905941/ CZ905942/ CZ905943/ CZ905944/ CZ905945/ CZ905946/ CZ905947/ CZ905948/ CZ905949/ CZ905950/ CZ905951/ CZ905952/ CZ905953/ CZ905954/ CZ905955/ CZ905956/ CZ905957/ CZ905958/ CZ905959/ CZ905960/ CZ905961/ CZ905962/ CZ905963/ CZ905964/ CZ905965/ CZ905966/ CZ905967/ CZ905968/ CZ905969/ CZ905970/ CZ905971/ CZ905972/ CZ905973/ CZ905974/ CZ905975/ CZ905976/ CZ905977/ CZ905978/ CZ905979/ CZ905980/ CZ905981/ CZ905982/ CZ905983/ CZ905984/ CZ905985/ CZ905986/ CZ905987/ CZ905988/ CZ905989/ CZ905990/ CZ905991/ CZ905992/ CZ905993/ CZ905994/ CZ905995/ CZ905996/ CZ905997/ CZ905998/ CZ905999/ CZ906000/ CZ906001/ CZ906002/ CZ906003/ CZ906004/ CZ906005/ CZ906006/ CZ906007/ CZ906008/ CZ906009/ CZ906010/ CZ906011/ CZ906012/ CZ906013/ CZ906014/ CZ906015/ CZ906016/ CZ906017/ CZ906018/ CZ906019/ CZ906020/ CZ906021/ CZ906022/ CZ906023/ CZ906024/ CZ906025/ CZ906026/ CZ906027/ CZ906028/ CZ906029/ CZ906030/ CZ906031/ CZ906032/ CZ906033/ CZ906034/ CZ906035/ CZ906036/ CZ906037/ CZ906038/ CZ906039/ CZ906040/ CZ906041/ CZ906042/ CZ906043/ CZ906044/ CZ906045/ CZ906046/ CZ906047/ CZ906048/ CZ906049/ CZ906050/ CZ906051/ CZ906052/ CZ906053/ CZ906054/ CZ906055/ CZ906056/ CZ906057/ CZ906058/ CZ906059/ CZ906060/ CZ906061/ CZ906062/ CZ906063/ CZ906064/ CZ906065/ CZ906066/ CZ906067/ CZ906068/ CZ906069/ CZ906070/ CZ906071/ CZ906072/ CZ906073/ CZ906074/ CZ906075/ CZ906076/ CZ906077/ CZ906078/ CZ906079/ CZ906080/ CZ906081/ CZ906082/ CZ906083/ CZ906084/ CZ906085/ CZ906086/ CZ906087/ CZ906088/ CZ906089/ CZ906090/ CZ906091/ CZ906092/ CZ906093/ CZ906094/ CZ906095/ CZ906096/ CZ906097/ CZ906098/ CZ906099/ CZ906100/ CZ906101
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI034786; United States / NIAID NIH HHS / AI / R01 AI052845; United States / NIAID NIH HHS / AI / AI34786; United States / NIAID NIH HHS / AI / AI52845
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 9007-49-2 / DNA
  • [Other-IDs] NLM/ PMC1212630
  •  go-up   go-down


64. Chen A, Weber IT, Harrison RW, Leis J: Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat Ends. J Biol Chem; 2006 Feb 17;281(7):4173-82
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat Ends.
  • A separate structural alignment of HIV-1, simian sarcoma virus (SIV), and avian sarcoma virus (ASV) INs predicted which of these residues were unique.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2005 Feb;79(4):2493-505 [15681450.001]
  • [Cites] Biochemistry. 1999 Jun 29;38(26):8458-68 [10387092.001]
  • [Cites] BMC Biol. 2004;2:8 [15153244.001]
  • [Cites] J Comput Aided Mol Des. 2004 Dec;18(12):739-60 [16075307.001]
  • [Cites] Nat Rev Drug Discov. 2005 Mar;4(3):236-48 [15729361.001]
  • [Cites] Nucleic Acids Res. 2005;33(3):977-86 [15718297.001]
  • [Cites] J Biol Chem. 1995 Feb 17;270(7):3320-6 [7852418.001]
  • [Cites] J Virol. 1995 May;69(5):2729-36 [7535863.001]
  • [Cites] Science. 1995 Oct 13;270(5234):253-4 [7569973.001]
  • [Cites] Genes Dev. 1995 Oct 15;9(20):2556-67 [7590235.001]
  • [Cites] Biochemistry. 1996 Mar 26;35(12):3837-44 [8620007.001]
  • [Cites] J Biol Chem. 1996 Mar 29;271(13):7712-8 [8631811.001]
  • [Cites] J Virol. 1996 Jun;70(6):3571-80 [8648691.001]
  • [Cites] J Biol Chem. 1996 Aug 16;271(33):19633-6 [8702660.001]
  • [Cites] Protein Eng. 1996 Aug;9(8):679-90 [8875645.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13659-64 [8942990.001]
  • [Cites] Virology. 1996 Dec 15;226(2):306-17 [8955050.001]
  • [Cites] Biochemistry. 1997 Jan 7;36(1):173-80 [8993331.001]
  • [Cites] Cell. 1997 Feb 21;88(4):483-92 [9038339.001]
  • [Cites] Genes Cells. 1997 Jan;2(1):1-12 [9112436.001]
  • [Cites] Biochemistry. 1997 Sep 2;36(35):10655-65 [9271496.001]
  • [Cites] J Biol Chem. 1997 Sep 19;272(38):23938-45 [9295344.001]
  • [Cites] EMBO J. 1997 Oct 1;16(19):6044-54 [9312061.001]
  • [Cites] EMBO J. 1997 Nov 17;16(22):6849-59 [9362498.001]
  • [Cites] Protein Sci. 1997 Nov;6(11):2365-74 [9385639.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4170-5 [9539708.001]
  • [Cites] J Virol. 1998 Jun;72(6):4841-8 [9573250.001]
  • [Cites] Biochemistry. 1998 May 12;37(19):6667-78 [9578550.001]
  • [Cites] J Virol. 1998 Oct;72(10):8396-402 [9733892.001]
  • [Cites] Biochemistry. 1998 Sep 29;37(39):13835-45 [9753473.001]
  • [Cites] EMBO J. 1998 Oct 1;17(19):5832-43 [9755183.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15270-4 [9860958.001]
  • [Cites] J Virol. 1999 Apr;73(4):2994-3003 [10074149.001]
  • [Cites] Acta Crystallogr D Biol Crystallogr. 1999 Apr;55(Pt 4):938-40 [10089341.001]
  • [Cites] J Biol Chem. 1999 Apr 23;274(17):11904-13 [10207011.001]
  • [Cites] J Virol. 1999 Jun;73(6):5079-88 [10233971.001]
  • [Cites] Adv Virus Res. 1999;52:351-69 [10384242.001]
  • [Cites] Nucleic Acids Res. 2000 Jan 1;28(1):235-42 [10592235.001]
  • [Cites] Science. 2000 Jan 28;287(5453):646-50 [10649997.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):521-33 [10669606.001]
  • [Cites] J Mol Biol. 2000 Feb 18;296(2):535-48 [10669607.001]
  • [Cites] Science. 2000 Jul 7;289(5476):77-85 [10884228.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8233-8 [10890912.001]
  • [Cites] Mol Cells. 2000 Oct 31;10(5):525-32 [11101143.001]
  • [Cites] J Biol Chem. 2000 Dec 15;275(50):39671-7 [11005805.001]
  • [Cites] J Virol. 2001 Feb;75(3):1132-41 [11152486.001]
  • [Cites] J Biol Chem. 2001 Jun 29;276(26):23213-6 [11346660.001]
  • [Cites] EMBO J. 2001 Jul 2;20(13):3565-76 [11432843.001]
  • [Cites] EMBO J. 2001 Dec 17;20(24):7333-43 [11743009.001]
  • [Cites] J Biol Chem. 2002 Mar 29;277(13):10938-48 [11788585.001]
  • [Cites] J Biol Chem. 2002 May 24;277(21):18357-64 [11897790.001]
  • [Cites] J Virol. 2002 Dec;76(23):12376-80 [12414981.001]
  • [Cites] Biopolymers. 2003 Jan;68(1):110-20 [12579583.001]
  • [Cites] J Virol. 2003 Nov;77(21):11459-70 [14557631.001]
  • [Cites] J Virol. 2004 Jun;78(11):5835-47 [15140981.001]
  • [Cites] Science. 2004 Jul 23;305(5683):528-32 [15247437.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11233-8 [15277684.001]
  • [Cites] J Virol. 1989 Dec;63(12):5319-27 [2555556.001]
  • [Cites] Cell. 1990 Aug 24;62(4):829-37 [2167180.001]
  • [Cites] Cell. 1990 Oct 5;63(1):87-95 [2170022.001]
  • [Cites] Acta Crystallogr A. 1991 Mar 1;47 ( Pt 2):110-9 [2025413.001]
  • [Cites] J Virol. 1992 Aug;66(8):5092-5 [1629963.001]
  • [Cites] Annu Rev Biochem. 1992;61:1011-51 [1323232.001]
  • [Cites] J Virol. 1992 Nov;66(11):6257-63 [1328665.001]
  • [Cites] Pharmacol Ther. 1994;61(1-2):185-203 [7938170.001]